{"raw_term": "2,6-sialyl-Sulfo-LN", "normalized_term": "α2-6-sialylated 6-sulfo-LacNAc", "retain": "keep", "synonyms": ["6-sialyl-6-sulfo LN", "α2-6-sialylated 6-sulfo-LacNAc"], "gsd_id": "GSD000002", "glytoucan_id": ["G41145LF"], "term_in_sentence": "The alpha2-6-sialylated 6-sulfo-LacNAc determinant defined by the antibody was significantly expressed on a majority of normal human peripheral B-lymphocytes as well as follicular B-lymphocytes in peripheral lymph nodes.[PMID:17728258]", "definition": "", "publication": ["PMID:17728258"], "term_xref": ["GlycoMotif:GGM.000026"], "function": [{"src": "PMID: 17728258", "content": "B-cell interaction with blood vessels and trafficking"}], "disease_associations": []}
{"raw_term": "2-Fucosyl-GD1b", "normalized_term": "2-fucosyl GD1b", "retain": "keep", "synonyms": [], "gsd_id": "GSD000003", "glytoucan_id": ["G67383AR"], "term_in_sentence": "They were fucosyl-Gv., fucoSyl-GDlb, and two uni que fucogangliosides having GMl or GOlb bas ic structure containing a substituent with the blood group B determinant. [PMID:3654655]", "definition": "(2S,4S,5R,6R)-5-Acetamido-6-[(1S,2R)-2-[(2S,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-2-[(2R,3S,4R,5R,6S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxyoxane-2-carboxylic acid.[CHEBI:156680]", "publication": ["PMID:3654655"], "term_xref": ["CHEBI:156680", "GlycoMotif:GGM.000103"], "function": [], "disease_associations": []}
{"raw_term": "2-Fucosyl-GM1", "normalized_term": "2-fucosyl GM1", "retain": "keep", "synonyms": [], "gsd_id": "GSD000004", "glytoucan_id": ["G56526JU"], "term_in_sentence": "These glycolipid products were identified as asialo-Gs.., GM h and fucosyl-Gq, by comparison with authentic glycolipid samples.[PMID:3654655]", "definition": "(2S,4S,5R,6R)-5-Acetamido-2-[(2R,3S,4R,5R,6S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid.[CHEBI:151476]", "publication": ["PMID:3654655"], "term_xref": ["KEGG:G12241", "CHEBI:151476", "CID:91849786", "GlycoMotif:GGM.000101"], "function": [], "disease_associations": []}
{"raw_term": "3-Sialyl-LN (type 2)", "normalized_term": "3-sialyl LN (type 2)", "retain": "keep", "synonyms": [], "gsd_id": "GSD000005", "glytoucan_id": ["G10203DW"], "term_in_sentence": "Using new crystal structures, we also provide the atomic resolution basis for the differential recognition of 3′ and 6′SiaLacNAc1–4 (with the Galβ1–4 linkage known as Type 2 backbone16; Scheme 1) by TgMIC1-MARR, and make comparisons with the Type 1 chain isomer of 3′SiaLacNAc1–4 (designated 3′SiaLacNAc1–3).[PMID:19593815]", "definition": "A linear amino trisaccharide consisting of α-neuraminyl, β-D-galactosyl and N-acetyl-D-glucosamine residues linked in a (2→3) and (1→4) sequence.[CHEBI:52472]", "publication": ["PMID:19593815", "PMID:15659615", "PMID:2414279", "PMID:8586620", "PMID:2111348", "PMID:23747419"], "term_xref": ["KEGG:G00253", "SugarBind_Ligand:109", "GlycoEpitope:EP0314", "CHEBI:52472", "GlycoMotif:GGM.000034"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:109", "content": "Chronic gastritis"}, {"src": "SugarBind_Ligand:109", "content": "Toxoplasmosis"}, {"src": "SugarBind_Ligand:109", "content": "Peptic ulcers"}, {"src": "SugarBind_Ligand:109", "content": "Gastric cancer"}]}
{"raw_term": "3'-Sulfo-Lewis a", "normalized_term": "3'-sulfo Lewis a", "retain": "keep", "synonyms": ["3'-Sulfo-Lea", "SuLe(a)", "3'-sulpho-Le(a)", "3-O-sulfo-Le(A)", "3'-Sulfo Le^a", "3'-Sulfo Lea", "3'-Sulfo Lewis a"], "gsd_id": "GSD000006", "glytoucan_id": ["G78706CK"], "term_in_sentence": "A remodeling system of the 3'-sulfo-Lewis a and 3'-sulfo-Lewis x epitopes.[PMID:11504739]", "definition": "A branched amino trisaccharide consisting of N-acetylglucosamine having a fucosyl residue attached at the 4-position via an α-linkage and a 3-sulfated galactosyl residue attached at the 3-position via a β-linkage.[CHEBI:65149]", "publication": ["PMID:11504739", "PMID:17499486", "PMID:17691854", "PMID:12944557", "PMID:19394320", "PMID:7534477", "PMID:11604107", "PMID:28025252", "PMID:9061363", "PMID:9878545", "PMID:11918697", "PMID:24239607", "PMID:28628803", "PMID:25339106", "PMID:21400496", "PMID:17998215", "PMID:12626387", "PMID:11425799", "PMID:12219077", "PMID:10955596", "PMID:9453593"], "term_xref": ["GlycoEpitope:EP0009", "CID:5289352", "GlycoMotif:GGM.000030"], "function": [{"src": "GlycoEpitope:EP0009", "content": "SO3-3-Gal and the SO3-3-Lea blood group antigen bound to H.pylori."}], "disease_associations": []}
{"raw_term": "3'-Sulfo-Lewis x", "normalized_term": "3'-sulfo Lewis X", "retain": "keep", "synonyms": ["3'-sulfo-Le(x)", "3'-Sulfo Lewis x", "3'-sulfo Le^x", "3'-sulfo Lex"], "gsd_id": "GSD000007", "glytoucan_id": ["G12295TB"], "term_in_sentence": "A remodeling system of the 3'-sulfo-Lewis a and 3'-sulfo-Lewis x epitopes.[PMID:11504739]", "definition": "An amino trisaccharide that consists of N-acetyl-β-D-glucosamine having an α-L-fucosyl residue attached at position 3 and a 3-sulfated β-D-galactosyl residue attached at position 4; β-D-Galp3S-(1→4)-[α-L-Fucp-(1→3)]-D-GlcpNAc in which the configuration at the anomeric centre of the reducing-end residue is β. [CHEBI:65171]", "publication": ["PMID:11504739", "PMID:20695481", "PMID:8688428", "PMID:10536036", "PMID:12770775", "PMID:11352731", "PMID:9784103", "PMID:9022803"], "term_xref": ["GlycoEpitope:EP0013", "CID:5289353", "CHEBI:65171", "GlycoMotif:GGM.000029"], "function": [], "disease_associations": []}
{"raw_term": "6,6'-bisSulfo-Lewis x", "normalized_term": "6,6′-dissulfo sialyl Lewis X", "retain": "keep", "synonyms": ["6,6'-bissulfo sialyl Lewis X", "6,6'-disulfo sLex"], "gsd_id": "GSD000008", "glytoucan_id": ["G00659GQ"], "term_in_sentence": "Comparison of the reactivity pattern of HEV with the reactivity of the pure 6-sulfo, 6'-sulfo, or 6,6'-bissulfo sialyl Lewis X determinant with hitherto known anti-sialyl Lewis X antibodies strongly suggested 6-sulfo sialyl Lewis X to be the best  candidate for the major sulfated sialyl Lewis X determinant on HEV, followed by 6,6'-bissulfo sialyl Lewis X, whereas 6'-sulfo sialyl Lewis X was unlikely. [PMID:9556613]", "definition": "(2S,4S,5R,6R)-5-Acetamido-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-5-acetamido-6-hydroxy-2-(sulfooxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid.[CHEBI:146095]", "publication": ["PMID:19756298", "PMID:14593101", "PMID:15175329", "PMID:14568956", "PMID:12163379", "PMID:11919403", "PMID:11520459", "PMID:10728707", "PMID:10200296", "PMID:10528213", "PMID:9712885", "PMID:9556613", "PMID:9456330", "PMID:9556613", "PMID:9257857", "PMID:9164959", "PMID:9015359", "PMID:8958810", "PMID:7560094", "PMID:7485559", "PMID:7538131", "PMID:8161542", "PMID:7684905"], "term_xref": ["GlycoEpitope:EP0016", "CHEBI:146095", "GlycoMotif:GGM.000028"], "function": [{"src": "GlycoEpitope:EP0016", "content": "lymphocyte homing"}], "disease_associations": []}
{"raw_term": "6-Sialyl-GalNAc", "normalized_term": "6-sialyl GalNAc", "retain": "keep", "synonyms": ["Sialyl Tn antigen", "6-Sialyl-GalNAc", "6-Sialyl LN", "6-Sialyl LN (type 1)", "6-Sialyl LN (type 2)"], "gsd_id": "GSD000009", "glytoucan_id": ["G08371CD"], "term_in_sentence": "mmunohistochemical distributions of carbohydrate antigens based on the type 2 chain in normal as well as fetal and neoplastic tissues of human gastrointestinal tract were investigated with a monoclonal antibody (MAb) H11 (specific for type 2 chain) alone and in combination with the two MAbs MSG15 (for alpha 2----6 sialylated type 2 chain) and IB9 (for the alpha 2----6 sialylated type 2 chain and glycoproteins having NeuAc alpha 2----6Gal-NAc), and 188C1 (for short- and long-chain Lex antigens) and FH2 (for the long-chain Lex antigen). [PMID: 1618643]", "definition": "An amino disaccharide composed of N-acetylneuraminic acid and 2-(acetylamino)-2-deoxy-D-galactopyranose residues joined by an (α-2→6) glycosidic bond.[CHEBI:146820]", "publication": ["PMID:1618643", "PMID:6194157"], "term_xref": ["GlycoEpitope:EP0352", "KEGG:G00455", "KEGG:G10625", "CHEBI:146820", "CID:11409652", "GlycoMotif:GGM.000035"], "function": [], "disease_associations": []}
{"raw_term": "9-O-Acetyl GD3", "normalized_term": "9-O-acetyl GD3", "retain": "keep", "synonyms": ["acGD3", "9-O-Acetylated GD3", "9-O-Acetyl-GD3", "9-O-Ac-GD3", "CD60b"], "gsd_id": "GSD000012", "glytoucan_id": ["G74121RX"], "term_in_sentence": "To determine whether 9-O-acetyl GD3 (acGD3) has a general antiapoptotic potential, the apoptosis-sensitive Jurkat cell line and an apoptosis-sensitive variant of the cell line Molt-4 were preincubated with micromolar concentrations of acGD3 and then treated with inducers of apoptosis.[PMID:16432837]", "definition": "", "publication": ["PMID:16432837", "PMID:21507905", "PMID:17512674", "PMID:21930212", "PMID:18194438", "PMID:20739294", "PMID:3216430", "PMID:14724245", "PMID:31373393", "PMID:7558412", "PMID:11273644", "PMID:17385751", "PMID:30694652", "PMID:22894715", "PMID:12973826", "PMID:7859075", "PMID:9749956", "PMID:9874495", "PMID:12486096", "PMID:1989525", "PMID:25330147", "PMID:23478187", "PMID:21807667", "PMID:8486686", "PMID:11465673", "PMID:9511990", "PMID:29270199", "PMID:9268945", "PMID:25045067", "PMID:21618115", "PMID:16434401", "PMID:12493756", "PMID:2302705", "PMID:2198284", "PMID:2685488", "PMID:9328574", "PMID:4055789", "PMID:10096568", "PMID:1644805", "PMID:2582447"], "term_xref": ["GlycoEpitope:EP0064", "CID:91852520", "GlycoMotif:GGM.000093"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0064", "content": "pancreas cancer"}]}
{"raw_term": "9-O-Acetyl sialic acid", "normalized_term": "9-O-acetyl sialic acid", "retain": "keep", "synonyms": [], "gsd_id": "GSD000013", "glytoucan_id": ["G47325QT"], "term_in_sentence": "Levels of 9-O-acetyl sialic acid provide a distinct way to define progenitors and thus facilitate the study of hematopoietic differentiation.[PMID:31411667]", "definition": "N-acetyl-9-O-acetyl-alpha-neuraminic acid is a member of the class of N-acetylneuraminic acids that is alpha-neuraminic acid which has acetylated on N-5 and O-9. It has functional parent alpha-neuraminic acid.[CHEBI:84941]", "publication": ["PMID:31411667", "PMID:27936566", "PMID:2509478", "PMID:10049046", "PMID:1826463"], "term_xref": ["GlycoEpitope:EP0065", "CID:13991612", "CHEBI:84941"], "function": [], "disease_associations": []}
{"raw_term": "Alpha-gal antigen", "normalized_term": "alpha-gal antigen", "retain": "keep", "synonyms": ["a-Gal antigen"], "gsd_id": "GSD000016", "glytoucan_id": ["G24432YB"], "term_in_sentence": "Therefore, alpha-gal antigen might be eliminated after a prolonged culture, when using human cells.[PMID:31267683]", "definition": "A glycosylgalactose that consists of β-D-galactose having an α-D-galactosyl residue at the 3-position.[CHEBI:62330]", "publication": ["PMID:31267683", "PMID:29319188", "PMID:29481481", "PMID:26140655", "PMID:30337555", "PMID:29235434", "PMID:22909134", "PMID:28280265", "PMID:7532618", "PMID:23390540", "PMID:22808845", "PMID:29898796", "PMID:22262104", "PMID:31267683", "PMID:25430953", "PMID:22993330", "PMID:23578170", "PMID:21043478", "PMID:28294277", "PMID:27696820", "PMID:15814276", "PMID:17991149", "PMID:25577211", "PMID:30578545", "PMID:19895316", "PMID:28068870", "PMID:18546155", "PMID:32907757", "PMID:26485996", "PMID:9771839", "PMID:12042247", "PMID:27567275", "PMID:12131678", "PMID:23114154", "PMID:19184002", "PMID:29577591", "PMID:29806570", "PMID:15638815", "PMID:21118731"], "term_xref": ["GlycoMotif:GGM.000015", "CID:52939789", "CHEBI:62330"], "function": [{"src": "CHEBI:62330", "content": "Has role as a carbohydrate allergen, epitope or an antigen."}], "disease_associations": []}
{"raw_term": "Alpha-galactosylceramide", "normalized_term": "alpha-galactosylceramide", "retain": "keep", "synonyms": ["alpha-GalCer", "alpha-GalCers", "α-GalCer"], "gsd_id": "GSD000017", "glytoucan_id": [], "term_in_sentence": "From 24 weeks of age, NZB/NZW F1 mice were injected with alpha-galactosylceramide (α-GalCer) or vehicle once a week for four weeks.[PMID:29844470]", "definition": "", "publication": ["PMID:29844470", "PMID:30421497", "PMID:31575643", "PMID:30745361", "PMID:30953000", "PMID:30556652", "PMID:29617191", "PMID:31689579", "PMID:28872688", "PMID:30195979", "PMID:29940370", "PMID:27004737", "PMID:27198610", "PMID:28743554", "PMID:31649670", "PMID:31484693", "PMID:25752588", "PMID:21383248", "PMID:25527277", "PMID:30821985", "PMID:28947140", "PMID:31244823", "PMID:29311431", "PMID:30803854", "PMID:29576533", "PMID:26101952", "PMID:31213291", "PMID:22412194", "PMID:28067024", "PMID:31199716", "PMID:27354638", "PMID:24465013", "PMID:25445911", "PMID:28120096", "PMID:15630427", "PMID:27803187", "PMID:21392534", "PMID:31075434", "PMID:22683545", "PMID:26191196", "PMID:26811064", "PMID:23935988", "PMID:28623127", "PMID:24913977", "PMID:25434827", "PMID:23420533", "PMID:21839133", "PMID:25314062", "PMID:27325450", "PMID:23874157"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Asialo-biantennary", "normalized_term": "asialo-biantennary N-glycan", "retain": "keep", "synonyms": ["asialo diantennary"], "gsd_id": "GSD000018", "glytoucan_id": [], "term_in_sentence": "Typical crystallizable fragment (Fc) glycans attached to the CH2 domain in therapeutic monoclonal antibodies (mAbs) are core-fucosylated and asialo-biantennary complex-type glycans, e.g., G2F (full galactosylation), G1aF (terminal galactosylation on the Man α1-6 arm), G1bF (terminal galactosylation on the Man α1-3 arm), and G0F (non-galactosylation).[PMID:30990348]", "definition": "", "publication": ["PMID:30990348", "PMID:17645671", "PMID:20959391", "PMID:18615430", "PMID:16945378", "PMID:2065054", "PMID:3084472", "PMID:2386787", "PMID:22911097", "PMID:24692304", "PMID:17013932", "PMID:7513972", "PMID:6626573", "PMID:10835250", "PMID:9684342"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Asialo-GM1", "normalized_term": "asialo-GM1", "retain": "keep", "synonyms": ["as-GM1", "GA-1", "Gangliotetraosylceramide", "GgO4", "Gg4", "Asialo-GM1a", "ganglio-N-tetraosylceramide"], "gsd_id": "GSD000019", "glytoucan_id": ["G21856LC"], "term_in_sentence": "We compared the lateral structure of giant unilamellar vesicles (GUVs) composed of three pseudo binary mixtures of different glycosphingolipid (GSL), i.e. sulfatide, asialo-GM1 or GM1, with POPC.[PMID:29106974]", "definition": "", "publication": ["PMID:29106974", "PMID:3418980", "PMID:26975993", "PMID:8613364", "PMID:9288228", "PMID:26710925", "PMID:24922516", "PMID:6839313", "PMID:1828259", "PMID:2581667", "PMID:8210226", "PMID:25062498", "PMID:9671150", "PMID:10377092", "PMID:6171919", "PMID:3093429", "PMID:6652964", "PMID:3124753", "PMID:8905612", "PMID:18788941", "PMID:1467432", "PMID:8225593", "PMID:2083955", "PMID:6171918", "PMID:7806377", "PMID:1802483", "PMID:7927723", "PMID:9209156", "PMID:21174147", "PMID:2584393", "PMID:12137200", "PMID:6175621", "PMID:2936802", "PMID:8610366", "PMID:21490162", "PMID:1548508", "PMID:3486908", "PMID:26453755", "PMID:7910939", "PMID:3756909", "PMID:1639356", "PMID:3259967", "PMID:2443562", "PMID:3112077", "PMID:2572647", "PMID:25137483", "PMID:2168971", "PMID:6950172"], "term_xref": ["GlycoMotif:GGM.000099", "CID:10169040", "GlycoEpitope:EP0047", "CHEBI:59216"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:2", "content": "Pleuropneumonia"}, {"src": "SugarBind_Ligand:2", "content": "Porcine fibrinohemorrhagic necrotizing pleuropneumonia"}, {"src": "SugarBind_Ligand:2", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:2", "content": "Lazy leukocyte syndrome"}, {"src": "SugarBind_Ligand:2", "content": "Pertussis"}, {"src": "SugarBind_Ligand:2", "content": "Cutaneous lesions"}, {"src": "SugarBind_Ligand:2", "content": "Melioidosis"}, {"src": "SugarBind_Ligand:2", "content": "Candidiasis"}, {"src": "SugarBind_Ligand:2", "content": "Taiwan acute respiratory agent"}, {"src": "SugarBind_Ligand:2", "content": "Trachoma"}, {"src": "SugarBind_Ligand:2", "content": "Cystitis"}, {"src": "SugarBind_Ligand:2", "content": "Chronic gastritis"}, {"src": "SugarBind_Ligand:2", "content": "Peptic ulcers"}, {"src": "SugarBind_Ligand:2", "content": "Gastric cancer"}, {"src": "SugarBind_Ligand:2", "content": "Klebsiella pneumonia infection"}, {"src": "SugarBind_Ligand:2", "content": "Pneumonia"}, {"src": "SugarBind_Ligand:2", "content": "Legionnaires' disease"}, {"src": "SugarBind_Ligand:2", "content": "Gonorrhea"}, {"src": "SugarBind_Ligand:2", "content": "Gastroenteritis"}, {"src": "SugarBind_Ligand:2", "content": "Toxoplasmosis"}, {"src": "SugarBind_Ligand:2", "content": "Plague"}, {"src": "SugarBind_Ligand:2", "content": "Diarrhea"}]}
{"raw_term": "B-GM1", "normalized_term": "B-GM1", "retain": "keep", "synonyms": [], "gsd_id": "GSD000021", "glytoucan_id": ["G11485ID"], "term_in_sentence": "The contribution of GM3 and GD3, which accounted for 95% of the ganglioside sialic acid at birth, decreased during the first 3 weeks of life. GM1, fucosyl-GM1, and B-GM1 were not detected at birth. [PMID: 3680254]", "definition": "(2S,4S,5R,6R)-5-Acetamido-2-[(2R,3S,4R,5R,6S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-4-[(2R,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid is a member of neuraminic acids.[CHEBI:147588]", "publication": ["PMID:3680254"], "term_xref": ["GlycoMotif:GGM.000102", "CID:91853157", "CHEBI:147588", "SugarBind_Ligand:181"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:181", "content": "Cholera"}]}
{"raw_term": "Biantennary", "normalized_term": "biantennary N-glycan", "retain": "keep", "synonyms": ["diantennary"], "gsd_id": "GSD000022", "glytoucan_id": [], "term_in_sentence": "We found an efficient isopropylidenation reaction that selectively protects the terminal Gal-3,4-OH of a biantennary complex-type nonasaccharide isolated from a natural source.[PMID:29249147]", "definition": "Type of N-linked glycan in which two antenna are present on the trimannosyl core, each initiated by GlcNAc additions catalyzed by position-specific N-acetylglucosaminyltransferases (GlcNAcTs). Each antenna can be exteneded or capped with HexNAc, deoxyHex, Hex, or sialic acid residues. [Essentials of Glycobiology:Glossary]", "publication": ["PMID:29249147", "PMID:24991291", "PMID:29409839", "PMID:30325416", "PMID:18083109", "PMID:26926155", "PMID:16715395", "PMID:12634321", "PMID:24211369", "PMID:23115267", "PMID:31907993", "PMID:23360551", "PMID:20861009", "PMID:33142198", "PMID:11442281", "PMID:18687680", "PMID:15680603", "PMID:31888963", "PMID:14686925", "PMID:15819890", "PMID:22530754", "PMID:22098756", "PMID:9346821", "PMID:19341309", "PMID:18529007", "PMID:20580347", "PMID:11784152", "PMID:7773775", "PMID:10913832", "PMID:8547276", "PMID:10463590", "PMID:9404657", "PMID:30525457", "PMID:15316280", "PMID:8068637", "PMID:3881425", "PMID:6425277", "PMID:8576139", "PMID:29956878", "PMID:1576211", "PMID:11129583", "PMID:30421263", "PMID:8069634", "PMID:30973186", "PMID:16704415", "PMID:21612260", "PMID:29806066", "PMID:29443078"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Biantennary complex", "normalized_term": "biantennary complex-type N-glycan", "retain": "keep", "synonyms": ["diantennary complex type"], "gsd_id": "GSD000023", "glytoucan_id": [], "term_in_sentence": "The crystal structure of Pterocarpus angolensis lectin is determined in its ligand-free state, in complex with the fucosylated biantennary complex type decasaccharide NA2F, and in complex with a series of smaller oligosaccharide constituents of NA2F.[PMID:16704415]", "definition": "A complex N-glycan that has two branches attached to the non-reducing terminal Man residues of the trimannosyl core. . Each branch is initiated with a GlcNAc and can be exteneded or capped with HexNAc, deoxyHex, Hex, or sialic acid residues. [CHEBI:156251]", "publication": ["PMID:16704415", "PMID:3731182", "PMID:26747427", "PMID:32597008", "PMID:6626573", "PMID:29249147", "PMID:28597152", "PMID:25045879", "PMID:30325416", "PMID:12634321", "PMID:31888963", "PMID:26926155", "PMID:23360551", "PMID:33142198", "PMID:9404657", "PMID:29956878", "PMID:14686925", "PMID:18687680", "PMID:11784152", "PMID:7773775", "PMID:22530754", "PMID:20580347", "PMID:22098756", "PMID:21612260", "PMID:6425277", "PMID:7691595", "PMID:26780731", "PMID:16285669", "PMID:15819890", "PMID:3924097", "PMID:30448401", "PMID:8547276", "PMID:17049014", "PMID:29408873"], "term_xref": ["CHEBI:156251"], "function": [], "disease_associations": []}
{"raw_term": "Blood group A trisaccharide", "normalized_term": "blood group A determinant", "retain": "keep", "synonyms": ["blood group A trisaccharide"], "gsd_id": "GSD000029", "glytoucan_id": ["G00066MO"], "term_in_sentence": "A readily detectable carbohydrate in the urine of two siblings with neuronal ceroid lipofuscinosis was found to be the blood group A trisaccharide.[PMID:7249368]", "definition": "A branched amino trisaccharide consisting of β-D-galactose having an α-L-fucosyl residue at the 2-position and an N-acetyl-α-D-galactosaminyl residue at the 3-position.[CHEBI:61012]", "publication": ["PMID:19582848", "PMID:7249368", "PMID:8774717", "PMID:2749874", "PMID:28771597", "PMID:30619340", "PMID:2122121", "PMID:11886841", "PMID:2991755", "PMID:12588002", "PMID:3149698", "PMID:7048329", "PMID:7015594", "PMID:10359132", "PMID:8724140", "PMID:1418679", "PMID:1446307"], "term_xref": ["GlycoEpitope:EP0255", "CID:49852448", "KEGG:G10638", "CHEBI:61012"], "function": [], "disease_associations": []}
{"raw_term": "Blood group A (Type 1)", "normalized_term": "blood group A type 1", "retain": "keep", "synonyms": ["Blood group A(1)", "blood group A antigen type 1"], "gsd_id": "GSD000030", "glytoucan_id": ["G66163TI"], "term_in_sentence": "he basis of blood group A(1) and A(2) phenotypes has been debated for many decades, and still the chemical basis is unresolved. [PMID:19121199]", "definition": "An α-D-GalpNAc-(1→3)-[α-L-Fucp-(1→2)]-β-D-Galp-(1→3)-D-GlcpNAc having β-configuration at the reducing end anomeric centre.[CHEBI:62485]", "publication": ["PMID:10942408", "PMID:19121199"], "term_xref": ["GlycoMotif:GGM.000044", "GlycoEpitope:EP0256", "CID:53262359", "CHEBI:62485"], "function": [], "disease_associations": []}
{"raw_term": "Blood group A (Type 2)", "normalized_term": "blood group A type 2", "retain": "keep", "synonyms": ["A Type 2", "Blood group A type 2 chain"], "gsd_id": "GSD000014", "glytoucan_id": ["G74353FF"], "term_in_sentence": "One hybridoma antibody (AH16), obtained on immunization with human gastric cancer cell MKN45, was directed to the blood group A determinant carried by both type 1 and type 2 chains. [PMID:6583282]", "definition": "A branched amino tetrasaccharide comprising N-acetyl-β-D-glucosamine at the reducing end with a N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl moiety attached at the 4-position.[CHEBI:62486]", "publication": ["PMID:27196314", "PMID:6583282", "PMID:8340255", "PMID:18701592", "PMID:21901093", "PMID:2413709", "PMID:8036794", "PMID:1615929", "PMID:3285099"], "term_xref": ["CID:53262376", "GlycoEpitope:EP0257", "CHEBI:62486", "GlycoMotif:GGM.000038"], "function": [], "disease_associations": []}
{"raw_term": "Blood group A (Type 3)", "normalized_term": "blood group A type 3", "retain": "keep", "synonyms": ["A type 3 antigen", "blood group A type 3", "A antigen (type 3)"], "gsd_id": "GSD000187", "glytoucan_id": ["G99315PE"], "term_in_sentence": "nan", "definition": "", "publication": ["PMID:7800218", "PMID:17998569", "PMID:19756298", "PMID:3191504"], "term_xref": ["GlycoMotif:GGM.000011"], "function": [], "disease_associations": []}
{"raw_term": "Blood group A (Type 4)", "normalized_term": "blood group A type 4", "retain": "keep", "synonyms": [], "gsd_id": "GSD000028", "glytoucan_id": ["G37830TX"], "term_in_sentence": "Moreover, we have found that αGal, but not αGalNAc, is a weak binder itself for DC-SIGN, which could endow an additional binding mode for the blood group B antigen, but not for blood group A.[PMID:31283166]", "definition": "", "publication": ["PMID:7800218", "PMID:7521740", "PMID:2458640", "PMID:31283166"], "term_xref": ["GlycoMotif:GGM.000088", "CID:91852258", "KEGG:G00474", "CHEBI:150159", "SugarBind_Ligand:48"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:48", "content": "Pyelonephritis"}, {"src": "SugarBind_Ligand:48", "content": "Acute cystitis"}]}
{"raw_term": "Blood group B (Type 1)", "normalized_term": "blood group B type 1", "retain": "keep", "synonyms": ["blood group B type 1 tetrasaccharide"], "gsd_id": "GSD000033", "glytoucan_id": ["G31734OS"], "term_in_sentence": "The minimal binding epitope was identified as the blood group H type 1 determinant (Fucα2Galβ3GlcNAc), while an optimal binding epitope was created by addition of the terminal α3-linked galactose or N-acetylgalactosamine of the blood group B type 1 determinant (Galα3(Fucα2)Galβ3GlcNAc) and the blood group A type 1 determinant (GalNAcα3(Fucα2)-Galβ3GlcNAc). [PMID: 19208633]", "definition": "α-D-Galp-(1→3)-[α-L-Fucp-(1→2)]-β-D-Galp-(1→3)-β-D-GlcpNAc with β configuration at the anomeric carbon of the GlcNAc residue at the reducing end.[CHEBI:63242]", "publication": ["PMID:18701592", "PMID:24749871", "PMID:19387828", "PMID:19208633", "PMID:29562255"], "term_xref": ["GlycoMotif:GGM.000043", "CID:56927779", "CHEBI:63242"], "function": [], "disease_associations": []}
{"raw_term": "Blood group B (Type 2)", "normalized_term": "blood group B type 2", "retain": "keep", "synonyms": ["blood group B type 2"], "gsd_id": "GSD000034", "glytoucan_id": ["G34881WK"], "term_in_sentence": "The detection of a B type 2 determinant is the first chemical evidence for the presence of an autologous difucosyl blood group B type 2 antigen in human adenocarcinoma cells.[PMID:2432062]", "definition": "", "publication": ["PMID:2432062", "PMID:27196314", "PMID:18701592"], "term_xref": ["GlycoMotif:GGM.000037", "GlycoEpitope:EP0262"], "function": [], "disease_associations": []}
{"raw_term": "Blood group B (Type 4)", "normalized_term": "blood group B type 4", "retain": "keep", "synonyms": [], "gsd_id": "GSD000035", "glytoucan_id": ["G25216QA"], "term_in_sentence": "The blood group B type-4 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys.[PMID:1390942]", "definition": "", "publication": ["PMID:1390942", "PMID:1841684"], "term_xref": ["GlycoMotif:GGM.000087"], "function": [], "disease_associations": []}
{"raw_term": "Blood group H (Type 1)", "normalized_term": "blood group H type 1", "retain": "keep", "synonyms": ["H type 1"], "gsd_id": "GSD000036", "glytoucan_id": ["G00294TN"], "term_in_sentence": "Blood group H type 1 [Fuc alpha (1,2)Gal beta (1,3)GlcNAc beta--&gt;] is known as the precursor structure of the blood group determinant, Lewis b [Fuc alpha (1,2)Gal beta (1,3)(Fuc alpha (1,4))GlcNAc beta--&gt;].[PMID:7718581]", "definition": "", "publication": ["PMID:7718581", "PMID:6309836", "PMID:19208633", "PMID:27431816", "PMID:2432062", "PMID:24219248", "PMID:6352465", "PMID:8499478", "PMID:3348768", "PMID:3718924"], "term_xref": ["GlycoMotif:GGM.000042", "SugarBind_Ligand:153"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:153", "content": "Gastroenteritis"}]}
{"raw_term": "Blood group H (Type 2)", "normalized_term": "blood group H type 2", "retain": "keep", "synonyms": ["Blood group H (type 2)", "H type 2", "H type 2 chain", "H type 2 antigen", "type 2 chain H", "blood group H type II"], "gsd_id": "GSD000037", "glytoucan_id": ["G70519XK"], "term_in_sentence": "We have examined the immunohistochemical distribution of H Type 1 and of H Type 2 substances of the ABO blood group system in human submandibular gland using either of the two anti-H monoclonal antibodies MAb 1E3 and MAb 3A5. MAb 3A5 was specific for H Type 2, and MAb 1E3 reacted with each of H Type 1-H Type 4 artificial antigens.[PMID:9405495]", "definition": "", "publication": ["PMID:9405495", "PMID:8082855", "PMID:6177241", "PMID:3944092", "PMID:21406562", "PMID:2410664", "PMID:8731502", "PMID:6203846", "PMID:2238560"], "term_xref": ["GlycoMotif:GGM.000036"], "function": [], "disease_associations": []}
{"raw_term": "Blood group H (Type 3)", "normalized_term": "blood group H type 3", "retain": "keep", "synonyms": ["H type 3", "H antigen (type 3)", "Type 3 chain H"], "gsd_id": "GSD000105", "glytoucan_id": ["G94435QH"], "term_in_sentence": "One particular lambody, VLRB.aGPA.23, was shown by glycan array analysis to be selective for the blood group H type 3 trisaccharide (BG-H3, Fucα1-2Galβ1-3GalNAcα), aGPA, and TFα (Galβ1-3GalNAcα), with affinity constants of 0.2, 1, and 8 nM, respectively.[PMID:23030719]", "definition": "", "publication": ["PMID:23030719", "PMID:20466654", "PMID:1563908", "PMID:3944092", "PMID:11218748", "PMID:11101633", "PMID:18842005", "PMID:27550195", "PMID:2469783", "PMID:2433836", "PMID:23118206", "PMID:8445257", "PMID:2664192", "PMID:3063304"], "term_xref": ["GlycoMotif:GGM.000010"], "function": [], "disease_associations": []}
{"raw_term": "Blood group H (Type 4)", "normalized_term": "blood group H type 4", "retain": "keep", "synonyms": [], "gsd_id": "GSD000039", "glytoucan_id": ["G98465JN"], "term_in_sentence": "In addition, the blood group H type 4 chain structure was present together with Le(a) and Le(b) compounds.[PMID:1841684]", "definition": "An amino hexasaccharide consisting of α-L-fucose, β-D-galactose, N-acetyl-α-D-galactosamine, α-D-galactose, β-D-galactose and β-D-glucose residues joined in sequence with (1→2)-, (1→3)-, (1→3)-, (1→4)- and (1→4)-linkages, respectively.[CHEBI:65245]", "publication": ["PMID:11261842", "PMID:1841684", "PMID:11101633", "PMID:9405495"], "term_xref": ["GlycoMotif:GGM.000086", "CID:10260428", "SugarBind_Ligand:61", "CHEBI:65245"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:61", "content": "Pyelonephritis"}]}
{"raw_term": "Chondroitin sulfate", "normalized_term": "chondroitin sulfate", "retain": "keep", "synonyms": ["chondroitin polysulfate", "chondroitin sulfate", "chondroitin sulfates", "chondroitin sulfuric acid", "chondroitin sulphate", "Chondroitinsulfate"], "gsd_id": "GSD000043", "glytoucan_id": [], "term_in_sentence": "The industrial production of chondroitin sulfate (CS) uses animal tissue sources as raw material derived from different terrestrial or marine species of animals.[PMID: 31013685]", "definition": "Any of a class of 10‚Äî60 kDa glycosaminoglycan sulfates, widely distributed in cartilage and other mammalian connective tissues.[CHEBI:37397]", "publication": ["PMID:31013685", "PMID:27526113", "PMID:27194526", "PMID:26980567", "PMID:28847361", "PMID:24413804", "PMID:29891297", "PMID:29600622", "PMID:25129732", "PMID:31317901", "PMID:29181550", "PMID:31250530", "PMID:22265655", "PMID:25756648", "PMID:29402610", "PMID:17928217", "PMID:20236040", "PMID:28091940", "PMID:30824935", "PMID:26572336", "PMID:31207331", "PMID:21110089", "PMID:30599999", "PMID:20399897", "PMID:27226567", "PMID:19388612", "PMID:23186102", "PMID:31494830", "PMID:28982096", "PMID:30241863", "PMID:30295666", "PMID:25366475", "PMID:20521042", "PMID:29456007", "PMID:31304829", "PMID:18661362", "PMID:28576008", "PMID:29494632", "PMID:30016441", "PMID:26906924", "PMID:24861964", "PMID:23774590", "PMID:31887904", "PMID:31339761", "PMID:12512856", "PMID:26957048", "PMID:29625000"], "term_xref": ["CHEBI:37397", "CID:24766"], "function": [], "disease_associations": []}
{"raw_term": "Chondroitin sulfate/dermatan sulfate", "normalized_term": "chondroitin sulfate/dermatan sulfate", "retain": "keep", "synonyms": ["CS/DS", "chondroitin/dermatan sulfate"], "gsd_id": "GSD000184", "glytoucan_id": [], "term_in_sentence": "Heparan sulfate (HS) and chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans are heavily glycosylated proteins, crucial for animal development and homeostasis. [PMID:35192612]", "definition": "", "publication": ["PMID:35192612", "PMID:35425970"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Complex-type N-glycans", "normalized_term": "complex-type N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000045", "glytoucan_id": [], "term_in_sentence": "In this study, 32 new complex-type glycans are characterized containing the Le(x), Le(Y), and sialyl-Le(x) determinants, the bloodgroup A and H antigens, as well as the ALe(Y) determinant.[PMID:10988252]", "definition": "Type of N-linked glycan in which at least two antenna are present on the trimannosyl core, each initiated by GlcNAc additions catalyzed by position-specific N-acetylglucosaminyltransferases (GlcNAcTs). Each antenna can be exteneded or capped with HexNAc, deoxyHex, Hex, or sialic acid residues.", "publication": ["PMID:29902282", "PMID:29212795", "PMID:29343819", "PMID:27705835", "PMID:26745022", "PMID:18399796", "PMID:16825488", "PMID:21964725", "PMID:15864431", "PMID:22890903", "PMID:12417032", "PMID:28039392", "PMID:19426135", "PMID:30253927", "PMID:16794314", "PMID:19806620", "PMID:22975979", "PMID:25931033", "PMID:15201278", "PMID:1912963419129628", "PMID:24032650", "PMID:22530754", "PMID:31021709", "PMID:30973186", "PMID:28091941", "PMID:23115339", "PMID:20829342", "PMID:27304954", "PMID:29090617", "PMID:21802690", "PMID:29725121", "PMID:30471292", "PMID:16581187", "PMID:26098720", "PMID:31080188", "PMID:1930135", "PMID:31888963", "PMID:30844485", "PMID:24014058", "PMID:11129583"], "term_xref": [], "function": [{"src": "PMID:12417032", "content": "Involved in protein stability."}], "disease_associations": []}
{"raw_term": "Core 1", "normalized_term": "core 1 O-glycan", "retain": "keep", "synonyms": ["C1G"], "gsd_id": "GSD000186", "glytoucan_id": ["G00031MO"], "term_in_sentence": "O-glycans are initiated by the addition of GalNAc to serine or threonine (via the ppGalNAcT family of glycosyltransferases), forming the Tn antigen (GalNAcα-O-Ser/Thr), which is used to generate the core 1 structure (Galβ1,3GalNAcα-O-Ser/Thr) on which most complex and branched O-glycans are derived. [PMID:31645367]", "definition": "", "publication": ["PMID:31645367", "PMID:32297877"], "term_xref": ["GlycoMotif:GGM.001005"], "function": [], "disease_associations": []}
{"raw_term": "Core 2", "normalized_term": "core 2 O-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000046", "glytoucan_id": ["G00033MO"], "term_in_sentence": "To investigate the biological roles of core 2 O-glycans, we produced and characterized mice deficient in one or more of the three known glycosyltransferases that generate core 2 O-glycans (C2GnT1, C2GnT2, and C2GnT3).[PMID: 19349303]", "definition": "The trisaccharide β-D-Gal-(1→3)-[β-D-GlcNAc-(1→6)]-D-GalNAc with α configuration at the anomeric centre of the N-acetylglucosamine residue at the reducing end.[CHEBI:62158]", "publication": ["PMID:19349303", "PMID:30315106", "PMID:23640779", "PMID:26677400"], "term_xref": ["CID:52921656", "CHEBI:62158"], "function": [], "disease_associations": []}
{"raw_term": "Core 3", "normalized_term": "core 3 O-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000047", "glytoucan_id": ["G00035MO"], "term_in_sentence": "Mechanically, we revealed that mucin-type core 3 O-glycan was synthesized at the membrane-tethered MUC1 N terminus because of core 3 synthase expression in colon cancer cells.[PMID: 28745318]", "definition": "An amino disaccharide comprising an N-acetyl-β-D-glucosamine residue linked (1→3) to an N-acetyl-β-D-galactosamine residue at the reducing end.[CHEBI:71344]", "publication": ["PMID:28745318", "PMID:27259834", "PMID:27143302"], "term_xref": ["CID:25061208", "CHEBI:71344"], "function": [], "disease_associations": []}
{"raw_term": "Core 4", "normalized_term": "core 4 O-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000048", "glytoucan_id": ["G00037MO"], "term_in_sentence": "The results confirm the predicted existence of a beta1,6GlcNAc-transferase that functions in both core 2 and core 4 O-glycan branch formation.[PMID: 9988682]", "definition": "A branched amino trisaccharide comprising an N -acetyl-α-D-galactosamine residue at the reducing end, to which are (1→3)- and (1→6)-linked two N -acetyl-α-D-glucosamine residues.[CHEBI:71341]", "publication": ["PMID:9988682", "PMID:10747980"], "term_xref": ["CID:25229562", "CHEBI:71341"], "function": [], "disease_associations": []}
{"raw_term": "Core-fucosylated", "normalized_term": "core-fucose", "retain": "keep", "synonyms": ["Core Fuc", "6-linked Fuc", "Fuca6 to chitobiose core", "a6-linked Fuc", "a1-6 Fuc", "Fuca6 to chitobiose core", "Fuc a1-6 to chitobiose core", "Fuca6 to internal GlcNAc", "Fuc a1-6 to internal GlcNAc"], "gsd_id": "GSD000049", "glytoucan_id": ["G78059CC"], "term_in_sentence": "The approach was validated for selective capture and analysis of core fucosylated N-glycans present in complex glycan mixtures derived from mammalian serum IgG.[PMID:27678371]", "definition": "Modification of the N-glycan core structure with fucose moiety attached at the innermost GlcNAc by FUT8 enzyme. Core Fuc is found on paucimannose, hybrid and complex type N-glycans. [https://doi.org/10.1016/bs.acr.2014.11.006].", "publication": ["PMID:27678371", "PMID:26514868", "PMID:15538974", "PMID:24914453", "PMID:17049014", "PMID:32078267", "PMID:31268672", "PMID:28674882", "PMID:29956878", "PMID:27798819", "PMID:32044029", "PMID:30962950", "PMID:31548313", "PMID:30907281", "PMID:29090617", "PMID:29571940", "PMID:28800497", "PMID:27629418", "PMID:29733746", "PMID:31623829", "PMID:28768188", "PMID:26897254", "PMID:31451706", "PMID:26514868", "PMID:29427759", "PMID:28982386", "PMID:26587313", "PMID:30940702", "PMID:15538974", "PMID:31249452", "PMID:27282921", "PMID:31229844", "PMID:30445455", "PMID:31325506", "PMID:24732908", "PMID:29209018", "PMID:26965517", "PMID:28609658", "PMID:24914453", "PMID:25573275", "PMID:17049014", "PMID:19218400", "PMID:27012207", "PMID:27139574", "PMID:32078267", "PMID:25861849", "PMID:32561391", "PMID:21374780", "PMID:31669139", "PMID:25732060", "PMID:29408166", "PMID:31268672", "PMID:30472795", "PMID:30614075", "PMID:19003000", "PMID:25664929"], "term_xref": ["CID:70679232", "CHEBI:70967", "CHEBI:156499"], "function": [{"src": "PMID: 29434598", "content": "Required for signaling through TCR"}, {"src": "PMID:17132494", "content": "VGF, PDGFr, and EGFr and TGFbeta receptor dysregulation in Fut8 KO mice"}, {"src": "PMID:29062024", "content": "IgG-Fcg receptor interactions destabilized by core Fuc"}], "disease_associations": [{"src": "unknown", "content": "Emphysema"}, {"src": "unknown", "content": "systemic lupus erythematosuslung cancer"}, {"src": "unknown", "content": "autoimmunity"}, {"src": "unknown", "content": "tumor metastasis"}]}
{"raw_term": "Core-fucosylated biantennary", "normalized_term": "core-fucosylated biantennary N-glycan", "retain": "keep", "synonyms": ["core-fucosylated diantennary"], "gsd_id": "GSD000050", "glytoucan_id": ["G78059CC"], "term_in_sentence": "The IFN-alpha14c N-glycans were shown to exhibit core-fucosylated biantennary glycans , with about 10% carrying an additional alpha1,3-linked fucose unit at the antennae.[PMID:9654101]", "definition": "A biantennary glycan with two GlcNAc branches linked to the core and fucosylation on the core GlcNAc.", "publication": ["PMID:9654101", "PMID:15819890", "PMID:28263871", "PMID:26763099", "PMID:22256781", "PMID:23681398", "PMID:25855029", "PMID:10529240", "PMID:26544759", "PMID:8206921", "PMID:33149259", "PMID:8547276"], "term_xref": ["CID:70679232", "CHEBI:70967", "CHEBI:156499"], "function": [], "disease_associations": []}
{"raw_term": "Core-fucosylated biantennary complex-type", "normalized_term": "core-fucosylated biantennary complex-type N-glycan", "retain": "keep", "synonyms": ["core fucosylated diantennary complex-type"], "gsd_id": "GSD000051", "glytoucan_id": ["G78059CC"], "term_in_sentence": "The oligosaccharide structure at Asn(32 ) is a mixture of the monosialo and asialo forms of a core fucosylated biantennary complex-type oligosaccharide.[PMID:10731668]", "definition": "A biantennary complex glycan with two GlcNAc branches linked to the core and fucosylation on the core GlcNAc.", "publication": ["PMID:10731668"], "term_xref": ["CID:70679232", "CHEBI:70967", "CHEBI:156499"], "function": [], "disease_associations": []}
{"raw_term": "Cytolipin R", "normalized_term": "Cytolipin R", "retain": "keep", "synonyms": [], "gsd_id": "GSD000053", "glytoucan_id": ["G57710SU"], "term_in_sentence": "The reaction can be inhibited completely by pure cytolipin R showing that (a) immune hemolysis can be mediated through lipid determinants in the membrane, and (b) that cytolipin R determinants are present in the intact erythrocyte membrane and exposed on the surface.[PMID:4110375]", "definition": "A ceramide tetrahexoside isolated from rat lymphosarcoma. The structure of cytolipin R to be N-acetylgalactosaminyl(beta1--&gt;3)galactosyl(alpha1--&gt;3) galactosyl(beta1--&gt;4)glucosyl ceramide.[PMID:5068000]", "publication": ["PMID:893368", "PMID:4375678", "PMID:51702", "PMID:186204", "PMID:4110375", "PMID:5068000", "PMID:24174198", "PMID:6072378", "PMID:389925", "PMID:7054174"], "term_xref": ["GlycoMotif:GGM.000083", "CID:91855936", "KEGG:G00392", "CHEBI:152175", "SugarBind_Ligand:17"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:17", "content": "Actinomycosis"}]}
{"raw_term": "Dermatan sulfate", "normalized_term": "dermatan sulfate", "retain": "keep", "synonyms": ["beta-Heparin", "Chondroitin sulfate B", "Dermatan L-iduronate"], "gsd_id": "GSD000054", "glytoucan_id": [], "term_in_sentence": "By utilizing sophisticated separation methods followed by compositional analysis, domain mapping, and tandem mass spectrometry coupled with analysis by a modified genetic algorithm approach, the structural motif for the decorin dermatan sulfate chain was determined.[PMID:29111696]", "definition": "Any of a group of glycosaminoglycans with repeating units consisting of variously sulfated β1→4-linked L-iduronyl-(α1→3)-N-acetyl-D-galactosamine units.[CHEBI:18376]", "publication": ["PMID:27526113", "PMID:29111696", "PMID:29891297", "PMID:26164146", "PMID:30869126", "PMID:7789716", "PMID:8597249", "PMID:12512856", "PMID:31250530", "PMID:17928217", "PMID:12213784", "PMID:27226567", "PMID:31455633", "PMID:28091940", "PMID:19075609", "PMID:31071403", "PMID:15078125", "PMID:18661328", "PMID:20581662", "PMID:17239765", "PMID:15749837", "PMID:2777747", "PMID:20632047", "PMID:8930750", "PMID:7762784", "PMID:31006321", "PMID:26876822", "PMID:1522290", "PMID:131009", "PMID:26986023", "PMID:8161353", "PMID:15315969", "PMID:12543559", "PMID:30637950", "PMID:2525357", "PMID:18156656", "PMID:9692613", "PMID:9200333", "PMID:19661164", "PMID:2299256", "PMID:16075147", "PMID:1126924", "PMID:9774430", "PMID:8537360", "PMID:15563459", "PMID:21077227", "PMID:23275130", "PMID:17137817", "PMID:6447930", "PMID:6209270"], "term_xref": ["CHEBI:18376", "CID:32756"], "function": [{"src": "Essentials of Glycobiology:Chapter 7", "content": "Wound healing"}, {"src": "Essentials of Glycobiology:Chapter 41", "content": "maintain the structure of the dermis."}], "disease_associations": []}
{"raw_term": "Desialylated", "normalized_term": "desialylated glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000055", "glytoucan_id": [], "term_in_sentence": "Furthermore, we found no evidence for \"desialylated\" apoB100 glycans in any of the samples analyzed.[PMID:11588155]", "definition": "A glycan from which sialyl groups have been removed. [https://en.wiktionary.org/wiki/desialylated]", "publication": ["PMID:30015642", "PMID:26168491", "PMID:29492899", "PMID:31774586", "PMID:32321401", "PMID:23780974", "PMID:7600681", "PMID:18045697", "PMID:1450583", "PMID:4137057", "PMID:28911304", "PMID:27562992", "PMID:29950245", "PMID:31978220", "PMID:2408573", "PMID:8612720", "PMID:10910970", "PMID:27195066", "PMID:1434544", "PMID:22175031", "PMID:24517196", "PMID:29794068", "PMID:30101537", "PMID:18972200", "PMID:1478792", "PMID:4440781", "PMID:21229239", "PMID:30844664", "PMID:31351722", "PMID:31330845", "PMID:1872910"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Difucosylated tetra-antennary N-glycans", "normalized_term": "difucosylated tetraantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000057", "glytoucan_id": [], "term_in_sentence": "While fucosylated N-glycans derived from serum haptoglobin of patients with CP slightly increased, di-fucosylated tetra-antennary N-glycans were observed only at this site in PC patients, and were absent in the haptoglobin of normal controls and individuals with CP.[PMID:18214858]", "definition": "The tetra-antennary N-linked glycans that have four GlcNAc branches linked to the core and two fucose added.", "publication": ["PMID:18214858"], "term_xref": [], "function": [], "disease_associations": [{"src": "PMID:18214858", "content": "pancreatic cancer"}]}
{"raw_term": "Dimeric Lewis x", "normalized_term": "dimeric Lewis x", "retain": "keep", "synonyms": ["DimLex^x", "dimeric Le(x)", "Lex-Lex", "diLe(x)", "Lewisx-Lewisx"], "gsd_id": "GSD000058", "glytoucan_id": ["G79535HZ"], "term_in_sentence": "The carbohydrate antigen dimeric Lewis X (DimLex), which accumulates in colonic and liver adenocarcinomas, is a valuable target to develop anti-cancer therapeutics.[PMID:32957489]", "definition": "A six-membered glucosamine oligosaccharide consisting of two repeating units of β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc joined by a (1→3)-linkage.[CHEBI:61325]", "publication": ["PMID:32957489", "PMID:31276881", "PMID:12062524", "PMID:15488731", "PMID:1979361", "PMID:8737237", "PMID:17939723", "PMID:7683631", "PMID:11384108", "PMID:11133015", "PMID:17388629", "PMID:15483381", "PMID:12662048", "PMID:3233598", "PMID:18618154", "PMID:21892456"], "term_xref": ["GlycoEpitope:EP0093", "CID:50909845", "CHEBI:61325", "GlycoMotif:GGM.000031"], "function": [{"src": "GlycoEpitope:EP0093", "content": "cancer-associated antigen"}], "disease_associations": [{"src": "GlycoEpitope:EP0093", "content": "colonic cancer"}, {"src": "GlycoEpitope:EP0093", "content": "liver cancer"}]}
{"raw_term": "Diphosphorylated Man6", "normalized_term": "diphosphorylated Man6", "retain": "keep", "synonyms": ["Diphosphorylated Man_6"], "gsd_id": "GSD000059", "glytoucan_id": ["G54792LL"], "term_in_sentence": "Here we report that the single-chain variable domain (scFv) M6P-1 is a unique antibody fragment with specificity for Man6P monosaccharide that, through an array-screening approach against a number of phosphorylated N-glycans, is shown to bind mono- and diphosphorylated Man6 and Man7 glycans that contain terminal αMan6P(1 → 2)αMan(1 → 3)αMan.[PMID:26503547]", "definition": "", "publication": ["PMID:26503547"], "term_xref": ["GlycoMotif:GGM.000054"], "function": [], "disease_associations": []}
{"raw_term": "Disialosyl globopentaosylceramide", "normalized_term": "disialosyl globopentaosylceramide", "retain": "keep", "synonyms": ["DSGb5", "Disialosyl Gb5", "V3NeuAcIV6NeuAc-Gb5Cer", "Disialosylgalactosylgloboside"], "gsd_id": "GSD000060", "glytoucan_id": ["G97932OH"], "term_in_sentence": "Disialosyl globopentaosylceramide (DSGb5) is often expressed by renal cell carcinomas.[PMID:31339142]", "definition": "Disialosyl globopentaosylceramide (DSGb5) is a ganglioside originally isolated from tissue extracts of renal cell carcinoma (RCC) with metastasis.[PMID:28205070]", "publication": ["PMID:31339142", "PMID:24637536", "PMID:25864532", "PMID:27344728", "PMID:12084983", "PMID:32567311", "PMID:28205070", "PMID:20663960", "PMID:18214042"], "term_xref": ["GlycoMotif:GGM.000082", "GlycoEpitope:EP0098", "CID:91860287", "KEGG:G00181", "SugarBind_Ligand:57"], "function": [{"src": "PMID:28205070", "content": "promotes metastasis"}], "disease_associations": [{"src": "PMID:24637536", "content": "prostate cancer"}, {"src": "GlycoEpitope:EP0098", "content": "renal cell carcinoma/RCC"}, {"src": "SugarBind_Ligand:57", "content": "Pyelonephritis"}]}
{"raw_term": "Disialyl Lewis a", "normalized_term": "disialyl Lewis a", "retain": "keep", "synonyms": ["disialyl Lea"], "gsd_id": "GSD000063", "glytoucan_id": ["G93400AK"], "term_in_sentence": "Biosynthesis of disialyl Lewis a (Lea) was analyzed using previously cloned ST6GalNAc V and ST6GalNAc VI, which were responsible for the synthesis of alpha-series gangliosides.[PMID:12668675]", "definition": "Disialyl Lewis is a sialyl Lewis a with an additional sialic acid attached at the C-6 position of penultimate GlcNAc. [PMID:15231659]", "publication": ["PMID:12668675", "PMID:17760270", "PMID:15231659", "PMID:12668106", "PMID:30716533", "PMID:32050430", "PMID:22467657"], "term_xref": ["GlycoEpitope:EP0040", "CID:91854138", "CHEBI:155549"], "function": [{"src": "GlycoEpitope:EP0040", "content": "The 2-3,2-6 disialyl Lea determinant on epithelial cells may play a role in protecting normal epithelial cells."}], "disease_associations": [{"src": "GlycoEpitope:EP0040", "content": "Mucin antigen carrying 2-3 sialylated Le a antigen or 2-3, 2-6 disialylated Lc4 antigen in cancer patients had the lowest carbohydrate/protein ratio. Thus, the carbohydrate/protein ratio in the type 1 chain mucin antigens in sera of normal subjects is higher than that in sera of cancer patients."}]}
{"raw_term": "Disialyl T antigen", "normalized_term": "disialyl T antigen", "retain": "keep", "synonyms": ["di-sialyl T antigen", "disialyl-T antigen", "disialylated T-antigen"], "gsd_id": "GSD000064", "glytoucan_id": ["G01614ZM"], "term_in_sentence": "The most potent glycoside was disialyl T antigen (NeuAcalpha2-3Galbeta1-3[NeuAcalpha2-6]GalNAc-R), followed by 3-sialyl T antigen (NeuAcalpha2-3Galbeta1-3GalNAc-R), structures expressed on O-linked glycoproteins as well as on gangliosides.[PMID: 15701648]", "definition": "α-Neup5Ac-(2→6)-[α-Neup5Ac-(2→3)-β-D-Galp-(1→3)]-α-D-GalpNAc in which the anomeric configuration of the reducing-end N-acetyl-D-glucosamine residue is α.[CHEBI:71602]", "publication": ["PMID:29113555", "PMID:17974963", "PMID:33242079", "PMID:12645620", "PMID:15701648", "PMID:26598643"], "term_xref": ["GlycoMotif:GGM.000014", "CID:70698317", "CHEBI:71602", "GlycoEpitope:EP0023", "KEGG:G00027"], "function": [{"src": "GlycoEpitope:EP0023", "content": "associated with von Willebrand factor(VWF) plasma levels"}], "disease_associations": []}
{"raw_term": "Disialylated fucosylated", "normalized_term": "disialylated fucosylated glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000067", "glytoucan_id": [], "term_in_sentence": "Disialylated fucosylated and monosialylated non-fucosylated oligosaccharides were also identified.[PMID:17591618]", "definition": "A fucosylated glycan with two sialic acid components.", "publication": ["PMID:17591618"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Forssman glycolipid", "normalized_term": "Forssman glycolipid", "retain": "keep", "synonyms": ["Forssman antigen", "Globopentosylceramide"], "gsd_id": "GSD000069", "glytoucan_id": ["G80062GG"], "term_in_sentence": "Analysis of metabolically labeled glycolipids released into the apical and basal culture medium, either as shed membrane vesicles or in budding viruses, also demonstrated the presence of the Forssman glycolipid on both apical and basolateral membranes of polarized cells.[PMID:3040119]", "definition": "A linear amino pentasaccharide comprising N-acetyl-α-D-galactosamine, N-acetyl-β-D-galactosamine, α-D-galactose, β-D-galactose and β-D-glucose residues linked sequentially (1→3), (1→3), (1→4) and (1→4).[CHEBI:85789]", "publication": ["PMID:3040119", "PMID:268649", "PMID:23240079", "PMID:28134301", "PMID:3495590", "PMID:1138893", "PMID:10460829", "PMID:10506200", "PMID:8855242", "PMID:1955453", "PMID:1933935", "PMID:3355161", "PMID:6773959", "PMID:14573676", "PMID:29898878", "PMID:10431785", "PMID:1747956", "PMID:11214737", "PMID:7423202", "PMID:389939", "PMID:3871816", "PMID:6187373", "PMID:16133832", "PMID:469271", "PMID:3753492", "PMID:2695680", "PMID:7037611", "PMID:25703376", "PMID:23798992", "PMID:414913", "PMID:1868069", "PMID:7960243"], "term_xref": ["GlycoMotif:GGM.000084", "CID:91825690", "KEGG:G00095", "CHEBI:85789", "GlycoEpitope:EP0037", "SugarBind_Ligand:86"], "function": [{"src": "PMID:3495590", "content": "an antigenic marker for a major subpopulation of macrophages from murine spleen and peripheral lymph nodes"}], "disease_associations": [{"src": "SugarBind_Ligand:86", "content": "Pyelonephritis"}, {"src": "SugarBind_Ligand:86", "content": "Acute cystitis"}]}
{"raw_term": "Fucose-containing tetraantennary", "normalized_term": "fucosylated tetraantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000070", "glytoucan_id": [], "term_in_sentence": "The two major N-linked oligosaccharides of Namalwa EPO were fucose-containing tetraantennary and fucose-containing triantennary structures.[PMID:2550193]", "definition": "A tetraantennary glycan with four GlcNAc branches linked to the core and the addition of fucose.", "publication": ["PMID:2550193"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Fucosyl GM1", "normalized_term": "fucosyl GM1", "retain": "keep", "synonyms": [], "gsd_id": "GSD000071", "glytoucan_id": ["G91532KA"], "term_in_sentence": "Unique localization of fucosyl GM1 implicates its possible role in cell adhesion and recognition in the nervous system.[PMID:8068725]", "definition": "A branched amino hexasaccharide consisting of the linear sequence α-L-Fuc-(1→2)-β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-β-D-Gal-(1→4)-D-Glc having a Neu5Ac residue attached to the inner galactose via an α-(2→3) linkage.[CHEBI:62686]", "publication": ["PMID:6619101", "PMID:16880505", "PMID:9089399", "PMID:29789847", "PMID:8068725", "PMID:19556222", "PMID:1660040", "PMID:2420639", "PMID:9076515", "PMID:15926079", "PMID:19555091", "PMID:2541996", "PMID:16211870", "PMID:1336587", "PMID:21174147", "PMID:14967068", "PMID:18923900", "PMID:30021910", "PMID:16941490", "PMID:27070150", "PMID:8305235", "PMID:10602885", "PMID:2645049", "PMID:7993838", "PMID:10537341", "PMID:3002616", "PMID:8336147", "PMID:15447995", "PMID:8905401", "PMID:11714535", "PMID:9260862", "PMID:32228455", "PMID:3315641", "PMID:8076384", "PMID:2317201", "PMID:3680254", "PMID:6403518"], "term_xref": ["GlycoEpitope:EP0049", "CID:53356699", "CHEBI:62686"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0049", "content": "small-cell lung cancer(SCLC)"}, {"src": "GlycoEpitope:EP0049", "content": "hepatoma"}]}
{"raw_term": "Fucosylated asialo-biantennary", "normalized_term": "fucosylated asialo-biantennary N-glycan", "retain": "keep", "synonyms": ["fucosylated asialo-diantennary"], "gsd_id": "GSD000072", "glytoucan_id": [], "term_in_sentence": "We found that approximately 63% of the total N-linked oligosaccharides were of the complex type, with bisialo-biantennary (28%), asialo-biantennary (7%), fucosylated bisialo-biantennary (25%), and fucosylated asialo-biantennary (3%) oligosaccharides representing the major complex-type carbohydrate species.[PMID:2065054]", "definition": "Describing a biantennary oligosaccharide that has no sialic acid component but has fucose.", "publication": ["PMID:2065054", "PMID:17013932"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Fucosylated biantennary", "normalized_term": "fucosylated biantennary N-glycan", "retain": "keep", "synonyms": ["fucosylated bisialo-diantennary"], "gsd_id": "GSD000073", "glytoucan_id": [], "term_in_sentence": "The profiles of the PSA N-glycans from the free and complexed molecules were quite similar to each other and consisted of fucosylated biantennary oligosaccharides as the major class.[PMID:17956937]", "definition": "a biantennary glycan with two GlcNAc branches linked to the core and the addition of fucose.", "publication": ["PMID:17956937", "PMID:30525457", "PMID:1933856"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Fucosylated bisialo-biantennary", "normalized_term": "fucosylated disialo-biantennary N-glycan", "retain": "keep", "synonyms": ["fucosylated disialo-biantennary"], "gsd_id": "GSD000074", "glytoucan_id": [], "term_in_sentence": "We found that approximately 63% of the total N-linked oligosaccharides were of the complex type, with bisialo-biantennary (28%), asialo-biantennary (7%), fucosylated bisialo-biantennary (25%), and fucosylated asialo-biantennary (3%) oligosaccharides representing the major complex-type carbohydrate species.[PMID:2065054]", "definition": "Describing a biantennary oligosaccharide that has two sialic acid component and fucose added.", "publication": ["PMID:2065054"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Fucosylated LDN", "normalized_term": "fucosylated lacdiNAc", "retain": "keep", "synonyms": ["LDNF", "Fucosylated lacdiNAc", "LDN-F", "(GalNAc)1 (GlcNAc)1 (LFuc)1"], "gsd_id": "GSD000075", "glytoucan_id": ["G02240AO"], "term_in_sentence": "To date, oligomeric LDN and oligomeric fucosylated LDN (LDNF) have been found only on N-glycans from mammalian cells engineered to express Caenorhabditis elegansbeta4-GalNAc transferase and human alpha3-fucosyltransferase IX [Z. S. Kawar et al. (2005) J Biol Chem280, 12810-12819]. [PMID:16403022]", "definition": "An amino trisaccharide comprising an acetamido-β-D-galactose and an α-L-fucose attached to an acetamidoglucose by 1→4 and 1→3 linkages, respectively.[CHEBI:61864]", "publication": ["PMID:16403022", "PMID:28151933", "PMID:19545571", "PMID:22448293"], "term_xref": ["GlycoMotif:GGM.000017", "GlycoEpitope:EP0151", "CID:52921591", "CHEBI:61864", "MeSH:C488538", "KEGG:G01594"], "function": [], "disease_associations": []}
{"raw_term": "Fucosylated N-glycans", "normalized_term": "fucosylated N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000076", "glytoucan_id": [], "term_in_sentence": "Haptoglobin , an acute phase protein , has four potential N-glycosylation sites , although it remains unknown which site is responsible for the change in fucosylated N-glycans.[PMID:18214858]", "definition": "The fucose from GDP-fucose is transferred to N-linked glycans.", "publication": ["PMID:18214858", "PMID:31141660", "PMID:26869352", "PMID:29790113", "PMID:31931062"], "term_xref": [], "function": [], "disease_associations": [{"src": "PMID: 26869352", "content": "pancreatic cancer."}]}
{"raw_term": "Fucosylated triantennary", "normalized_term": "fucosylated triantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000077", "glytoucan_id": [], "term_in_sentence": "Asn184 is only partially glycosylated and substituted by fucosylated triantennary and small amounts of diantennary N-acetyllactosaminic glycans.[PMID:2513186]", "definition": "A triantennary glycan with three GlcNAc branches linked to the core and the addition of fucose.", "publication": ["PMID:2513186", "PMID:29642865", "PMID:7679920", "PMID:31110965", "PMID:2551687", "PMID:15051952", "PMID:12943224"], "term_xref": [], "function": [{"src": "PMID: 7679920", "content": "appears in human alpha-fetoprotein (AFP)."}], "disease_associations": [{"src": "PMID: 7679920 ", "content": "neoplastic diseases of the liver"}, {"src": "unknown", "content": "hepatocellular carcinoma[PMID: 7679920]."}]}
{"raw_term": "Galabiosylceramide", "normalized_term": "galabiosylceramide", "retain": "keep", "synonyms": [], "gsd_id": "GSD000078", "glytoucan_id": ["G67988RO"], "term_in_sentence": "LacCer and its structural isomer, galabiosylceramide (Gb2, Galβ(1,4)Galβ-ceramide), are classified as ceramide dihexosides (CDH).[PMID:33360824]", "definition": "A disaccharide consisting of β-D-galactopyranose having a D-galactopyranosyl residue attached at the 4-position via an α-linkage.[CHEBI:59314]", "publication": ["PMID:33360824", "PMID:29099167", "PMID:25582508", "PMID:2824515", "PMID:4027258", "PMID:32854306", "PMID:32868283", "PMID:31319156", "PMID:29530250", "PMID:27367163", "PMID:2564247", "PMID:27727434", "PMID:10216186", "PMID:10460829", "PMID:24992926", "PMID:23590301", "PMID:15702404", "PMID:1854798", "PMID:14761135", "PMID:3600200", "PMID:8603914", "PMID:8601603", "PMID:1965141", "PMID:17400502", "PMID:3840690", "PMID:15959771", "PMID:7930586", "PMID:7721812", "PMID:17095952", "PMID:2500499", "PMID:3815386", "PMID:8842706", "PMID:10746023", "PMID:3928791", "PMID:3782065", "PMID:6440894"], "term_xref": ["GlycoEpitope:EP0113", "CID:5288350", "KEGG:G00497", "KEGG:G10645", "CHEBI:59314"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0113", "content": "tumor/lung"}, {"src": "GlycoEpitope:EP0113", "content": "tumor/gallbladder"}, {"src": "GlycoEpitope:EP0113", "content": "tumor/kidney"}, {"src": "GlycoEpitope:EP0113", "content": "tumor/pancreas"}]}
{"raw_term": "Galactosylceramide", "normalized_term": "galactosylceramide", "retain": "keep", "synonyms": ["GalCer", "Galactocerebroside", "LC"], "gsd_id": "GSD000079", "glytoucan_id": ["G65889KE"], "term_in_sentence": "Galactosylceramide improved behavioral, neuropathological, and biochemical parameters in Cln3 Cln3 Δex7/8 mice, paving the way for effective therapy for CLN3 disease and use of serum ceramide as a potential biomarker to track impact of therapies.[PMID:31393621]", "definition": "", "publication": ["PMID:31393621", "PMID:19941861", "PMID:9883654", "PMID:33006978", "PMID:26735924", "PMID:22032265", "PMID:18035062", "PMID:25129050", "PMID:2802541", "PMID:1761517", "PMID:28660574", "PMID:475780", "PMID:2302222"], "term_xref": ["GlycoEpitope:EP0074", "SugarBind_Ligand:1", "GlycoMotif:GGM.000061"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:1", "content": "Pleuropneumonia"}, {"src": "SugarBind_Ligand:1", "content": "Porcine fibrinohemorrhagic necrotizing pleuropneumonia"}, {"src": "SugarBind_Ligand:1", "content": "Lyme disease"}, {"src": "SugarBind_Ligand:1", "content": "Plague"}, {"src": "SugarBind_Ligand:1", "content": "Acquired immune deficiency syndrome"}]}
{"raw_term": "Gb5", "normalized_term": "Gb5", "retain": "keep", "synonyms": ["Globopentaosylceramide"], "gsd_id": "GSD000081", "glytoucan_id": ["G99053DY"], "term_in_sentence": "LnbB, a member of the glycoside hydrolase family 20 isolated from Bifidobacterium bifidum, was shown to release GNB from Gb5 and GA1 oligosaccharides.[PMID:25839135]", "definition": "A linear amino pentasaccharide comprising D-glucose at the reducing end with a β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl moiety at the 4-position.[CHEBI:141842]", "publication": ["PMID:12401210", "PMID:25839135", "PMID:31540393", "PMID:31140679", "PMID:3028540", "PMID:3674263", "PMID:31339142", "PMID:30026902", "PMID:10721708", "PMID:30671362", "PMID:26176557", "PMID:25039255", "PMID:24044869", "PMID:32567311", "PMID:27857717", "PMID:21491978", "PMID:24910250", "PMID:29077212", "PMID:8014006", "PMID:27107335", "PMID:32679486", "PMID:1747956", "PMID:8679447", "PMID:28352526", "PMID:11341836", "PMID:10837462", "PMID:7960243", "PMID:16158941", "PMID:3297853", "PMID:2431136", "PMID:21734356", "PMID:8625206", "PMID:30732055", "PMID:12716912", "PMID:20128040", "PMID:2582447", "PMID:14659673"], "term_xref": ["GlycoMotif:GGM.000076", "CID:53239691", "KEGG:G00097", "CHEBI:62311", "SugarBind_Ligand:12"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:12", "content": "Pyelonephritis"}, {"src": "unknown", "content": "Actinomycosis[SugarBind_Ligand:12"}, {"src": "SugarBind_Ligand:12", "content": "Influenza"}]}
{"raw_term": "GD1", "normalized_term": "GD1", "retain": "keep", "synonyms": ["GD1c"], "gsd_id": "GSD000082", "glytoucan_id": ["G81983KG"], "term_in_sentence": "Hormonal and metabolic disturbances observed in both adult and paediatric patients with Gaucher disease type 1 (GD1) are discussed in this review. The PubMed database was used to identify articles on endocrine and metabolic disorders in GD1.[PMID:31791361]", "definition": "", "publication": ["PMID:5652802", "PMID:25345088", "PMID:31791361", "PMID:29361370", "PMID:31234327", "PMID:30264864", "PMID:25250137", "PMID:7528216", "PMID:31669751", "PMID:20684311", "PMID:16306603", "PMID:10420586", "PMID:7766692", "PMID:31614613", "PMID:26384672", "PMID:31613991", "PMID:19210136", "PMID:8926633", "PMID:29696051", "PMID:32300455", "PMID:7513313", "PMID:26674302", "PMID:20336376", "PMID:24259734", "PMID:31704237", "PMID:21067946", "PMID:30516933", "PMID:27979707", "PMID:26345314", "PMID:30516941", "PMID:31849452", "PMID:27789132", "PMID:30218706", "PMID:29388611", "PMID:20177787"], "term_xref": ["GlycoMotif:GGM.000105", "CID:91859783", "KEGG:G00126"], "function": [], "disease_associations": []}
{"raw_term": "GD1a", "normalized_term": "GD1a", "retain": "keep", "synonyms": ["GD1alpha"], "gsd_id": "GSD000083", "glytoucan_id": ["G46677TE", "G45714BQ"], "term_in_sentence": "Exclusive exposure of rat oligodendrocytes to GD1a, but not other gangliosides, overcomes aggregated fibronectin-induced inhibition of myelin membrane formation, in vitro, and OPC differentiation in fibronectin aggregate containing cuprizone-induced demyelinated lesions in male mice. [PMID: 28899916]", "definition": "A branched amino hexasaccharide consisting of the linear sequence α-Neu5Ac-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-β-D-Gal-(1→4)-β-D-Glc having a Neu5Ac residue attached to a galactose via an α-(2→3) linkage. The oligosaccharide of ganglioside GD1a.[CHEBI:59209]", "publication": ["PMID:28899916", "PMID:26860251", "PMID:21930390", "PMID:32906699", "PMID:26054879", "PMID:29951721", "PMID:11745410", "PMID:17653976", "PMID:26119566", "PMID:21554929", "PMID:18435913", "PMID:15342262", "PMID:26865725", "PMID:21151139", "PMID:15716397", "PMID:21492147", "PMID:16942752", "PMID:26973195", "PMID:24449473", "PMID:14999485", "PMID:22735313", "PMID:20589721", "PMID:10521808", "PMID:22929125", "PMID:7827024", "PMID:16897174", "PMID:25062498", "PMID:17227759"], "term_xref": ["GlycoMotif:GGM.000106", "GlycoMotif:GGM.000107", "CID:45266861", "CHEBI:59209", "GlycoEpitope:EP0056", "SugarBind_Ligand:22", "KEGG:G00111"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:22", "content": "Gastroenteritis"}, {"src": "SugarBind_Ligand:22", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:22", "content": "Lazy leukocyte syndrome"}, {"src": "SugarBind_Ligand:22", "content": "Toxoplasmosis"}, {"src": "SugarBind_Ligand:22", "content": "Lyme disease"}, {"src": "SugarBind_Ligand:22", "content": "Botulism"}, {"src": "SugarBind_Ligand:22", "content": "Keratoconjunctivitis"}, {"src": "SugarBind_Ligand:22", "content": "Influenza"}]}
{"raw_term": "GD1b", "normalized_term": "GD1b", "retain": "keep", "synonyms": [], "gsd_id": "GSD000084", "glytoucan_id": ["G37184KW"], "term_in_sentence": "Gangliosides have been known to play a role in the regulation of apoptosis in cancer cells. This study has employed disialyl-ganglioside GD1b to apoptosis in human breast cancer MCF-7 cells using exogenous treatment of the cells with GD1b and endogenous expression of GD1b in MCF-7 cells.[PMID: 27144558]", "definition": "A branched amino hexasaccharide comprising a β-D-galactosyl-(1→4)-β-D-glucose disaccharide, the galactosyl residue of which carries β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl and N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl disaccharide units through (2→4) and (2→3) linkages respectively. It is the carbohydrate portion of ganglioside GD1b.[CHEBI:59222]", "publication": ["PMID:27144558", "PMID:24859332", "PMID:18625966", "PMID:7945223", "PMID:32518172", "PMID:26710925", "PMID:31837178", "PMID:20594196", "PMID:30985655", "PMID:11511306", "PMID:1742806", "PMID:11123278", "PMID:7685064", "PMID:2709011", "PMID:33279873", "PMID:22929125", "PMID:9179156", "PMID:17964572", "PMID:8821498", "PMID:32726962", "PMID:26560950", "PMID:2611779", "PMID:10072058", "PMID:20030259", "PMID:16415013", "PMID:10797556", "PMID:11342695", "PMID:8619520", "PMID:21519903", "PMID:16199892", "PMID:23777091", "PMID:30246056", "PMID:10481046"], "term_xref": ["GlycoMotif:GGM.000108", "CID:45266846", "CHEBI:59222", "GlycoEpitope:EP0059", "SugarBind_Ligand:14"], "function": [], "disease_associations": []}
{"raw_term": "GD2", "normalized_term": "GD2", "retain": "keep", "synonyms": [], "gsd_id": "GSD000085", "glytoucan_id": ["G02657AK"], "term_in_sentence": "Ganglioside GD2 is a tumor-associated surface antigen found in a broad spectrum of human cancers and stem cells. [PMID: 25440605]", "definition": "A branched amino pentasaccharide consisting of a linear sequence of two α-sialyl residues, a β-D-galactosyl residue and an N-acetyl-β-D-glucosamine residue linked respectively (2→8), (2→8) and (1→4), to the galactosyl residue of which is also linked (1→4) an N-acetyl-β-D-glucosaminyl residue. It is the carbohydrate portion of ganglioside GD2.[CHEBI:59218]", "publication": ["PMID:28154831", "PMID:32002293", "PMID:32733795", "PMID:28145567", "PMID:31500597", "PMID:31903906", "PMID:29180536", "PMID:28415563", "PMID:25440605", "PMID:30617136", "PMID:25604432", "PMID:30198960", "PMID:31075227", "PMID:31721713", "PMID:30955398", "PMID:32195035", "PMID:27304202", "PMID:31015228", "PMID:31653037", "PMID:31016728", "PMID:30670592", "PMID:30613134", "PMID:29221154", "PMID:30027525", "PMID:29442009", "PMID:31762628", "PMID:30485077", "PMID:25642322", "PMID:29436609", "PMID:29151270", "PMID:24773917", "PMID:30612272", "PMID:27654028", "PMID:26298772"], "term_xref": ["GlycoMotif:GGM.000094", "CID:45266844", "CHEBI:59218", "GlycoEpitope:EP0061", "SugarBind_Ligand:88"], "function": [], "disease_associations": [{"src": "PMID:28415563", "content": "breast cancer"}]}
{"raw_term": "GD3", "normalized_term": "GD3", "retain": "keep", "synonyms": [], "gsd_id": "GSD000086", "glytoucan_id": ["G98544DH"], "term_in_sentence": "In mammalian cells, the intracellular accumulation of ganglioside GD3, an acidic glycosphingolipid, contributes to mitochondrial damage, a crucial event during the apoptopic program. [PMID: 12531552]", "definition": "A linear amino tetrasaccharide consisting of two sialyl, one galactose and one glucose residue (at the reducing end) connected by sequential α-(2→8)-, α-(2→3)- and β-(1→4)-linkages. The oligosaccharide of ganglioside GD3.[CHEBI:59210]", "publication": ["PMID:30245960", "PMID:27591028", "PMID:12531552", "PMID:29069780", "PMID:12470841", "PMID:29436609", "PMID:28295752", "PMID:27304202", "PMID:31138648", "PMID:27288875", "PMID:30446565", "PMID:8721669", "PMID:3903474", "PMID:16081368", "PMID:32743804", "PMID:24372645", "PMID:26792897", "PMID:20890432", "PMID:25330147", "PMID:20581115", "PMID:11174200", "PMID:16040804", "PMID:23783008", "PMID:17368571", "PMID:11023989", "PMID:12901230", "PMID:21807667", "PMID:7061953", "PMID:2231782", "PMID:19423750", "PMID:22632091", "PMID:18202973", "PMID:6392333", "PMID:15896784", "PMID:8261439", "PMID:20052288", "PMID:12847141", "PMID:12486096", "PMID:12118012", "PMID:19912988", "PMID:22795094", "PMID:18655184", "PMID:17043769", "PMID:21395555", "PMID:2472199", "PMID:19776077"], "term_xref": ["GlycoMotif:GGM.000091", "CID:45266862", "CHEBI:59210", "GlycoEpitope:EP0062", "SugarBind_Ligand:89", "MeSH:C509062"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:89", "content": "Cholera"}, {"src": "SugarBind_Ligand:89", "content": "Influenza"}]}
{"raw_term": "Globoside", "normalized_term": "globoside", "retain": "keep", "synonyms": ["Cytolipin K", "Gb4", "Globoside I", "Globotetraosylceramide", "P antigen"], "gsd_id": "GSD000087", "glytoucan_id": ["G00061MO"], "term_in_sentence": "Results of TLC immunostaining of neutral glycolipids from the cDNA-transfected cells also supported the identity of the newly synthesized component as globoside. [PMID:10993897]", "definition": "", "publication": ["PMID:10993897"], "term_xref": ["GlycoMotif:GGM.000070"], "function": [], "disease_associations": []}
{"raw_term": "Globotetraosylceramide", "normalized_term": "globotetraosylceramide", "retain": "keep", "synonyms": ["Gb4Cer", "Gb4", "Globoside", "P antigen", "Cytolipin K"], "gsd_id": "GSD000088", "glytoucan_id": ["G00061MO"], "term_in_sentence": "Here we report that PUGNAc treatment provokes globotetraosylceramide (Gb4Cer) accumulation in human umbilical vein endothelial cells (HUVEC).[PMID:28392398]", "definition": "An amino tetrasaccharide consisting of 2-acetamido-2-deoxy-β-D-galactopyranosyl, α-D-galactopyranosyl, β-D-galactopyranosyl, and β-D-glucopyranose units joined together in sequence by (1→3), (1→4), and (1→4) glycosidic linkages, respectively.[CHEBI:145578]", "publication": ["PMID:28392398", "PMID:25787850", "PMID:23471986", "PMID:2559078", "PMID:32455599", "PMID:2663859", "PMID:32796033", "PMID:3517161", "PMID:20082214", "PMID:30853699", "PMID:15279935", "PMID:26104834", "PMID:20732996", "PMID:30224239", "PMID:31142708", "PMID:30338271", "PMID:25033755", "PMID:30413389", "PMID:7104376", "PMID:29866658", "PMID:24983355", "PMID:6794884", "PMID:31361021", "PMID:21740983", "PMID:33168837", "PMID:31752441", "PMID:28123520", "PMID:29068380", "PMID:24841197", "PMID:27932383", "PMID:28535204", "PMID:31691795", "PMID:27916888", "PMID:27558838", "PMID:10227680", "PMID:26464281", "PMID:22348006", "PMID:22279060", "PMID:25156739", "PMID:32314902", "PMID:22718629", "PMID:23701631", "PMID:23906628", "PMID:8613382", "PMID:23555772", "PMID:20059899", "PMID:7868240"], "term_xref": ["GlycoMotif:GGM.000070", "GlycoEpitope:EP0073", "CID:5288889", "CHEBI:145578", "SugarBind_Ligand:18", "MeSH:C024032"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:18", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:18", "content": "Pyelonephritis"}, {"src": "SugarBind_Ligand:18", "content": "Acute cystitis"}, {"src": "SugarBind_Ligand:18", "content": "Shigellosis"}, {"src": "SugarBind_Ligand:18", "content": "Lazy leukocyte syndrome"}, {"src": "SugarBind_Ligand:18", "content": "Influenza"}]}
{"raw_term": "Globotriaosylceramide", "normalized_term": "globotriaosylceramide", "retain": "keep", "synonyms": ["Gb3", "GL3", "Pk antigen", "P^K antigen", "Gb(3)", "Gb_3", "CD77", "globotriaosylceramide", "ceramide trihexoside", "CTH", "Trihexosylceramide"], "gsd_id": "GSD000089", "glytoucan_id": ["G00059MO"], "term_in_sentence": "Defects in the gene encoding α-galactosidase A lead to accumulation of globotriaosylceramide (GL3) in various cell types.[PMID:32127409]", "definition": "Globotriaosylceramide is a type of globoside(glycosphingolipid) which is formed by alpha linkage of galactose to lactosylceramide. The reaction is catalyzed by enzyme A4GALT.[Wiki:Globotriaosylceramide]", "publication": ["PMID:32127409", "PMID:28674962", "PMID:30875019", "PMID:30413389", "PMID:31778662", "PMID:31101366", "PMID:24335674", "PMID:31241709", "PMID:24158513", "PMID:28947349", "PMID:31566927", "PMID:28672034", "PMID:31939530", "PMID:29530250", "PMID:27851774", "PMID:26426881", "PMID:25031264", "PMID:29982630", "PMID:24496231", "PMID:29983334", "PMID:28756410", "PMID:27190352", "PMID:29274327", "PMID:29099167", "PMID:28402705", "PMID:23680766", "PMID:28625968", "PMID:26960552", "PMID:26797827", "PMID:22742555", "PMID:27756537", "PMID:31630715", "PMID:3827883", "PMID:28384397", "PMID:29523338", "PMID:31010832", "PMID:27195818", "PMID:26661087", "PMID:23093409", "PMID:30879639", "PMID:27081853", "PMID:17409683", "PMID:29921669", "PMID:25575293", "PMID:26291612", "PMID:23146289", "PMID:25857295", "PMID:26070511"], "term_xref": ["GlycoMotif:GGM.000068", "GlycoEpitope:EP0071", "CID:5279515", "CHEBI:68485", "MeSH:C018549", "SugarBind_Ligand:27"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:27", "content": "Pyelonephritis"}, {"src": "SugarBind_Ligand:27", "content": "Acute cystitis"}, {"src": "SugarBind_Ligand:27", "content": "Shigellosis"}, {"src": "SugarBind_Ligand:27", "content": "Lyme disease"}, {"src": "SugarBind_Ligand:27", "content": "Cutaneous lesions"}, {"src": "SugarBind_Ligand:27", "content": "Diarrhea"}]}
{"raw_term": "Glucosylceramide", "normalized_term": "glucosylceramide", "retain": "keep", "synonyms": ["GlcCer", "Glucocerebroside", "Ceramide monohexoside", "CMH"], "gsd_id": "GSD000090", "glytoucan_id": ["G71142DF"], "term_in_sentence": "Glucosylceramide (GlcCer), the initial GSL synthesized from ceramide by GCS (GlcCer synthase), is required for embryonic survival, but its role in the lung is unknown.[PMID:31265321]", "definition": "Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher's disease.[MeSH:D005963]", "publication": ["PMID:31265321", "PMID:29290548", "PMID:29627573", "PMID:20919653", "PMID:28427052", "PMID:30550553", "PMID:24415933", "PMID:31914593", "PMID:31051284", "PMID:23073611", "PMID:30146946", "PMID:31619618", "PMID:26840726", "PMID:29750412", "PMID:8065509", "PMID:27412675", "PMID:27840079", "PMID:30611744", "PMID:31353719", "PMID:25661072", "PMID:28686011", "PMID:25803043", "PMID:28865794", "PMID:28154347", "PMID:31466334", "PMID:30242129", "PMID:12531551", "PMID:30639288", "PMID:30864417", "PMID:27711049", "PMID:22764777", "PMID:27905603", "PMID:29077010", "PMID:28744000", "PMID:23555901", "PMID:24115322", "PMID:12803919", "PMID:29204666", "PMID:23628459", "PMID:28851512", "PMID:26136173", "PMID:23563543", "PMID:30110701", "PMID:26572681", "PMID:2193825", "PMID:29926415", "PMID:31727994", "PMID:27479571"], "term_xref": ["MeSH:D005963", "GlycoMotif:GGM.000060", "CHEBI:83264"], "function": [{"src": "PMID:30611744", "content": "The structural characterization of mixed membranes made of cationic lipids and glucosylceramides may be important for developing novel immunotherapeutic tools such as vaccine adjuvants."}, {"src": "PMID:31265321", "content": "Glucosylceramide (GlcCer), the initial GSL synthesized from ceramide by GCS (GlcCer synthase), is required for embryonic survival, but its role in the lung is unknown."}], "disease_associations": [{"src": "unknown", "content": "Gaucher's Disease"}, {"src": "SugarBind_Ligand:3", "content": "Pharyngitis"}, {"src": "SugarBind_Ligand:3", "content": "Tracheobronchitis"}, {"src": "SugarBind_Ligand:3", "content": "Pleuropneumonia"}, {"src": "SugarBind_Ligand:3", "content": "Porcine fibrinohemorrhagic necrotizing pleuropneumonia"}, {"src": "SugarBind_Ligand:3", "content": "Diarrhea"}]}
{"raw_term": "GM1", "normalized_term": "GM1", "retain": "keep", "synonyms": ["GM1 ganglioside", "GM1-ganglioside"], "gsd_id": "GSD000091", "glytoucan_id": ["G48558GR"], "term_in_sentence": "GM1-induced fluidization of the phospholipid membranes and probable physical contact between bulky sugar head group of GM1 and spectrin, may explain the modulatory role of GM1 on aminophospholipid interactions with nonerythroid brain spectrin.[PMID: 29920238]", "definition": "A branched amino pentasaccharide consisting of the linear sequence β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-β-D-Gal-(1→4)-β-D-Glc having a Neu5Ac residue attached to the inner galactose via an α-(2→3) linkage. The oligosaccharide of ganglioside GM1a.[CHEBI:59208]", "publication": ["PMID:18524657", "PMID:31761138", "PMID:36180805", "PMID:29920238", "PMID:33859490", "PMID:31937438", "PMID:25762012", "PMID:25931034", "PMID:31776384", "PMID:32013258", "PMID:30776097", "PMID:31048748", "PMID:31447771", "PMID:30292198", "PMID:28796418", "PMID:27806275", "PMID:21076871", "PMID:27552916", "PMID:17986147", "PMID:26960162", "PMID:27815022", "PMID:25851126", "PMID:32916822", "PMID:11462671", "PMID:28236574", "PMID:15911874", "PMID:28577204", "PMID:28497346", "PMID:1794005", "PMID:31934908", "PMID:30267299", "PMID:16902585", "PMID:29439846", "PMID:32325905", "PMID:29747823", "PMID:27576485", "PMID:26338710", "PMID:27858734", "PMID:24501414", "PMID:26818965", "PMID:26629687", "PMID:26958633", "PMID:1854596", "PMID:32134593", "PMID:32198666", "PMID:6619101"], "term_xref": ["GlycoMotif:GGM.000098", "CID:196569", "CHEBI:59208", "GlycoEpitope:EP0050", "SugarBind_Ligand:13", "KEGG:G00110"], "function": [{"src": "PMID:16267866", "content": "The branched pentasaccharide chain of ganglioside GM1 is a prominent cell surface ligand, for example, for cholera toxin or tumor growth-regulatory homodimeric galectins."}], "disease_associations": [{"src": "PMID: 33859490", "content": "GM1 gangliosidosis (GM1)"}, {"src": "SugarBind_Ligand:13", "content": "Gastroenteritis"}, {"src": "SugarBind_Ligand:13", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:13", "content": "Lazy leukocyte syndrome"}, {"src": "SugarBind_Ligand:13", "content": "Toxoplasmosis"}, {"src": "SugarBind_Ligand:13", "content": "Cholera"}, {"src": "SugarBind_Ligand:13", "content": "Botulism"}]}
{"raw_term": "GM2", "normalized_term": "GM2", "retain": "keep", "synonyms": [], "gsd_id": "GSD000092", "glytoucan_id": ["G79389NT"], "term_in_sentence": "GM1 gangliosidosis has both central nervous system and systemic findings; while, GM2 gangliosidosis is restricted primarily to the central nervous system.[PMID: 27491214]", "definition": "A branched amino tetrasaccharide consisting of the linear sequence β-D-GalNAc-(1→4)-β-D-Gal-(1→4)-β-D-Glc having a Neu5Ac residue attached to the galactose via an α-(2→3) linkage. Corresponds to the carbohydrate portion of ganglioside GM2.[CHEBI:59220]", "publication": ["PMID:29618308", "PMID:27491214", "PMID:32867370", "PMID:30030044", "PMID:27499644", "PMID:31097363", "PMID:29100724", "PMID:27402091", "PMID:31852956", "PMID:30389374", "PMID:30988135", "PMID:8786814", "PMID:14533808", "PMID:23370522", "PMID:28192816", "PMID:32692591", "PMID:29106755", "PMID:28833537", "PMID:11339652", "PMID:9728335", "PMID:27270764", "PMID:9714704", "PMID:26175473", "PMID:27018595", "PMID:28615102", "PMID:28974375", "PMID:32951593", "PMID:11462672", "PMID:28955902", "PMID:17192692", "PMID:26538065", "PMID:25421609", "PMID:9572057", "PMID:11596983", "PMID:15264019", "PMID:23236285", "PMID:11596984", "PMID:31261761", "PMID:30113798", "PMID:24391178", "PMID:24309906", "PMID:22224667", "PMID:7980537", "PMID:18272501", "PMID:9006924"], "term_xref": ["GlycoMotif:GGM.000095", "CID:45266845", "CHEBI:59220", "GlycoEpitope:EP0051", "SugarBind_Ligand:39", "KEGG:G00109", "KEGG:G10351"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0051", "content": "lung adenocarcinoma"}, {"src": "GlycoEpitope:EP0051", "content": "embryonal carcinoma"}, {"src": "GlycoEpitope:EP0051", "content": "germ cell tumor"}, {"src": "GlycoEpitope:EP0051", "content": "teratocarcinoma"}, {"src": "GlycoEpitope:EP0051", "content": "squamous cell carcinoma"}, {"src": "SugarBind_Ligand:39", "content": "Gastroenteritis"}, {"src": "SugarBind_Ligand:39", "content": "Cholera"}, {"src": "SugarBind_Ligand:39", "content": "Clostridial myonecrosis"}, {"src": "SugarBind_Ligand:39", "content": "Tetanus"}]}
{"raw_term": "GM3", "normalized_term": "GM3", "retain": "keep", "synonyms": [], "gsd_id": "GSD000093", "glytoucan_id": ["G91237TK"], "term_in_sentence": "We also demonstrated an essential role of GM3 in murine and human auditory systems; a common pathological feature of GM3S deficiency is deafness. [PMID: 29747813]", "definition": "Ganglioside GM3 (d18:1/16:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GM3 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissuesGangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.[HMDB0004844]", "publication": ["PMID:29376491", "PMID:29747813", "PMID:25613425", "PMID:30318083", "PMID:31526872", "PMID:31004109", "PMID:28019668", "PMID:26434718", "PMID:27313500", "PMID:27539856", "PMID:30111401", "PMID:28544772", "PMID:29407985", "PMID:19364317", "PMID:30190430", "PMID:31297734", "PMID:30091781", "PMID:26043887", "PMID:32183071", "PMID:30665141", "PMID:27873002", "PMID:25801320", "PMID:30209782", "PMID:32378734", "PMID:23050851", "PMID:22768242", "PMID:14993837", "PMID:24934090", "PMID:17638075", "PMID:21518140", "PMID:26102277", "PMID:19759399", "PMID:24502144", "PMID:25303960", "PMID:23564406", "PMID:16636105", "PMID:16491123", "PMID:11259118", "PMID:15102521", "PMID:12724312", "PMID:24985965", "PMID:8496625", "PMID:25403557", "PMID:15690123", "PMID:15939439", "PMID:25893133", "PMID:23591593", "PMID:20634908", "PMID:2004380", "PMID:739008"], "term_xref": ["GlycoMotif:GGM.000090", "CID:5288424", "CHEBI:59226", "GlycoEpitope:EP0053", "SugarBind_Ligand:35"], "function": [{"src": "unknown", "content": "Membrane stabilizer"}, {"src": "unknown", "content": "Energy source"}, {"src": "unknown", "content": "Energy storage"}, {"src": "unknown", "content": "Molecular messenger:"}, {"src": "unknown:HMDB0004844", "content": "Signaling molecule"}], "disease_associations": [{"src": "SugarBind_Ligand:35", "content": "Gastroenteritis"}, {"src": "SugarBind_Ligand:35", "content": "Chronic gastritis"}, {"src": "SugarBind_Ligand:35", "content": "Toxoplasmosis"}, {"src": "unknown", "content": "Peptic ulcerSugarBind_Ligand:35]"}, {"src": "SugarBind_Ligand:35", "content": "Gastric cancer"}, {"src": "SugarBind_Ligand:35", "content": "Influenza"}, {"src": "SugarBind_Ligand:35", "content": "Diarrhea"}, {"src": "SugarBind_Ligand:35", "content": "Botulism"}]}
{"raw_term": "GM4", "normalized_term": "GM4", "retain": "keep", "synonyms": ["Sialylated GalCer"], "gsd_id": "GSD000094", "glytoucan_id": ["G30207PZ"], "term_in_sentence": "GM4 is synthesized by the sialylation of galactosylceramide (GalCer), while the ganglioside GM3 is synthesized by the sialylation of lactosylceramide (LacCer).[PMID:23999868]", "definition": "An amino disaccharide consisting of β-D-galactose having an α-N-acetylneuraminyl residue attached at the 3-position [CHEBI:63155]", "publication": ["PMID:23999868", "PMID:2332419", "PMID:12091485", "PMID:19542236", "PMID:8407875", "PMID:23320941", "PMID:28808804", "PMID:3621237", "PMID:23203271", "PMID:7057115", "PMID:26362868", "PMID:6170387", "PMID:18034482", "PMID:7076644", "PMID:2391348", "PMID:25464080", "PMID:3701369", "PMID:11217952", "PMID:6201236", "PMID:30744426", "PMID:9388026", "PMID:27177620", "PMID:30246056", "PMID:15979459", "PMID:7586078", "PMID:6779816", "PMID:29402905", "PMID:7335153", "PMID:3306476", "PMID:17499534", "PMID:7074082", "PMID:9668345", "PMID:3701884", "PMID:26862430", "PMID:6831238", "PMID:27311552", "PMID:26831445", "PMID:24417799", "PMID:7097284", "PMID:4169231", "PMID:16854400", "PMID:26483798"], "term_xref": ["GlycoMotif:GGM.000089", "CID:5289366", "CHEBI:63155", "KEGG:G00317", "SugarBind_Ligand:110"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:110", "content": "Chronic gastritis"}, {"src": "SugarBind_Ligand:110", "content": "Peptic ulcers"}, {"src": "SugarBind_Ligand:110", "content": "Gastric cancer"}]}
{"raw_term": "GP1c", "normalized_term": "GP1c", "retain": "keep", "synonyms": [], "gsd_id": "GSD000095", "glytoucan_id": ["G93805MV"], "term_in_sentence": "n this report, we describe an efficient convergent synthesis of the GP1c glycolipid epitope, which is one of the most complex c-series gangliosides. [PMID:19053458]", "definition": "", "publication": ["PMID:1606358", "PMID:19053458", "PMID:1695858", "PMID:4091974", "PMID:10775425", "PMID:2468656", "PMID:2299350", "PMID:3064875", "PMID:11432974", "PMID:9613831", "PMID:11831845", "PMID:1879553", "PMID:10699494", "PMID:8969459", "PMID:8474578", "PMID:12031286", "PMID:1304332", "PMID:9153001", "PMID:10564776"], "term_xref": ["GlycoMotif:GGM.000118"], "function": [], "disease_associations": []}
{"raw_term": "GQ1b", "normalized_term": "GQ1b", "retain": "keep", "synonyms": [], "gsd_id": "GSD000096", "glytoucan_id": ["G18625KA"], "term_in_sentence": "Bilateral infusion of GQ1b into the hippocampus ameliorates cognitive deficits in the triple-transgenic AD mouse model (3xTg-AD).[PMID:31186474]", "definition": "An amino oligosaccharide that is a branched octasaccharide derivative consisting of four sialyl residues, two galactose residues, one N-acetylglucosamine and a glucose residue at the reducing end.[CHEBI:59212]", "publication": ["PMID:30798387", "PMID:31186474", "PMID:26704905", "PMID:23677659", "PMID:26984947", "PMID:24184316", "PMID:23804237", "PMID:9819299", "PMID:18514410", "PMID:22189683", "PMID:24859332"], "term_xref": ["GlycoMotif:GGM.000115", "GlycoEpitope:EP0069", "CID:45266843", "KEGG:G00117", "CHEBI:59212"], "function": [], "disease_associations": []}
{"raw_term": "GQ1c", "normalized_term": "GQ1c", "retain": "keep", "synonyms": [], "gsd_id": "GSD000098", "glytoucan_id": ["G99524KA"], "term_in_sentence": "The neural specific monoclonal antibody A2B5 was found to interact with GQ1c but not with Gq1b, nor did it interact with other glycolipids such as GM1, GD1a, GD1b, GT1a, GT1b and GA1.[PMID: 6640289]", "definition": "Alpha-Neu5Ac-(2-&gt;8)-alpha-Neu5Ac-(2-&gt;8)-alpha-Neu5Ac-(2-&gt;3)-[alpha-Neu5Ac-(2-&gt;3)-beta-D-Galp-(1-&gt;3)-beta-D-GalpNAc-(1-&gt;4)]-beta-D-Galp-(1-&gt;4)-beta-D-Glcp is a member of neuraminic acids and an amino octasaccharide.[CID:91860352]", "publication": ["PMID:6640289", "PMID:1695858", "PMID:7798936", "PMID:1729139", "PMID:2468656", "PMID:20368669", "PMID:2723647", "PMID:1814411", "PMID:3064875", "PMID:6085330", "PMID:1613492", "PMID:17883393", "PMID:11831845", "PMID:10775425", "PMID:8219015", "PMID:8804704", "PMID:1384262", "PMID:7066685", "PMID:2299192", "PMID:9613831", "PMID:10350354", "PMID:1304337", "PMID:9153001", "PMID:11959025", "PMID:8474578", "PMID:2299350", "PMID:10564776", "PMID:10699494", "PMID:3942818", "PMID:12031286", "PMID:7361620"], "term_xref": ["GlycoMotif:GGM.000117", "CID:91860352", "CHEBI:145645", "KEGG:G00121"], "function": [], "disease_associations": []}
{"raw_term": "GT1a", "normalized_term": "GT1a", "retain": "keep", "synonyms": [], "gsd_id": "GSD000099", "glytoucan_id": ["G68110IF"], "term_in_sentence": "GT1a mimicry was found in the lipo-oligosaccharides of strain ICDCCJ07002 and ICDCCJ07004; but a combination of GM3/GD3 mimics was observed in ICDCCJ07001, although this patient had anti-GT1a IgG antibodies.[PMID:26197476]", "definition": "A branched heptasaccharide derivative consisting of three sialyl residues, two galactose residues, one N-acetylglucosamine and a glucose residue at the reducing end.[CHEBI:59215]", "publication": ["PMID:12023422", "PMID:32623212", "PMID:26197476", "PMID:9585812", "PMID:29747820", "PMID:23804237", "PMID:11993188", "PMID:31683059", "PMID:19631994", "PMID:9742882", "PMID:29709941", "PMID:8971119", "PMID:8706663", "PMID:893404", "PMID:31829433", "PMID:8910600", "PMID:30600291", "PMID:29319803", "PMID:26176883", "PMID:29063860", "PMID:6766128", "PMID:31602715", "PMID:29808463", "PMID:30711390", "PMID:29847988", "PMID:30116054", "PMID:28187751"], "term_xref": ["CID:45266863", "GlycoMotif:GGM.000110", "GlycoEpitope:EP0066", "KEGG:G00112", "CHEBI:59215"], "function": [], "disease_associations": []}
{"raw_term": "GT1b", "normalized_term": "GT1b", "retain": "keep", "synonyms": [], "gsd_id": "GSD000101", "glytoucan_id": ["G40183QN"], "term_in_sentence": "GT1b ganglioside is axonally transported to the spinal cord dorsal horn and contributes to characteristics of neuropathic pain such as mechanical and thermal hypersensitivity.[PMID: 32030804]", "definition": "A branched amino heptasaccharide comprising a β-D-galactosyl-(1→4)-β-D-glucose disaccharide, the galactosyl residue of which carries an N-acetyl-α-neuraminyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl trisaccharide unit and an N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl disaccharide unit through (2→4) and (2→3) linkages respectively. It corresponds to the carbohydrate portion of ganglioside GT1b.[CHEBI:59225]", "publication": ["PMID:32030804", "PMID:26370787", "PMID:32046393", "PMID:9712688", "PMID:7636307", "PMID:9931455", "PMID:25520869", "PMID:19605473", "PMID:17188834", "PMID:10233751", "PMID:22735313", "PMID:20540782", "PMID:22746533", "PMID:1861141", "PMID:19490186", "PMID:9521848", "PMID:11921200", "PMID:10731661", "PMID:31431523", "PMID:15274627", "PMID:32726962", "PMID:12573517", "PMID:18277613", "PMID:11370834", "PMID:11234774", "PMID:11123278", "PMID:18704164", "PMID:16291967", "PMID:11411041", "PMID:27549393", "PMID:25253868", "PMID:22720883", "PMID:10686582", "PMID:11511306", "PMID:29904724", "PMID:31472390", "PMID:19156870"], "term_xref": ["GlycoMotif:GGM.000112", "CID:45266781", "CHEBI:59225", "GlycoGlycoEpitope:130680", "SugarBind_Ligand:26", "KEGG:G00116"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:26", "content": "Toxoplasmosis"}, {"src": "SugarBind_Ligand:26", "content": "Lyme disease"}, {"src": "SugarBind_Ligand:26", "content": "Cholera"}, {"src": "SugarBind_Ligand:26", "content": "Botulism"}, {"src": "SugarBind_Ligand:26", "content": "Tetanus"}, {"src": "SugarBind_Ligand:26", "content": "Influenza"}]}
{"raw_term": "GT1c", "normalized_term": "GT1c", "retain": "keep", "synonyms": [], "gsd_id": "GSD000102", "glytoucan_id": ["G78818SP"], "term_in_sentence": "We show here that VVH associates with ganglioside GM1a, Fucosyl-GM1, GD1a, GT1c, and GD1b by glycan array.[PMID: 32228455]", "definition": "A branched amino heptasaccharide consisting of a linear tetrasaccharide of β-D-galactose, N-acetyl-β-D-galactosamine, β-D-galactose and β-D-glucose residues linked sequentially (1→3), (1→4) and (1→4), to the galactose residue proximal to the reducing end is also linked (2→3) an N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl trisaccharide side-chain. The carbohydrate moiety of ganglioside GT1c.[CHEBI:90509]", "publication": ["PMID:28088450", "PMID:30085356", "PMID:32228455", "PMID:2468656", "PMID:19841910", "PMID:23877172", "PMID:1695858", "PMID:10564776", "PMID:1613492", "PMID:8474578", "PMID:7798936", "PMID:11180643", "PMID:2723647", "PMID:7066685", "PMID:9613831", "PMID:7361620", "PMID:10699494"], "term_xref": ["GlycoMotif:GGM.000113", "CID:91846734", "CHEBI:90509", "GlycoEpitope:EP0033", "KEGG:G00120"], "function": [], "disease_associations": []}
{"raw_term": "GT2", "normalized_term": "GT2", "retain": "keep", "synonyms": [], "gsd_id": "GSD000103", "glytoucan_id": ["G36476BA"], "term_in_sentence": "Biosynthesis of the c-series gangliosides GT3, GT2 and GP1c was studied in Golgi derived from rat liver.[PMID:1606358]", "definition": "A branched amino hexasaccharide consisting of a chain of three α-sialyl residues, a β-D-galactosyl residue and a β-D-glucose residue linked sequentially (2→8), (2→8), (2→3) and (1→4), to the galactosyl residue of which is also linked (1→4) an N-acetyl-β-D-galactosaminyl residue. The carbohydrate moiety of ganglioside GT2.[CHEBI:72446]", "publication": ["PMID:1606358", "PMID:15498585", "PMID:16005859", "PMID:27540730", "PMID:31533196", "PMID:31201844"], "term_xref": ["GlycoMotif:GGM.000109", "CID:70788971", "CHEBI:72446", "KEGG:G00119"], "function": [], "disease_associations": []}
{"raw_term": "GT3", "normalized_term": "GT3", "retain": "keep", "synonyms": [], "gsd_id": "GSD000104", "glytoucan_id": ["G93899SO"], "term_in_sentence": "The purpose of this study was two-fold: (1) to formulate γ-tocotrienol (GT3) in a nanoemulsion formulation as a prophylactic orally administered radioprotective agent; and (2) to optimize the storage conditions to preserve the structural integrity of both the formulation and the compound.[PMID: 28029115]", "definition": "A linear amino pentasaccharide consisting of a chain of three α-sialyl residues, a β-D-galactosyl residue and a β-D-glucose residue linked sequentially (2→8), (2→8), (2→3) and (1→4).[CHEBI:72444]", "publication": ["PMID:28029115", "PMID:31355968", "PMID:30987413", "PMID:27869747", "PMID:27216753", "PMID:8631981", "PMID:29672891", "PMID:10385047", "PMID:29642403", "PMID:10412028", "PMID:27193023", "PMID:30068561", "PMID:23415908", "PMID:8858920", "PMID:2303428", "PMID:27153057", "PMID:27128741", "PMID:2654294", "PMID:26930378", "PMID:7561885", "PMID:25860286", "PMID:30845647", "PMID:24712339", "PMID:30070965", "PMID:8910600", "PMID:1606358", "PMID:27356050", "PMID:8514740", "PMID:18509108", "PMID:23000517", "PMID:29769046", "PMID:29566611"], "term_xref": ["GlycoEpitope:EP0070", "KEGG:G00118", "CID:70788970", "GlycoMotif:GGM.000092", "CHEBI:72444"], "function": [], "disease_associations": []}
{"raw_term": "Heparan sulfate", "normalized_term": "heparan sulfate", "retain": "keep", "synonyms": ["Heparan N-sulfate", "Heparan sulfate", "Heparan sulphate", "Heparatan sulfate", "Heparin monosulfate", "Heparin sulfate", "Heparitin monosulfate", "Heparitin sulfate", "N-Acetylheparan sulfate"], "gsd_id": "GSD000106", "glytoucan_id": [], "term_in_sentence": "In Niemann-Pick C-1 fibroblasts, where deaminative degradation of heparan sulfate is defective, carbonylated proteins were abundant.[PMID: 17540770]", "definition": "A linear polysaccharide in which the backbone consists of a variably sulfated repeating disaccharide unit.[CHEBI:28815]", "publication": ["PMID:32266657", "PMID:29554552", "PMID:29032302", "PMID:30003471", "PMID:25197032", "PMID:28538085", "PMID:26236728", "PMID:16917509", "PMID:22899865", "PMID:17080204", "PMID:23042481", "PMID:28982096", "PMID:24146040", "PMID:25081076", "PMID:15719168", "PMID:17453622", "PMID:25325954", "PMID:21110089", "PMID:29797526", "PMID:21967329", "PMID:23313092", "PMID:11212344", "PMID:28465034", "PMID:11746174", "PMID:12512855", "PMID:8836040", "PMID:28394734", "PMID:24182748", "PMID:28264929", "PMID:28745308", "PMID:26555370", "PMID:14718374", "PMID:16767693", "PMID:25246018", "PMID:19584012", "PMID:8274190", "PMID:25034023", "PMID:8370471", "PMID:26571620", "PMID:29920400", "PMID:31731076", "PMID:20816205", "PMID:16880267", "PMID:31547957", "PMID:11457867", "PMID:27241222", "PMID:28718936", "PMID:21204109", "PMID:31016560", "PMID:11166215", "PMID:11457866"], "term_xref": ["CHEBI:28815", "CID: 53477715", "GlycoEpitope: EP0086"], "function": [{"src": "GlycoEpitope: EP0086", "content": "Heparan sulfate proteoglycans (HSPGs) play crucial roles regulating key developmental signaling pathways, such as the Wnt, Hedgehog, transforming growth factor-beta, and fibroblast growth factor pathways."}], "disease_associations": []}
{"raw_term": "Heparin", "normalized_term": "heparin", "retain": "keep", "synonyms": ["bemiparin", "bemiparin", "certoparin", "Cy 222", "enoxaparin", "fluxum", "Heparin", "Heparinic acid", "parnaparin", "reviparin", "sandoparin"], "gsd_id": "GSD000107", "glytoucan_id": [], "term_in_sentence": "Two cellulose-based membranes, containing 5 and 20% N, N-diethyl-aminoethyl cellulose (DEAE) respectively, were investigated for ionic attachment of heparin and heparin release.[PMID:6416324]", "definition": "A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1→4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule.[CHEBI:28304]", "publication": ["PMID:27100512", "PMID:22566218", "PMID:27264866", "PMID:30094590", "PMID:31077659", "PMID:26975675", "PMID:2083874", "PMID:25088334", "PMID:3333067", "PMID:2191809", "PMID:28118750", "PMID:28224913", "PMID:22495506", "PMID:29385025", "PMID:10332503", "PMID:22393937", "PMID:19947315", "PMID:27655335", "PMID:14529394", "PMID:2419035", "PMID:22048616", "PMID:23849978", "PMID:10204652", "PMID:28958760", "PMID:12627673", "PMID:9042555", "PMID:15639107", "PMID:28880550", "PMID:27238483", "PMID:1964668", "PMID:16716101", "PMID:10796377", "PMID:25981976", "PMID:24680753", "PMID:2191118", "PMID:21166465", "PMID:30582884", "PMID:1322434", "PMID:15330727", "PMID:9752370", "PMID:6416324", "PMID:14996629", "PMID:20452241", "PMID:1340407", "PMID:29050610", "PMID:345399", "PMID:6916469", "PMID:6565376", "PMID:26714061"], "term_xref": ["CID:772", "CHEBI:28304"], "function": [], "disease_associations": []}
{"raw_term": "High mannose", "normalized_term": "high-mannose N-glycan", "retain": "keep", "synonyms": ["oligomannose, high-mannose, oligomannose-type"], "gsd_id": "GSD000108", "glytoucan_id": ["G55220VL"], "term_in_sentence": "Each glycoform contained a number of peaks differing by 162 Da indicating heterogeneity and suggesting the presence of high-mannose sugars.[PMID:11258925]", "definition": "An N-linked oligosaccharide that possesses between five and nine mannose residues attached to the chitobiose [(GlcNAc)2] core. [CHEBI:5717] None of the Man residues are substituted with any monosaccharide other than Man .", "publication": ["PMID:11258925", "PMID:17956937", "PMID:2059624", "PMID:2065054", "PMID:26791533", "PMID:4077844", "PMID:7780197", "PMID:9136890", "PMID:30659065", "PMID:30075362", "PMID:21421994", "PMID:31076349", "PMID:29738673", "PMID:29508223", "PMID:26747427", "PMID:30634645", "PMID:23007868", "PMID:29051951", "PMID:24549150", "PMID:12417032", "PMID:26724786", "PMID:26956389", "PMID:26493153", "PMID:31102532", "PMID:29673624", "PMID:8348230", "PMID:25586968", "PMID:24975601", "PMID:29803109", "PMID:28465212", "PMID:25776945", "PMID:30151520", "PMID:21097542", "PMID:24326091", "PMID:27995699", "PMID:26003537", "PMID:6722291", "PMID:2925680", "PMID:25565276", "PMID:21460211", "PMID:25196214", "PMID:27387600", "PMID:22373601", "PMID:3729933", "PMID:16423983", "PMID:24174266", "PMID:30605318", "PMID:32371950"], "term_xref": ["CID:70698382", "CHEBI:71514"], "function": [{"src": "unknown", "content": "Involved in promotion of protein folding in ER. [PMID:12417032]."}, {"src": "PMID: 17516205", "content": "High Man glycans are enriched at cell surface during apoptosis."}], "disease_associations": [{"src": "PMID: 28484880", "content": "Relative abundance changes in multiple CDGs [PMID: 30770376]"}]}
{"raw_term": "HNK-1", "normalized_term": "HNK-1", "retain": "keep", "synonyms": ["HNK-1 carbohydrate epitope", "CD57", "HNK-1 antigen"], "gsd_id": "GSD000109", "glytoucan_id": ["G54406UD"], "term_in_sentence": "The human natural killer-1 (HNK-1) carbohydrate, a unique trisaccharide possessing sulfated glucuronic acid in a non-reducing terminus (HSO3-3GlcAß1-3Galß1-4GlcNAc-), is highly expressed in the nervous system and its spatiotemporal expression is strictly regulated.[PMID:28709864]", "definition": "An amino trisaccharide consisting of a 3-O-sulfo-β-D-glucuronic acid residue, a D-galactosyl residue and an N-acetyl-D-glucosamine residue (at the reducing end) in a linear sequence.[CHEBI:60322]", "publication": ["PMID:28709864", "PMID:31738061", "PMID:26738850", "PMID:30306736", "PMID:11070366", "PMID:20855890", "PMID:18024472", "PMID:22669261", "PMID:19729452", "PMID:19796667", "PMID:26850637", "PMID:11769463", "PMID:18263654", "PMID:15843379", "PMID:26659409", "PMID:9003039", "PMID:22087768", "PMID:21771787", "PMID:15173636", "PMID:9210489", "PMID:15258996", "PMID:17924534", "PMID:26382082", "PMID:16171882", "PMID:18802400", "PMID:9800516", "PMID:7504418", "PMID:11891229", "PMID:15232286", "PMID:9013478", "PMID:21621858", "PMID:11677051", "PMID:18668221", "PMID:11414798", "PMID:19265195", "PMID:8982638", "PMID:8798480", "PMID:28403522", "PMID:17935701", "PMID:1691305", "PMID:10998116", "PMID:9364602", "PMID:7528651", "PMID:12472892", "PMID:21176892", "PMID:28416698", "PMID:19389918", "PMID:28427937", "PMID:25450311"], "term_xref": ["GlycoEpitope:EP0001", "CID:46906103", "CHEBI:60322", "GlycoMotif:GGM.000058"], "function": [{"src": "GlycoEpitope:EP0001", "content": "learning and memory"}, {"src": "GlycoEpitope:EP0001", "content": "neural crest cell migration"}, {"src": "GlycoEpitope:EP0001", "content": "neurite extension"}, {"src": "GlycoEpitope:EP0001", "content": "neuron-astrocyte adhesion"}], "disease_associations": [{"src": "GlycoEpitope:EP0001", "content": "schizophrenia-like psychosis"}, {"src": "GlycoEpitope:EP0001", "content": "neuropathy"}, {"src": "GlycoEpitope:EP0001", "content": "exfoliation syndrome"}, {"src": "GlycoEpitope:EP0001", "content": "secondary cataract"}]}
{"raw_term": "Hybrid", "normalized_term": "hybrid N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000110", "glytoucan_id": ["G16828VN"], "term_in_sentence": "A hybrid-type N-glycan was accessed by total synthesis, converted to an oxazoline, and used as a donor substrate with both wild type Endo M and an N175Q glycosynthase Endo M mutant allowing the convergent synthesis of a glycosylated amino acid bearing a hybrid N-glycan structure. [PMID:27058295]", "definition": "An N-linked glycan in which the Manα1-6 arm of the trimannosyl core Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1–4GlcNAcβ1–Asn-X-Ser/Thr is substituted by one or more additional Man residues and the Manα1-3 arm is substituted by a GlcNAc residue added by GlcNAcT1. The GlcNAc linked to the a3 Man can be extended in the same manner as any complex glycan antenna. The trimannosyl core can also be core fucosylated and/or bisected by the addition of a GlcNAc to the 3 position of the α-linked Man residue.[Essentials of Glycobiology:Chapter 9]", "publication": ["PMID:27058295", "PMID:15044398", "PMID:28714086", "PMID:29578688", "PMID:26999365"], "term_xref": ["CID:91847108", "CHEBI:147471"], "function": [], "disease_associations": []}
{"raw_term": "Hyaluronan", "normalized_term": "hyaluronan", "retain": "keep", "synonyms": ["HA"], "gsd_id": "GSD000183", "glytoucan_id": ["G29086KO"], "term_in_sentence": "Hyaluronan (HA) comprises a major component of the extracellular matrix (ECM) in vertebrate connective tissues and is abundant in the cartilage, skin, brain, vitreous body, umbilical cord, and synovial fluid. [PMID:33171800]", "definition": "", "publication": ["PMID:33171800", "PMID:34209222"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "i antigen", "normalized_term": "i antigen", "retain": "keep", "synonyms": ["Type 2 LN2"], "gsd_id": "GSD000111", "glytoucan_id": ["G00058MO", "G46055MA"], "term_in_sentence": "Inasmuch as the hybridoma was established by hybridization of lymphocytes derived from regional lymph nodes of lung cancer, and the antigen was found in the patient's lung cancer tissue, the i antigen in lung cancer is probably recognized as a tumor-associated antigen by the host's immune cell system.[PMID:2422274]", "definition": "", "publication": ["PMID:2422274", "PMID:15679458", "PMID:21912254", "PMID:12468428", "PMID:28508465", "PMID:6203982", "PMID:30728302", "PMID:8449405", "PMID:9122902", "PMID:10360315", "PMID:6159787", "PMID:6183759", "PMID:518539", "PMID:6715951", "PMID:21933024"], "term_xref": ["GlycoMotif:GGM.000004", "GlycoMotif:GGM.000002"], "function": [], "disease_associations": []}
{"raw_term": "I antigen", "normalized_term": "I antigen", "retain": "keep", "synonyms": [], "gsd_id": "GSD000112", "glytoucan_id": ["G56045WU"], "term_in_sentence": "The I antigen is formed by the action of an enzyme (a glycosyltransferase), which adds branches onto the i antigen.[PMID:15679458]", "definition": "N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4S,5S,6R)-4-[(2R,3R,4R,5S,6R)-3-Acetamido-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[[(2R,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide (CHEBI:151390) is a amino sugar.[CHEBI:151390]", "publication": ["PMID:15679458", "PMID:21912254", "PMID:30705292", "PMID:33403394", "PMID:6715951", "PMID:12468428", "PMID:6088627", "PMID:6159787"], "term_xref": ["GlycoMotif:GGM.000003", "GlycoEpitope:EP0138", "CID:91852915", "CHEBI:151390"], "function": [], "disease_associations": []}
{"raw_term": "Isoglobotetraosylceramide", "normalized_term": "isoglobotetraosylceramide", "retain": "keep", "synonyms": [], "gsd_id": "GSD000113", "glytoucan_id": ["G57710SU"], "term_in_sentence": "Furthermore, isoglobotetraosylceramide seems to play a direct role in the metastatic process since the blocking of exposed antigen with monoclonal antibodies, or their Fab fragments, results in a highly significant decrease in lung colony formation.[PMID:8504431]", "definition": "", "publication": ["PMID:1396705", "PMID:8504431", "PMID:2713378", "PMID:3489485", "PMID:18997175", "PMID:7053385", "PMID:3379797", "PMID:2465279", "PMID:3743633", "PMID:11479210"], "term_xref": ["GlycoMotif:GGM.000071", "CID:91849719", "KEGG:G03211", "CHEBI:148232", "SugarBind_Ligand:17"], "function": [{"src": "PMID:8504431", "content": "a marker for highly metastatic cells in rat mammary adenocarcinomas"}], "disease_associations": [{"src": "SugarBind_Ligand:17", "content": "Actinomycosis"}]}
{"raw_term": "Keratan sulfate", "normalized_term": "keratan sulfate", "retain": "keep", "synonyms": ["keratan", "Kerato sulphate", "Kerato sulfate", "Keratan sulphate", "kerato 6'-sulfate", "keratan 6'-sulfate", "Kerato 6'-sulphate", "Keratan 6'-sulphate"], "gsd_id": "GSD000114", "glytoucan_id": ["G82109MW"], "term_in_sentence": "Compared to the other classes of glycosaminoglycans (GAGs), that is, chondroitin/dermatan sulfate, heparin/heparan sulfate and hyaluronan, keratan sulfate (KS), have the least known of its interactive properties.[PMID: 30578672]", "definition": "A sulfated glycosaminoglycan, a linear polymer that consists of the repeating disaccharide [3)-β-Gal-(1→4)-β-GlcNAc-(1→] and containing sulfo groups located at random positions.[CHEBI:60924]", "publication": ["PMID:29340594", "PMID:30578672", "PMID:12512857", "PMID:29625490", "PMID:25325967", "PMID:30025865", "PMID:29924315", "PMID:9549787", "PMID:11030741", "PMID:28078490", "PMID:8298243", "PMID:29096187", "PMID:30059256", "PMID:26958998", "PMID:26773479", "PMID:22840010", "PMID:15597951", "PMID:28110685", "PMID:28535934", "PMID:2942429", "PMID:18234072", "PMID:8641829", "PMID:8940154", "PMID:2027120", "PMID:30849116", "PMID:41589", "PMID:6238957", "PMID:1907283", "PMID:7722002", "PMID:29275050", "PMID:24274541", "PMID:2527236", "PMID:1731862", "PMID:8991509", "PMID:24291704", "PMID:10517185", "PMID:6451953", "PMID:7688312", "PMID:8663590", "PMID:139406", "PMID:25770829", "PMID:25036480", "PMID:9275006", "PMID:25179279", "PMID:32627425", "PMID:26903438", "PMID:27941632", "PMID:12807022", "PMID:32266652", "PMID:21624346"], "term_xref": ["CHEBI:60924", "CID:446715", "GlycoEpitope: EP0085"], "function": [{"src": "PMID: 11030741", "content": "Tissue hydration."}], "disease_associations": []}
{"raw_term": "LacdiNac", "normalized_term": "LacdiNac", "retain": "keep", "synonyms": ["LDN"], "gsd_id": "GSD000115", "glytoucan_id": ["G31736BK"], "term_in_sentence": "We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer.[PMID:25003135]", "definition": "An amino disaccharide consisting of N-acetylglucosamine having an N-acetylgalactosaminyl resiude attached at the 4-position via a β-linkage.[CHEBI:61190]", "publication": ["PMID:25003135", "PMID:31711843", "PMID:31145522", "PMID:27601469", "PMID:30669833", "PMID:25210040", "PMID:24633693", "PMID:24755437", "PMID:22653491", "PMID:30898876", "PMID:7758724", "PMID:22474328", "PMID:21305673", "PMID:31558607", "PMID:31271862", "PMID:28549117", "PMID:26213980", "PMID:9134425", "PMID:25561735", "PMID:31756927", "PMID:31170332", "PMID:16282603", "PMID:15265923", "PMID:32267274", "PMID:23015818", "PMID:32676595", "PMID:16728562", "PMID:10814702", "PMID:9591048", "PMID:22245701", "PMID:29751628", "PMID:22997242", "PMID:15535969", "PMID:31911241", "PMID:30622255", "PMID:29888905", "PMID:30236114", "PMID:30298790", "PMID:29373511", "PMID:22298779", "PMID:19179461", "PMID:31606752", "PMID:15653684", "PMID:16403022", "PMID:11162373", "PMID:32005658", "PMID:30529570"], "term_xref": ["GlycoEpitope:P0150", "CID:25257164", "CHEBI:61190", "GlycoMotif:GGM.000016"], "function": [{"src": "CHEBI:61190", "content": "Has a role of epitope."}], "disease_associations": []}
{"raw_term": "Lactosylceramide", "normalized_term": "lactosylceramide", "retain": "keep", "synonyms": ["LacCer", "Lc2", "CDH"], "gsd_id": "GSD000116", "glytoucan_id": ["G84224TW"], "term_in_sentence": "In the 1970s, a neutral glycosphingolipid lactosylceramide (LacCer) was found to bind specifically to several kinds of microorganisms.[PMID:30175814]", "definition": "Glycosphingolipids which contain as their polar head group a lactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in lactosylceramide beta-galactosidase, is the cause of lactosylceramidosis.[MeSH:D007790]", "publication": ["PMID:30175814", "PMID:26900161", "PMID:30502090", "PMID:29624959", "PMID:28444900", "PMID:25408340", "PMID:31801289", "PMID:29099167", "PMID:25595946", "PMID:32592089", "PMID:27729551", "PMID:24658420", "PMID:25216636", "PMID:25638276", "PMID:9499377", "PMID:17986153", "PMID:8143857", "PMID:23801329", "PMID:18077097", "PMID:32708181", "PMID:15346887", "PMID:19015977", "PMID:18393821", "PMID:25279740", "PMID:21057870", "PMID:11915327", "PMID:25212460", "PMID:23882130", "PMID:11915329", "PMID:8195125", "PMID:8808768", "PMID:3396945", "PMID:22128256", "PMID:6733104", "PMID:24968752", "PMID:32518749", "PMID:30688114", "PMID:7666005", "PMID:8200356", "PMID:24718572", "PMID:6193809", "PMID:25781947", "PMID:12383912", "PMID:26086247", "PMID:30606995", "PMID:12419803"], "term_xref": ["MeSH:D007790", "GlycoMotif:GGM.000064", "GlycoEpitope:EP0078", "SugarBind_Ligand:3"], "function": [{"src": "GlycoEpitope:EP0078", "content": "mammalian cell receptors for Neisseria gonorrhoeae recognized by Helicobacter pylori"}], "disease_associations": [{"src": "GlycoEpitope:EP0078,SugarBind_Ligand:3", "content": "chronic gastritis"}, {"src": "GlycoEpitope:EP0078", "content": "duodenal ulcers"}, {"src": "GlycoEpitope:EP0078,SugarBind_Ligand:3", "content": "gastric adenocarcinoma"}, {"src": "GlycoEpitope:EP0078", "content": "gastric ulcers"}, {"src": "SugarBind_Ligand:3", "content": "Pleuropneumonia"}, {"src": "SugarBind_Ligand:3", "content": "Porcine fibrinohemorrhagic necrotizing pleuropneumonia"}, {"src": "SugarBind_Ligand:3", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:3", "content": "Pertussis"}, {"src": "SugarBind_Ligand:3", "content": "Candidiasis"}, {"src": "SugarBind_Ligand:3", "content": "Cryptococcosis"}, {"src": "SugarBind_Ligand:3", "content": "Hemorrhagic colitis"}, {"src": "SugarBind_Ligand:3", "content": "Peptic ulcers"}, {"src": "SugarBind_Ligand:3", "content": "Histoplasmosis"}, {"src": "SugarBind_Ligand:3", "content": "Pharyngitis"}, {"src": "SugarBind_Ligand:3", "content": "Tracheobronchitis"}, {"src": "SugarBind_Ligand:3", "content": "Gonorrhea"}, {"src": "SugarBind_Ligand:3", "content": "Sporotrichosis"}, {"src": "SugarBind_Ligand:3", "content": "Plague"}, {"src": "SugarBind_Ligand:3", "content": "Diarrhea"}]}
{"raw_term": "Lactotriaosylceramide", "normalized_term": "lactotriaosylceramide", "retain": "keep", "synonyms": ["Lc3", "Lc(3)Cer", "Lc_3"], "gsd_id": "GSD000117", "glytoucan_id": ["G06239NA"], "term_in_sentence": "The results showed that AML patients had higher expression of the GSL lactotriaosylceramide (Lc3), GM3 and neolactotetraosylceramide (nLc4) in their bone marrow than did the healthy donors (P &lt; 0.05), especially the M1 subtype of AML.[PMID:22411838]", "definition": "A linear amino trisaccharide consisting of β-D-glucose at the reducing end having an N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl group attached at the 4-position.[CHEBI:61758]", "publication": ["PMID:22411838", "PMID:20693232", "PMID:26104834", "PMID:27435676", "PMID:26405105", "PMID:32340400", "PMID:25241919", "PMID:23404501", "PMID:32452379", "PMID:2960671", "PMID:272643", "PMID:27711049", "PMID:33202844", "PMID:4060695", "PMID:27638607", "PMID:20547865", "PMID:2277039", "PMID:6238026", "PMID:8448388", "PMID:8489255", "PMID:9363437", "PMID:11836161", "PMID:6892925", "PMID:1551117", "PMID:6811267", "PMID:8059935", "PMID:7861954", "PMID:11283017", "PMID:8514762", "PMID:1291049", "PMID:3805024", "PMID:10816509", "PMID:12393713", "PMID:6417117", "PMID:11054095", "PMID:8781973", "PMID:1692829"], "term_xref": ["GlycoMotif:GGM.000067", "MeSH:C025575", "CID:10230777", "CHEBI:61758", "SugarBind_Ligand:20"], "function": [{"src": "PMID:22411838", "content": "acute myeloid leukemia-associated glycosphingolipids lactotriaosylceramide, GM3 and neolactotetraosylceramide are possibly involved in initiation and differentiation of acute myeloid leukemia."}], "disease_associations": [{"src": "SugarBind_Ligand:20", "content": "Pharyngitis"}, {"src": "SugarBind_Ligand:20", "content": "Tracheobronchitis"}, {"src": "SugarBind_Ligand:20", "content": "Gonorrhea"}, {"src": "SugarBind_Ligand:20", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:20", "content": "Diarrhea"}]}
{"raw_term": "LcGg4", "normalized_term": "LcGg4", "retain": "keep", "synonyms": [], "gsd_id": "GSD000118", "glytoucan_id": ["G62554JH"], "term_in_sentence": "Murine leukemia cells (M1), in their undifferentiated state, have been characterized by the presence of cancer-associated lactoganglio-series glycolipids, one of which was identified as lactogangliotetraosylceramide (LcGg4) having a novel branching at the II-Gal of lactosylceramide through GlcNAc beta 1----3 and GalNAc beta 1----4 linkage, as shown below (Kannagi, R., Levery, S.B., and Hakomori, S. (1984) J. Biol. Chem., 259, 8444-8451): GalNAc beta 1----4 Gal beta 1----4Glc beta 1----1Cer GlcNac beta 1----3 [PMID: 3805024]", "definition": "N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5R,6S)-4-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide is an oligosaccharide.[CHEBI:152521]", "publication": ["PMID:3805024", "PMID:33395290"], "term_xref": ["GlycoMotif:GGM.000075", "CID:91850076", "CHEBI:152521", "GlycoEpitope:EP0035"], "function": [], "disease_associations": []}
{"raw_term": "Lewis a", "normalized_term": "Lewis a", "retain": "keep", "synonyms": ["Le(a)", "Lea-3", "Lea", "Le^a"], "gsd_id": "GSD000119", "glytoucan_id": ["G00047MO"], "term_in_sentence": "Regardless of the vaccine administered, significantly fewer of the children with Lewis A phenotype (0/14) seroconverted after receiving the first vaccine dose compared to 26% (45/175) of those with the Lewis B phenotype and 32% (15/47) of the Lewis negative individuals (P &lt; 0.01). [PMID:29367698]", "definition": "A lewis blood group antigen with structure beta-D-Galp-(1-&gt;3)-[alpha-L-Fucp-(1-&gt;4)]-D-GlcpNAc consisting of N-acetylglucosamine having a fucosyl residue attached at the 4-position via an alpha-linkage and a galactosyl residue attached at the 3-position via a beta-linkage. It has a role as an epitope and an antigen. It is an amino trisaccharide and a glucosamine oligosaccharide.[CHEBI:62265]", "publication": ["PMID:29367698", "PMID:27187324", "PMID:30562693", "PMID:27646625", "PMID:26911286", "PMID:30225822", "PMID:28600306", "PMID:32527016", "PMID:2385097", "PMID:11064310", "PMID:23809433", "PMID:30050155", "PMID:1615929", "PMID:29527514", "PMID:9207264", "PMID:1675497", "PMID:3677023", "PMID:27705835", "PMID:7593252", "PMID:2579997", "PMID:17630273", "PMID:9350993", "PMID:9098001"], "term_xref": ["CID:22806751", "CHEBI:62265", "GlycoMotif:GGM.000020", "SugarBind_Ligand:155"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:155", "content": "Gastroenteritis"}]}
{"raw_term": "Lewis b", "normalized_term": "Lewis b", "retain": "keep", "synonyms": ["Le(b)", "Lewis(b)", "Le^b"], "gsd_id": "GSD000120", "glytoucan_id": ["G39211DH"], "term_in_sentence": "Human mannose-binding lectin preferentially binds to human colon adenocarcinoma cell lines expressing high amount of Lewis A and Lewis B antigens.[PMID:10328552]", "definition": "", "publication": ["PMID:10328552", "PMID:23408949", "PMID:31927399", "PMID:26601230", "PMID:28279343", "PMID:32527016", "PMID:30831115", "PMID:27318698", "PMID:9207264", "PMID:23828675", "PMID:29527514", "PMID:1615929", "PMID:2385097", "PMID:2579997", "PMID:25516619", "PMID:3677023", "PMID:8509439", "PMID:19832116", "PMID:15270746", "PMID:3166398", "PMID:30909206", "PMID:7718581", "PMID:18400963", "PMID:29751628", "PMID:8982241", "PMID:30284922", "PMID:24576035", "PMID:30974776", "PMID:9098001", "PMID:31768613", "PMID:1651804", "PMID:25428879", "PMID:15946883", "PMID:30298790", "PMID:30544260", "PMID:29197783", "PMID:8632739", "PMID:7679772", "PMID:18666312", "PMID:20231766", "PMID:29922666", "PMID:95124", "PMID:2247887", "PMID:21519121", "PMID:25153235", "PMID:28751211"], "term_xref": ["GlycoMotif:GGM.000021", "SugarBind_Ligand:146", "CID:45480568", "CHEBI:59440"], "function": [{"src": "https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/blood-group-lewis-system", "content": "possible receptor for Helicobacter pylori"}], "disease_associations": [{"src": "SugarBind_Ligand:146", "content": "Gastroenteritis"}]}
{"raw_term": "Lewis x", "normalized_term": "Lewis x", "retain": "keep", "synonyms": ["Lex", "Galbeta1-4(Fucalpha1-3)GlcNAc", "Lewis x trisaccharide", "Le(X)", "Le^x", "SSEA-1"], "gsd_id": "GSD000121", "glytoucan_id": ["G00051MO"], "term_in_sentence": "In particular, the observation of oxonium ions at m/z 512.2 and 803.2 is useful for probing outer non-reducing terminal fucosylation, which represented carbohydrate structures consisting of Hex Hex , dHex Hex , and HexNAc , and NeuNAc , Hex Hex , dHex Hex , and HexNAc , respectively, from which the Lewis X structure (Galbeta1-4(Fucalpha1-3)GlcNAc) was readily deduced.[PMID:15536627]", "definition": "A Lewis blood group antigen with structure α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc where the glucosamine at the reducing end has β-configuration at its anomeric centre. Commonly known as Lewis x trisaccharide or Lex.[CHEBI:59294]", "publication": ["PMID:15536627", "PMID:31666308", "PMID:29019053", "PMID:28296340", "PMID:29593094", "PMID:17607374", "PMID:16581086", "PMID:20858014", "PMID:19962782", "PMID:7912739", "PMID:25121780", "PMID:24059473", "PMID:29210428", "PMID:31276881", "PMID:9015359", "PMID:7628844", "PMID:7499837", "PMID:16850248", "PMID:28425129", "PMID:28869691", "PMID:19576189", "PMID:10223649", "PMID:22593503", "PMID:15632313", "PMID:27198630", "PMID:26582608", "PMID:11500392", "PMID:31256373", "PMID:23399157", "PMID:21984435", "PMID:26244810", "PMID:26162743", "PMID:17335083", "PMID:15388363", "PMID:9556613", "PMID:10760152", "PMID:11267844", "PMID:20876654", "PMID:12131290"], "term_xref": ["GlycoEpitope:EP0011", "CID:44611539", "CHEBI:59294", "GlycoMotif:GGM.000018"], "function": [{"src": "unknown", "content": "Involved in carbohydrate-carbohydrate interaction[Glycoepitope:EP0011]."}, {"src": "Glycoepitope:EP0011", "content": "Also implicated in apoptosis."}, {"src": "Glycoepitope:EP0011", "content": "influence antigenic presentation and interfere with pathogen transfer in breastfed infants."}], "disease_associations": [{"src": "GlycoEpitope:EP0011", "content": "acute leukemia"}, {"src": "GlycoEpitope:EP0011", "content": "lymphoma"}]}
{"raw_term": "Lewis y", "normalized_term": "Lewis y", "retain": "keep", "synonyms": ["LeY", "Le(y)", "Ley", "Le^y"], "gsd_id": "GSD000122", "glytoucan_id": ["G00052MO"], "term_in_sentence": "In conclusion, Lewis y antigen and CD147 were significantly upregulated in ovarian tumors, and the altered expression of Lewis y may cause changes in CD147.[PMID:30816446]", "definition": "A Lewis blood group antigen which is a branched amino tetrasaccharide with structure alpha-L-Fucp-(1-&gt;2)-beta-D-Galp-(1-&gt;4)-[alpha-L-Fucp-(1-&gt;3)]-beta-D-GlcpNAc, consisting of consisting of N-acetyl-beta-D-glucosamine at the reducing end having an alpha-L-fucosyl residue attached at the 3-position and an alpha-L-fucosyl-(1→2)-beta-D-galactosyl moiety attached at the 4-position. A cancer-associated tetrasaccharide antigen which constitutes the core structure recognised by therapeutic antibody BR96. Conformational restriction around the GlcNAc residue is a key feature of its structure. It has a role as an antigen and an epitope. [CHEBI:59045]]", "publication": ["PMID:30816446", "PMID:20003467", "PMID:24692145", "PMID:24998328", "PMID:25726913", "PMID:29299130", "PMID:30816446", "PMID:20003467", "PMID:24692145", "PMID:24998328", "PMID:20127027", "PMID:22138668", "PMID:23894390", "PMID:25726913", "PMID:25416440", "PMID:27646625", "PMID:23725446", "PMID:21294926", "PMID:22312289", "PMID:25973320", "PMID:23242548", "PMID:30328452", "PMID:21119363", "PMID:29130097", "PMID:23443083", "PMID:23708102", "PMID:28671040", "PMID:19715603", "PMID:23468946", "PMID:27723168", "PMID:21747684", "PMID:19771739"], "term_xref": ["GlycoEpitope:EP0018", "CID:45266908", "CHEBI:59045", "GlycoMotif:GGM.000019"], "function": [{"src": "GlycoEpitope:EP0018", "content": "The expression of the fucosylated histo-blood group antigen CD174 in CD34+ hematopoietic progenitor cells and down-regulation of FUT1 in mature lymphocytes may be important factors influencing the homing process of hematopoietic stem cells to the bone marrow."}], "disease_associations": [{"src": "GlycoEpitope:EP0018", "content": "AIDS/acquired immune deficiency syndrome"}, {"src": "GlycoEpitope:EP0018", "content": "cholangiocarcinoma"}, {"src": "GlycoEpitope:EP0018", "content": "hepatocellular carcinoma"}]}
{"raw_term": "Monosialylated", "normalized_term": "monosialylated N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000123", "glytoucan_id": [], "term_in_sentence": "The structures of the asparagine-linked sugar chains of U- CD59 were biantennary complex type , only 4.2% of which are monosialylated.[PMID:7514386]", "definition": "A glycan that have the addition of one sialic acid residues.", "publication": ["PMID:7514386", "PMID:8477709", "PMID:8942648", "PMID:29752599", "PMID:31669586", "PMID:29747818", "PMID:16425369", "PMID:12089170", "PMID:31390883", "PMID:1632647", "PMID:29733234", "PMID:31110965", "PMID:31566965", "PMID:30555678", "PMID:28263871", "PMID:29652662", "PMID:25915761", "PMID:16381065", "PMID:29247593", "PMID:28370937", "PMID:23896595", "PMID:26633899", "PMID:32155999", "PMID:25261856", "PMID:2737211", "PMID:26945091", "PMID:27065039", "PMID:26784838", "PMID:26582205"], "term_xref": [], "function": [{"src": "PMID: 29752599", "content": "appears in bovine brain gangliosides."}], "disease_associations": []}
{"raw_term": "Monosialyl-biantennary", "normalized_term": "monosialylated biantennary N-glycan", "retain": "keep", "synonyms": ["monosialyl biantennary", "sialylated diantennary", "sialylated biantennary"], "gsd_id": "GSD000124", "glytoucan_id": [], "term_in_sentence": "In contrast, the sugar chain structure of HCC highly specific AFP isoform was found to comprise a monosialyl-biantennary sugar chain with additional fucosylation of the proximal N-acetylglucosamine.[PMID:7686446]", "definition": "A biantennary glycan with two GlcNAc branches linked to the core and the addition of one sialic acid residues.", "publication": ["PMID:7686446", "PMID:1374031", "PMID:9648261", "PMID:10460833", "PMID:19524219", "PMID:10207016", "PMID:15797573", "PMID:15218190"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Monosialyl-Gb5", "normalized_term": "monosialyl Gb5", "retain": "keep", "synonyms": ["GL-7 globoseries ganglioside (SSEA-4)", "Monosialyl Gb5", "Sialosyl galactosyl globoside", "GL-7 globoseries ganglioside", "SSEA-4"], "gsd_id": "GSD000125", "glytoucan_id": ["G32254QI"], "term_in_sentence": "Thus, malignancy of MCF-7 is highly dependent on monosialyl-Gb5, and its activation of cSrc and FAK in GEM.[PMID:12401210]", "definition": "alpha-Neup5Ac-(2-&gt;3)-beta-D-Galp-(1-&gt;3)-beta-D-GalpNAc-(1-&gt;3)-alpha-D-Galp-(1-&gt;4)-beta-D-Galp-(1-&gt;4)-beta-D-Glcp is a linear amino hexasaccharide comprising β-D-glucose at the reducing end with at the 4-position a β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl moiety, α(2→3)-sialylated at the terminal galactosyl residue.[CHEBI:62313]", "publication": ["PMID:12401210", "PMID:16995838", "PMID:27318475"], "term_xref": ["GlycoEpitope:EP0099", "GlycoMotif:GGM.000080", "CID:73427363", "CHEBI:62313"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0099", "content": "renal cell carcinoma/RCC"}]}
{"raw_term": "Mono-sulfated globopentaosylceramide", "normalized_term": "monosulfated globopentaosylceramide", "retain": "keep", "synonyms": ["Monosulfated globopentaosylceramide"], "gsd_id": "GSD000126", "glytoucan_id": ["G80193TN"], "term_in_sentence": "Mono-sulfated globopentaosylceramide from human kidney.[PMID:2777788]", "definition": "", "publication": ["PMID:2777788"], "term_xref": ["GlycoMotif:GGM.000072"], "function": [], "disease_associations": []}
{"raw_term": "Mono-sulfated globotetraosylceramide", "normalized_term": "monosulfated globotetraosylceramide", "retain": "keep", "synonyms": [], "gsd_id": "GSD000127", "glytoucan_id": ["G05297EK"], "term_in_sentence": "Mono-sulfated globotetraosylceramide from human kidney.[PMID:2559078]", "definition": "", "publication": ["PMID:2559078"], "term_xref": ["GlycoMotif:GGM.000073"], "function": [], "disease_associations": []}
{"raw_term": "N-acetyl GM2", "normalized_term": "N-acetyl GM2", "retain": "keep", "synonyms": [], "gsd_id": "GSD000128", "glytoucan_id": ["G79389NT"], "term_in_sentence": "The appearance of the N-acetyl GM2 antigen correlated well with the degree of differentiation of the cancer cells in patients with squamous cell carcinoma and adenocarcinoma of the lung.[PMID:3167861]", "definition": "beta-D-GalpNAc-(1-&gt;4)-[alpha-Neup5Ac-(2-&gt;3)]-beta-D-Galp-(1-&gt;4)-beta-D-Glcp is a branched amino tetrasaccharide consisting of the linear sequence β-D-GalNAc-(1→4)-β-D-Gal-(1→4)-β-D-Glc having a Neu5Ac residue attached to the galactose via an α-(2→3) linkage. Corresponds to the carbohydrate portion of ganglioside GM2.[CHEBI:59220]", "publication": ["PMID:3167861", "PMID:2153431", "PMID:25673107"], "term_xref": ["GlycoEpitope:EP0051", "CID:45266845", "CHEBI:59220"], "function": [{"src": "CHEBI:59220", "content": "The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds."}], "disease_associations": [{"src": "GlycoEpitope:EP0051", "content": "lung adenocarcinoma"}, {"src": "GlycoEpitope:EP0051", "content": "embryonal carcinoma"}, {"src": "GlycoEpitope:EP0051", "content": "germ cell tumor"}, {"src": "GlycoEpitope:EP0051", "content": "teratocarcinoma"}, {"src": "GlycoEpitope:EP0051", "content": "squamous cell carcinoma"}]}
{"raw_term": "N-acetyllactosamine (Type 1)", "normalized_term": "N-acetyllactosamine (type 1)", "retain": "keep", "synonyms": ["LacNAc type 1", "Type 1 LN", "Type-1 lactosamine"], "gsd_id": "GSD000181", "glytoucan_id": ["G00056MO"], "term_in_sentence": "The N-acetyllactosamine type 1 (LacNAc type 1, Galβ1,3GlcNAc) is a well-known precursor of several important blood group epitopes, such as Lewis A, Lewis B, or sialyl Lewis A [1], which are involved in many biological processes, e.g., fertilization [2] and pathogen adhesion [3]. [PMID:28796164]", "definition": "", "publication": ["PMID:28796164", "PMID:28167527"], "term_xref": ["GlycoMotif:GGM.000005"], "function": [], "disease_associations": []}
{"raw_term": "N-acetyllactosamine (Type 2)", "normalized_term": "N-acetyllactosamine (type 2)", "retain": "keep", "synonyms": ["LacNAc", "Type 2 LN"], "gsd_id": "GSD000129", "glytoucan_id": ["G00055MO"], "term_in_sentence": "Utilising a fast and sensitive screening method based on imidazolium-tagged probes, we report unprecedented reversible activity of bacterial beta1,4-galactosyltransferases to catalyse the transgalactosylation from lactose to N-acetylglucosamine to form N-acetyllactosamine in the presence of UDP.[PMID:31165848]", "definition": "N-acetyllactosamine is a beta-D-galactopyranosyl-(1→4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. It is also known as galb1-4glcnacb or lacnac, belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through N-acyl group. N-Acetyllactosamine is an extremely weak basic (essentially neutral) compound (based on its pKa). N-Acetyllactosamine exists in all living organisms, ranging from bacteria to humans.[CHEBI:16153,HMDB0001542]", "publication": ["PMID:31165848", "PMID:31126011", "PMID:28796164", "PMID:6236210", "PMID:9751793", "PMID:29740087", "PMID:9151975", "PMID:10567443", "PMID:21472942", "PMID:26477523", "PMID:6548353", "PMID:28167527", "PMID:20056550", "PMID:7737204", "PMID:22052010", "PMID:10223649", "PMID:11323440", "PMID:10420596", "PMID:7766648", "PMID:25257940", "PMID:17977857", "PMID:15556936", "PMID:26541999", "PMID:23650594", "PMID:9692202", "PMID:29429899", "PMID:21062783", "PMID:25034434", "PMID:8985145", "PMID:28503789", "PMID:8720464/"], "term_xref": ["CID:439271", "CHEBI:16153", "MeSH:C000458", "GlycoMotif:GGM.000001"], "function": [], "disease_associations": []}
{"raw_term": "N-Glycolyl-GM2", "normalized_term": "N-glycolyl GM2", "retain": "keep", "synonyms": [], "gsd_id": "GSD000130", "glytoucan_id": ["G56478LD"], "term_in_sentence": "The monoclonal antibodies MK2-34 and MK1-16 (both IgM), which specifically detect N-glycolyl GM2 and N-acetyl GM2, respectively, were generated by immunizing mice with liposomes containing monophosphoryl lipid A, trehalose dimycolate, and the antigenic ganglioside.[PMID:3167861]", "definition": "(2S,4S,5R,6R)-2-[(2R,3S,4R,5R,6S)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-5-[(2-hydroxyacetyl)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid is a member of carbohydrates and carbohydrate derivatives.[CHEBI:151464]", "publication": ["PMID:3167861", "PMID:11861662", "PMID:17980710", "PMID:3731079", "PMID:25673107"], "term_xref": ["GlycoEpitope:EP0052", "CID:91845742", "CHEBI:151464", "GlycoEpitope:GGM.000096"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0052", "content": "choriocarcinoma"}, {"src": "unknown", "content": "teratocarcinoma"}, {"src": "GlycoEpitope:EP0052", "content": "[GlycoEpitope:EP0052]yolk sac tumor"}]}
{"raw_term": "N-linked glycans", "normalized_term": "N-glycans", "retain": "keep", "synonyms": [], "gsd_id": "GSD000131", "glytoucan_id": ["G78059CC"], "term_in_sentence": "Our study identifies extracellular N-linked glycans-and the glycoprotein neurexin 1β specifically-as key modulators of neuronal uptake of αSacetyl, drawing attention to the potential therapeutic value of αSacetyl-glycan interactions.[PMID:31211781]", "definition": "The carbohydrate portion of a glycoprotein that has a glycan linked through the nitrogen of an asparagine side-chain.[CHEBI:59520]", "publication": ["PMID:31211781", "PMID:28384382", "PMID:30305477", "PMID:31364612", "PMID:26899268", "PMID:29945790", "PMID:29652253", "PMID:29723274", "PMID:30962676", "PMID:29778448", "PMID:25325701", "PMID:31100702", "PMID:28898525", "PMID:22944671", "PMID:19277537", "PMID:24473128", "PMID:17957771", "PMID:27554083", "PMID:15189166", "PMID:11269317", "PMID:19577919", "PMID:24303005", "PMID:12042249", "PMID:22191536", "PMID:28324664", "PMID:25965797", "PMID:25434632", "PMID:30484244", "PMID:28110657", "PMID:29865036", "PMID:20129637", "PMID:27346875", "PMID:30280442", "PMID:26911286", "PMID:22491358", "PMID:26582281", "PMID:26398792", "PMID:31548313", "PMID:31066275", "PMID:28331984", "PMID:25482090", "PMID:28518173", "PMID:30733536", "PMID:22326428", "PMID:30063825", "PMID:30315103", "PMID:21558494", "PMID:31676555", "PMID:31256374"], "term_xref": ["CID:70679232", "CHEBI:70967"], "function": [{"src": "PMID: 25151374", "content": "N-glycans modulate the function of several cell surface proteins which involved in migration, adhesion and which are responsible for regulating myelination."}, {"src": "PMID: 25151374", "content": "Affect transportation of the glycosylated proteins in the Golgi."}, {"src": "PMID: 25151374", "content": "Affects cell-cell interaction, adhesion, expression, proper folding."}, {"src": "unknown", "content": "extracellular N-glycans act as key modulators of neuronal uptake of αacetyl [PMID: 31211781]."}], "disease_associations": [{"src": "PMID:17392038", "content": "Rheumatoid arthritis"}, {"src": "PMID:29146600", "content": "Type 1 Diabetes"}, {"src": "PMID: 23766031", "content": "Lung Cancer"}]}
{"raw_term": "Nonfucosylated", "normalized_term": "nonfucosylated N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000132", "glytoucan_id": [], "term_in_sentence": "In the carbohydrate moiety , alpha-subunit from normal pregnancy hCG contained nonfucosylated , mono- and biantennary N-linked structures (49.3 and 36.7%, means); fucosylated biantennary and triantennary oligosaccharides were also identified (7.3 and 6.9%).[PMID:9449027]", "definition": "glycans without a fucose component/monosaccharide residue.", "publication": ["PMID:9449027", "PMID:30258536", "PMID:23554380", "PMID:16675584", "PMID:26747427", "PMID:22457527", "PMID:24362443", "PMID:19657637", "PMID:8811881", "PMID:19218011", "PMID:20022111", "PMID:17363544", "PMID:17368483", "PMID:20564614", "PMID:27054024", "PMID:28397880", "PMID:31490688", "PMID:31860772", "PMID:17012310", "PMID:29633346", "PMID:9442021", "PMID:30350565", "PMID:30296068", "PMID:31800250", "PMID:30021910", "PMID:31133022", "PMID:29224385", "PMID:28630087", "PMID:26444434", "PMID:31697975", "PMID:30991260"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Nonfucosylated biantennary", "normalized_term": "nonfucosylated biantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000133", "glytoucan_id": [], "term_in_sentence": "Structural analysis combining methylation-mass spectrometry and 400 MHz 1H-n.m.r. spectrometry of oligosaccharide alditols released from human leucocyte lactotransferrin shows the presence of two disialylated and non-fucosylated biantennary glycans of the N-acetyl-lactosaminic type.[PMID:2390069]", "definition": "A biantennary glycan with two GlcNAc branches linked to the core and no fucose appears.", "publication": ["PMID:2390069", "PMID:9449027", "PMID:1375510", "PMID:9101715", "PMID:2390069", "PMID:2332109"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Nonfucosylated triantennary", "normalized_term": "nonfucosylated triantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000135", "glytoucan_id": [], "term_in_sentence": "Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.[PMID:7679920]", "definition": "A triantennary N-linked glycan with three GlcNAc branches linked to the core and no fucose appears.", "publication": ["PMID:7679920", "PMID:23274891"], "term_xref": [], "function": [{"src": "PMID:7679920", "content": "Appears in human alpha-fetoprotein (AFP)."}], "disease_associations": [{"src": "unknown", "content": "hepatocellular carcinoma[PMID:7679920]."}]}
{"raw_term": "Nonsialylated", "normalized_term": "nonsialylated N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000136", "glytoucan_id": [], "term_in_sentence": "The pattern of nonsialylated oligosaccharides was used for interpretation of the fully sialylated species using bioinformatics tools. From pooled human plasma, we find 90, 101, and 64 different glycan compositions for genetic variants ORM1*F1, ORM1*S, and ORM2, respectively. Glycan structures carry dominantly between 15 and 16 sialic acids indicating an almost complete termination of all antenae with sialic acid.[PMID:30295034]", "definition": "A glycan which is not sialylated.", "publication": ["PMID:14533820", "PMID:1377689", "PMID:9705949", "PMID:30788437", "PMID:28090561", "PMID:12498371", "PMID:26839900", "PMID:31490688", "PMID:2656426", "PMID:30295034", "PMID:31545048", "PMID:12381155", "PMID:25730103", "PMID:26787879", "PMID:25646460", "PMID:29224385", "PMID:26063435", "PMID:26954852", "PMID:32889432", "PMID:2825412", "PMID:27504786", "PMID:22431161"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "O-fucose glycans", "normalized_term": "O-fucose glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000137", "glytoucan_id": ["G39294YF"], "term_in_sentence": "Recently, a number of laboratories have shown that O-fucose glycans on the epidermal growth factor (EGF)-like repeats of the Notch extracellular domain modulate Notch signaling.[PMID:12417415]", "definition": "Form of glycosylation where the protein is modified by a fucose residue and can be extended futher to form a tetrasaccharide in certain cases. alpha-linked o-fucose have a consensus motif of C2X4(s/T)C3 where C2 and C3 are conserved cysteines number 2 and 3 respectively of the EGFR like repeats. [Essentials of Glycobiology:Chapter13]", "publication": ["PMID:19594638", "PMID:30690220", "PMID:18952191", "PMID:22415200", "PMID:12417415", "PMID:16400812", "PMID:18948267", "PMID:21464368", "PMID:20816394", "PMID:30207383", "PMID:20301232", "PMID:27129198", "PMID:17132502", "PMID:22492969", "PMID:30030822", "PMID:30214079", "PMID:26175457", "PMID:25378397", "PMID:18272537", "PMID:28729422", "PMID:11524432", "PMID:31722217", "PMID:23045360", "PMID:24803430", "PMID:28876865", "PMID:25700513", "PMID:32518939", "PMID:30523691", "PMID:18227520", "PMID:20816217", "PMID:24909690", "PMID:17964136", "PMID:12036964", "PMID:27268051", "PMID:15653671", "PMID:19948734", "PMID:31590629", "PMID:32201074", "PMID:15189151", "PMID:17263732", "PMID:32913123", "PMID:12909620", "PMID:28785176", "PMID:17132500", "PMID:22949680", "PMID:25053492", "PMID:28939751"], "term_xref": ["GlycoEpitope:EP0005"], "function": [{"src": "GlycoEpitope:EP0005", "content": "modification of Notch signaling."}], "disease_associations": []}
{"raw_term": "O-GlcNAc", "normalized_term": "O-linked N-acetylglucosamine", "retain": "keep", "synonyms": [], "gsd_id": "GSD000138", "glytoucan_id": ["G49108TO"], "term_in_sentence": "A better understanding of the mechanisms of OGT/OGA action would enable us to derive therapeutic benefits of resetting cellular O-GlcNAc levels within an optimal range.[PMID:30464755]", "definition": "Form of glycosylation which exclusively occurs in the mitochondrial, cytoplasmic or nuclear compartments of the cell where the protein is modified by a GlcNAc monosaccharide on the serine or threonine residues and is generally not modified or elongated further to form more complex structures. [Essentials of Glycobiology:Chapter19]", "publication": ["PMID:30464755", "PMID:29049853", "PMID:29594839", "PMID:31654859", "PMID:29404877", "PMID:30105004", "PMID:30669087", "PMID:29790000", "PMID:28408483", "PMID:26862193", "PMID:30523150", "PMID:30037904", "PMID:28408480", "PMID:29352075", "PMID:29456783", "PMID:29577901", "PMID:29223644", "PMID:28638491", "PMID:30221662", "PMID:29904918", "PMID:32155042", "PMID:30298013", "PMID:31630803", "PMID:31847126", "PMID:29784830", "PMID:30181664", "PMID:28768194", "PMID:30134155", "PMID:25336654", "PMID:30356792", "PMID:30199580", "PMID:32329777", "PMID:28408494", "PMID:29774032", "PMID:29044951", "PMID:23836420", "PMID:20301273", "PMID:29772801", "PMID:28922739", "PMID:30100348", "PMID:30793403", "PMID:30657688", "PMID:31237748", "PMID:29756380", "PMID:29954943", "PMID:30018219", "PMID:32207184", "PMID:25566193", "PMID:30626734", "PMID:24759912"], "term_xref": ["GlycoEpitope:EP0004", "CID:24139", "HMDB:HMDB0000803"], "function": [], "disease_associations": []}
{"raw_term": "O-linked glycans", "normalized_term": "O-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000139", "glytoucan_id": [], "term_in_sentence": "Among these, six fucosylated N-linked glycansand four O-linked glycans exhibited significantly increased expression levels in GC, while five fucosylated N-linked glycans and ten fucosylated O-linked glycans exhibited significantly decreased expression levels in GC.[PMID:29865036]", "definition": "The carbohydrate portion of a glycoprotein that has a glycan linked through the hydroxyl oxygen of serine, threonine, hydroxylysine or hydroxyproline side-chains.[CHEBI:59521]", "publication": ["PMID:29865036", "PMID:30952424", "PMID:31611643", "PMID:19577919", "PMID:32019882", "PMID:19139197", "PMID:26184710", "PMID:11159917", "PMID:21536259", "PMID:25186198", "PMID:19277556", "PMID:22261557", "PMID:24115046", "PMID:18725413", "PMID:15966855", "PMID:24256304", "PMID:25477510", "PMID:10359703", "PMID:24406064", "PMID:22259135", "PMID:29279989", "PMID:15966855", "PMID:30619255", "PMID:9673446", "PMID:31676555", "PMID:28745859", "PMID:28196325", "PMID:27975143", "PMID:30591584", "PMID:28518173", "PMID:17522109", "PMID:26328495", "PMID:32178593", "PMID:27529638", "PMID:24663386", "PMID:22474328", "PMID:28096352", "PMID:27496768", "PMID:18952191", "PMID:11135308", "PMID:24917611", "PMID:11532966", "PMID:22786570", "PMID:11891229", "PMID:18332077", "PMID:26867212", "PMID:26925665", "PMID:16769205", "PMID:23475718", "PMID:16005634", "PMID:28785176"], "term_xref": ["CHEBI:59521"], "function": [{"src": "PMID:9673446", "content": "Affects several important activities like protein stability, modulation of signaling molecules and enzyme activity."}], "disease_associations": []}
{"raw_term": "O-linked mannose", "normalized_term": "O-mannose glycan", "retain": "keep", "synonyms": ["O-mannosyl glycan"], "gsd_id": "GSD000140", "glytoucan_id": ["G59126YU"], "term_in_sentence": "Protein O-linked mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGNT2) catalyzes the first step toward the functional matriglycan structure on alpha-dystroglycan that is responsible for binding extracellular matrix proteins and certain arenaviruses.[PMID: 27932460]", "definition": "O-linked glycans that are initiated by the addtion of a Man residue to Ser or Thr. Subsequent extension of the Man defines the O-Man core type, either M1, M2, or M3. The M1 type is initated by addition of a GlcNAc in β-linkage to the 2 position of the Man residue. M2 is initiated by addition of another GlcNAc to the 6 position of the M1 core. M3 is initiated by the addition of a GlcNAc in β-linkage to the 4 position of the Man residue. M1 and M2 type core glycans can be extended and branched with Gal, Fuc, Sialic Acid, and GlcA. The M3 core is uniquely extended by a multienzyme system to generate the matriglycan polysaccharide, a protein-specific modification found only on alpha-dystroglycan. [CHEBI:87761]", "publication": ["PMID:27932460", "PMID:24526361", "PMID:25381909", "PMID:26644575", "PMID:23851827", "PMID:28810660", "PMID:19054127", "PMID:23929950", "PMID:21684258", "PMID:22608994", "PMID:28973932", "PMID:24733390", "PMID:31851597", "PMID:29884773", "PMID:28711406", "PMID:14577328", "PMID:21089343", "PMID:14617637", "PMID:9838223", "PMID:17072003", "PMID:26328495", "PMID:11181560", "PMID:31949166", "PMID:31988979", "PMID:20362685", "PMID:27733679", "PMID:27493216", "PMID:20044576", "PMID:30643095", "PMID:29732660", "PMID:10580142", "PMID:14568618", "PMID:28079948", "PMID:15467391", "PMID:27812179", "PMID:23761899", "PMID:25737452", "PMID:32930586", "PMID:25381372", "PMID:23434682", "PMID:16857188", "PMID:21452199", "PMID:19429925", "PMID:25361541", "PMID:24297939", "PMID:30322079", "PMID:23428289", "PMID:28427937", "PMID:22746206", "PMID:27533452", "PMID:17502374", "PMID:20816174", "PMID:27496765"], "term_xref": ["GlycoMotif:GGM.000055", "CHEBI:87761", "GlycoEpitope:EP0002", "CID:91859038"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0002", "content": "MEB/muscle-eye-brain disease"}, {"src": "unknown", "content": "WWS/walker-warburg syndrome"}, {"src": "GlycoEpitope:EP0002", "content": "muscular dystrophy"}, {"src": "GlycoEpitope:EP0002", "content": "neuronal migration disorder"}, {"src": "GlycoEpitope:EP0002", "content": "Muscle-Eye-Brain disease (MEB) and Walker-Warburg Syndrome (WWS) have mutations in genes encoding glycosyltransferases needed for O -mannosyl oligosaccharide synthesis"}, {"src": "GlycoEpitope:EP0002", "content": "Muscular dystrophy and neuronal migration disorder are caused by mutations in a glycosyltransferase, POMGnT1."}]}
{"raw_term": "P1 antigen", "normalized_term": "P1 antigen", "retain": "keep", "synonyms": [], "gsd_id": "GSD000141", "glytoucan_id": ["G12460DL"], "term_in_sentence": "The P1 antigen was disovered in 1927 by Landsteiner and Levine, and Pk and NOR were described in 1951 and 1982, respectively.[PMID: 24046920]", "definition": "An amino pentasaccharide consisting of α-D-galactose, β-D-galactose N-acetyl-α-D-glucosamine, β-D-galactose, and β-D-glucose residues joined in sequence with ((1→4)-, (1→4)-, (1→3)- and (1→4)-linkages, respectively.[CHEBI:68484]", "publication": ["PMID:29622537", "PMID:26773500", "PMID:24046920", "PMID:6207232", "PMID:8550516", "PMID:6609976", "PMID:6375319", "PMID:817855", "PMID:2428855", "PMID:3312011", "PMID:15364312", "PMID:1937801", "PMID:7729906"], "term_xref": ["GlycoMotif:GGM.000069", "CID:71296137", "CHEBI:68484", "SugarBind_Ligand:160"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:160", "content": "Shigellosis"}]}
{"raw_term": "Para-Forssman glycolipid", "normalized_term": "Para-Forssman glycolipid", "retain": "keep", "synonyms": [], "gsd_id": "GSD000142", "glytoucan_id": ["G51699SI"], "term_in_sentence": "A novel pentaglycosyl ceramide containing di-beta-N-acetylgalactos-aminyl residue (Para-Forssman glycolipid) isolated from human erythrocyte membrane. [PMID:6814203]", "definition": "GalNAcβ1→3GalNAcβ1→3Galα1→4Galβ1→4Glcβ1→1Cer [https://doi.org/10.1016/S0040-4039(01)93814-6]", "publication": ["PMID:6814203"], "term_xref": ["GlycoMotif:GGM.000085", "CID:56836111", "KEGG:G00096", "SugarBind_Ligand:19", "CHEBI:151565"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:19", "content": "Actinomycosis"}]}
{"raw_term": "Paragloboside", "normalized_term": "paragloboside", "retain": "keep", "synonyms": [], "gsd_id": "GSD000143", "glytoucan_id": ["G58896AZ"], "term_in_sentence": "Galactosyltransferase activities in sera of cancer patients were determined by assaying the formation of paragloboside from UDP-galactose and lactotriaosylceramide immobilized on microtiter plates by means of the enzyme-linked immunosorbent assay using a monoclonal antibody, H-11, directed to paragloboside. [PMID: 1551117]", "definition": "α-Neup5Ac-(2→3)-β-D-Galp-(1→3)-D-GalpNAc in which the configuration at the GalNAc anomeric carbon is α.[CHEBI:65257]", "publication": ["PMID:3345524", "PMID:850070", "PMID:10569746", "PMID:30624951", "PMID:29438961", "PMID:6816790", "PMID:1551117", "PMID:6865961", "PMID:25039255"], "term_xref": ["GlycoMotif:GGM.000077", "CID:21670519", "CHEBI:65257", "GlycoEpitope:EP0075", "SugarBind_Ligand:15"], "function": [], "disease_associations": [{"src": "SugarBind_Ligand:15", "content": "Pharyngitis"}, {"src": "SugarBind_Ligand:15", "content": "Tracheobronchitis"}, {"src": "SugarBind_Ligand:15", "content": "Gonorrhea"}, {"src": "SugarBind_Ligand:15", "content": "Actinomycosis"}, {"src": "SugarBind_Ligand:15", "content": "Diarrhea"}, {"src": "SugarBind_Ligand:15", "content": "Hemorrhagic colitis"}, {"src": "SugarBind_Ligand:15", "content": "Chronic gastritis"}, {"src": "SugarBind_Ligand:15", "content": "Peptic ulcers"}, {"src": "SugarBind_Ligand:15", "content": "Gastric cancer"}, {"src": "SugarBind_Ligand:15", "content": "Influenza"}]}
{"raw_term": "Paucimannose", "normalized_term": "paucimannose N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000144", "glytoucan_id": [], "term_in_sentence": "The galactosylation of core fucose (GalFuc epitope) in paucimannose and complex-type N-glycans is characteristic of protostome organisms, including flatworms (planarians).[PMID:29475940]", "definition": "Any N-linked glycan derivative with composition Man1-4Fuc0-1 GlcNAc2, in which the chitobiose core (GlcNAc2) is intact. Found in relatively large amounts in invertebrates and plants, they are formed by removal of the non-reducing terminal GlcNAc (\\added by GlcNAcT1) from GlcNAcMan3-5GlcNAc2 by a Golgi hexosaminidase and subsequent removal of Man residues by Golgi mannosidases. Pauscimannose glycans have also been detected in vertebrates.[CHEBI:144386]", "publication": ["PMID:29475940", "PMID:29803109", "PMID:12603202", "PMID:31817246", "PMID:31719144", "PMID:21057214", "PMID:31932305", "PMID:17132514", "PMID:30382146", "PMID:27731363", "PMID:31325506", "PMID:25746926", "PMID:26513758", "PMID:16522637", "PMID:21169367", "PMID:25190359", "PMID:27928741", "PMID:22496646", "PMID:27384337", "PMID:16897177", "PMID:15228383", "PMID:27379103", "PMID:27189951", "PMID:23475714", "PMID:24907509", "PMID:20558211", "PMID:28060516", "PMID:20441997", "PMID:27720757", "PMID:28817611", "PMID:24550396", "PMID:19494052", "PMID:19515361", "PMID:28630087", "PMID:31320997", "PMID:30651366", "PMID:30253927", "PMID:25922361", "PMID:31655162", "PMID:18056652", "PMID:24467287", "PMID:32367383"], "term_xref": ["CHEBI:144386"], "function": [], "disease_associations": []}
{"raw_term": "Polysialic acid", "normalized_term": "polysialic acid", "retain": "keep", "synonyms": ["polySia", "PSA"], "gsd_id": "GSD000182", "glytoucan_id": [], "term_in_sentence": "Polysialic acid (PSA) is a carbohydrate composed of a linear polymer of α2,8-linked sialic acids, primarily attached to the Neural Cell Adhesion Molecule (NCAM). [PMID:36076963]", "definition": "", "publication": ["PMID:36076963", "PMID:35222358"], "term_xref": ["GlycoMotif:GGM.000252"], "function": [], "disease_associations": []}
{"raw_term": "Seminolipid", "normalized_term": "seminolipid", "retain": "keep", "synonyms": [], "gsd_id": "GSD000147", "glytoucan_id": ["G72548RZ"], "term_in_sentence": "A concise total synthesis of seminolipid, a sulfoglycolipid, has been achieved; key features include regioselective, tin-free sulfation of allyl β-d-galactopyranoside using 2,6-bis(trifluoromethyl)phenylboronic acid as protective reagent, stereoselective epoxidation, and site-selective acylation. [PMID: 31353379]", "definition": "", "publication": ["PMID:31353379", "PMID:31736776", "PMID:12810822", "PMID:19582571", "PMID:19542524", "PMID:20670037", "PMID:15659616", "PMID:20817833", "PMID:870059", "PMID:10801776", "PMID:21965315", "PMID:8095813", "PMID:1280685", "PMID:4690236", "PMID:34199863", "PMID:4207869", "PMID:2373957", "PMID:845131"], "term_xref": ["GlycoMotif:GGM.000062"], "function": [], "disease_associations": []}
{"raw_term": "Sialopentaosylceramide", "normalized_term": "sialopentaosylceramide", "retain": "keep", "synonyms": [], "gsd_id": "GSD000148", "glytoucan_id": ["G13224CR"], "term_in_sentence": "Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosap[PMID: 2139874]", "definition": "A ganglioside in which the oligosaccharide portion is composed of a pentasaccharide containing one or more sialic acid residues.[CHEBI:36542]", "publication": ["PMID:2139874"], "term_xref": ["GlycoMotif:GGM.000097", "CID:91859576", "CHEBI:148045", "KEGG:G00883", "CHEBI:36542"], "function": [], "disease_associations": []}
{"raw_term": "Sialosyl paragloboside", "normalized_term": "sialosyl paragloboside", "retain": "keep", "synonyms": [], "gsd_id": "GSD000149", "glytoucan_id": ["G50123ZO"], "term_in_sentence": "Unlike CNS myelin, human peripheral nerve myelin has the acidic glycosphingolipids sialosyl paragloboside (SPG), sialosyl lactosaminyl paragloboside (SLPG), and sulfated glucuronyl paragloboside (SGPG).[PMID:8862128]", "definition": "α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-D-GlcpNAc with β configuration at the anomeric position of the reducing-end N-acetyl-D-glucosamine residue.[CHEBI:71612]", "publication": ["PMID:8862128", "PMID:7236652", "PMID:2370108", "PMID:3133978", "PMID:2905604", "PMID:1749114", "PMID:1573418"], "term_xref": ["GlycoMotif:GGM.000081", "CID:91845504", "KEGG:G01429", "CHEBI:151914"], "function": [], "disease_associations": []}
{"raw_term": "Sialyl Lewis a", "normalized_term": "sialyl Lewis a", "retain": "keep", "synonyms": ["SLea", "CA19-9", "CA19-9 antigen", "SLe^a", "Slea"], "gsd_id": "GSD000150", "glytoucan_id": ["G00053MO"], "term_in_sentence": "By comparing the serum O-glycan profiles from healthy controls with those of cancer patients, we identified a marker candidate, core 1 sialyl Lewis A (NeuAcα2-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Gal) (abbreviated C1SLA), whose concentration appeared to be weakly correlated with CA19-9 values.[PMID:26641888]", "definition": "A sialyated version of Lewis A with a branched structure of amino tetrasaccharide consisting of a sialyl residue, linked (2→3) to a galactosyl residue that in turn is linked (1→3) to a glucosaminyl residue at the reducing end, which is also carrying a fucosyl residue at the 4-position.[CHEBI:62681]", "publication": ["PMID:26641888", "PMID:31424423", "PMID:26530370", "PMID:17760270", "PMID:18343410", "PMID:16033091", "PMID:8829184", "PMID:11907351", "PMID:20592391", "PMID:26641888", "PMID:24128856", "PMID:30249386", "PMID:10773785", "PMID:16149606", "PMID:10996727", "PMID:10436809", "PMID:10667238", "PMID:7720892", "PMID:7630017", "PMID:10612415", "PMID:9836451", "PMID:12511721", "PMID:22623153"], "term_xref": ["GlycoEpitope:EP0008", "CID:53356732", "CHEBI:62681", "GlycoMotif:GGM.000024"], "function": [{"src": "GlycoEpitope:EP0008", "content": "The carbohydrate determinants,Sialyl Lea and Sialyl Lex,which are frequently expressed on human cancer cells,serve as ligands for a cell adhesion molecule of the selectin family,E-selectin,which is expressed on vascular endothelial cells. These carbohydrate determinants are involved in the adhesion of cancer cells to vascular endothelium and thus contribute to hematogenous metastasis of cancer."}], "disease_associations": [{"src": "GlycoEpitope:EP0008", "content": "pancreatic adenocarcinoma"}, {"src": "GlycoEpitope:EP0008", "content": "hepatocellular cancer"}, {"src": "GlycoEpitope:EP0008", "content": "cholangiocellular cancer"}, {"src": "unknown", "content": "gastric cancer"}, {"src": "GlycoEpitope:EP0008", "content": "[GlycoEpitope:EP0008]colorectal cancer"}, {"src": "GlycoEpitope:EP0008", "content": "ovarian cancer"}, {"src": "GlycoEpitope:EP0008", "content": "lung cancer"}, {"src": "GlycoEpitope:EP0008", "content": "breast cancer"}, {"src": "GlycoEpitope:EP0008", "content": "uterine cancer"}]}
{"raw_term": "Sialyl Lewis x", "normalized_term": "sialyl Lewis x", "retain": "keep", "synonyms": ["SLe(x)", "SLe^x", "SLex", "Slex"], "gsd_id": "GSD000151", "glytoucan_id": ["G00054MO"], "term_in_sentence": "As sialyl Lewis X is a lignad of the selectin family, it has been proposed that sialyl Lewis X-rich colon cancer cells metastasize to the liver by adhesion to selectins on hepatic endothelial cells.[PMID:12828079]", "definition": "A sialylated version of Lewis X antigen expressed on cell surfaces with structure alpha-Neup5Ac-(2-&gt;3)-beta-D-Galp-(1-&gt;4)-[alpha-L-Fucp-(1-&gt;3)]-beta-D-GlcpNAcis α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-[α-L-Fucp-(1→3)]-D-GlcpNAc in which the anomeric configuration of the reducing-end N-acetyl-beta-D-glucosamine residue is beta. It is a ligand for selectins. [MESH:2030970,CHEI:71622]", "publication": ["PMID:12828079", "PMID:8940172", "PMID:10075923", "PMID:19054801", "PMID:9642161", "PMID:31054033", "PMID:15229399", "PMID:29061785", "PMID:16033070", "PMID:10728707", "PMID:9556613", "PMID:8940172", "PMID:9298692", "PMID:18607721", "PMID:22593503", "PMID:25944902", "PMID:9642161", "PMID:15780091", "PMID:20401888"], "term_xref": ["GlycoEpitope:EP0012", "CID:44456859", "CHEBI:71622", "MESH:2030970", "GlycoMotif:GGM.000022"], "function": [{"src": "GlycoEpitope:EP0012", "content": "Sialyl Lex was shown to be a specific ligand on human leukocytes for vascular E- and P-selectins,and was shown to mediate leukocyte recruitment."}, {"src": "GlycoEpitope:EP0012", "content": "The determinant is also frequently expressed on human cancer cells,and is involved in the adhesion of cancer cells to vascular endothelium and thus contribute to hematogenous metastasis of cancer."}], "disease_associations": [{"src": "GlycoEpitope:EP0012", "content": "colon cancer"}, {"src": "GlycoEpitope:EP0012", "content": "colorectal cancer"}]}
{"raw_term": "Sialyl T antigen", "normalized_term": "sialyl T antigen", "retain": "keep", "synonyms": [], "gsd_id": "GSD000153", "glytoucan_id": ["G65562ZE"], "term_in_sentence": "The expression and functional analysis of the sialyl-T antigen in prostate cancer.[PMID:32583304]", "definition": "Alpha-Neup5Ac-(2→3)-beta-D-Galp-(1→3)-alpha-D-GalpNAc is alpha-Neup5Ac-(2→3)-beta-D-Galp-(1→3)-D-GalpNAc in which the configuration at the GalNAc anomeric carbon is alpha. It has a role as an epitope.[CHEBI:65257]", "publication": ["PMID:32583304", "PMID:31897478", "PMID:31719620", "PMID:10365852", "PMID:25727149", "PMID:11523928", "PMID:20407596", "PMID:25464017", "PMID:30864133", "PMID:26391208", "PMID:19811634", "PMID:29796594", "PMID:23725156", "PMID:8905873", "PMID:11192238", "PMID:18275089", "PMID:27037304", "PMID:11949946", "PMID:15604091", "PMID:24118321"], "term_xref": ["GlycoMotif:GGM.000013", "CID:44611726", "CHEBI:65257"], "function": [], "disease_associations": []}
{"raw_term": "Sialylated biantennary", "normalized_term": "sialylated biantennary N-glycan", "retain": "keep", "synonyms": ["sialyl biantennary"], "gsd_id": "GSD000154", "glytoucan_id": [], "term_in_sentence": "Simbucus nigra agglutinin or an antibody specific to sialylated lactosamine with a preference for Neu5Acalpha2-6Gal rather than Neu5Acalpha2-3Gal reduced sperm binding to oviduct isthmic cells, as did occupying putative receptors on sperm with sialylated biantennary glycans.[PMID:23115267]", "definition": "A binantennary glycan with one or two sialic acid residues as non-reducing terminal residues on one or both antennae. [RN]", "publication": ["PMID:23115267", "PMID:31510952", "PMID:29265394", "PMID:31589880", "PMID:3979568", "PMID:26045275", "PMID:29029079", "PMID:30252064"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Sialylated complex-type", "normalized_term": "sialylated complex-type N-glycan", "retain": "keep", "synonyms": ["sialo-complex type"], "gsd_id": "GSD000155", "glytoucan_id": [], "term_in_sentence": "By using 1H-NMR spectroscopy we were able to establish that our product contains a single N-linked biantennary , fully sialylated complex-type oligosaccharide , typical of human hepatomas.[PMID:1694115]", "definition": "Complex N-linked glycan that have added GlcNAc residues at both the α-3 and α-6 mannose sites and do not contain mannose residues apart from the core structure but with sialic acid residues.", "publication": ["PMID:1694115", "PMID:15201278", "PMID:30471292", "PMID:30969765", "PMID:11058758", "PMID:28342150"], "term_xref": [], "function": [{"src": "PMID:20647032 ", "content": "enhance the signaling activity of soluble intercellular adhesion molecule-1 in mouse astrocytes [PMID: 15201278] Appears in IgG-Fc."}], "disease_associations": []}
{"raw_term": "Sialylated LacdiNAc", "normalized_term": "sialylated LacdiNAc", "retain": "keep", "synonyms": ["sialylated-LacdiNAc", "Sialylated LDN"], "gsd_id": "GSD000192", "glytoucan_id": ["G55583HW"], "term_in_sentence": "The major non-reducing epitopes in the complex-type glycans are: Gal beta 1-4GlcNAc (lacNAc), GalNAc beta 1-4GlcNAc (lacdiNAc), NeuAc alpha 2-6Gal beta 1-4GlcNAc (sialylated lacNAc), NeuAc alpha 2-6Gal beta 1-4GlcNAc (sialylated lacdiNAc), Gal beta 1-4(Fuc alpha 1-3)GlcNAc (Lewisx), and GalNAc beta 1-4(Fuc alpha 1-3)GlcNAc (lacdiNAc analogue of Lewisx).[PMID:7592613]", "definition": "", "publication": ["PMID:7592613", "PMID:34192302", "PMID:19756298", "PMID:16286643"], "term_xref": ["GlycoMotif:GGM.000050"], "function": [], "disease_associations": []}
{"raw_term": "Sialylated tetraantennary", "normalized_term": "sialylated tetraantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000156", "glytoucan_id": [], "term_in_sentence": "A small amount of sialylated tetraantennary oligosaccharide was detected.[PMID:16321355]", "definition": "A tetraantennary glycan with four GlcNAc branches linked to the core and the addition of one sialic acid residues.", "publication": ["PMID:16321355", "PMID:1940447", "PMID:27501865"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Sialyl-Tn antigen", "normalized_term": "sialyl Tn antigen", "retain": "keep", "synonyms": [], "gsd_id": "GSD000157", "glytoucan_id": ["G36123IU"], "term_in_sentence": "The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.[PMID:23035012]", "definition": "N-acetyl-alpha-neuraminyl-(2→6)-N-acetyl-alpha-D-galactosamine is an N-acetyl-alpha-neuraminyl-(2→6)-N-acetyl-D-galactosamine in which the carbon bearing the anomeric hydroxy group has alpha configuration. It has a role as an epitope. It derives from a N-acetyl-alpha-D-galactosamine and a N-acetyl-alpha-neuraminic acid.[CHEBI:61818]", "publication": ["PMID:23035012", "PMID:29273237", "PMID:15770530", "PMID:31595388", "PMID:26617889", "PMID:1720922", "PMID:15466199", "PMID:10971172", "PMID:14652017", "PMID:8616877", "PMID:1543361", "PMID:16965854", "PMID:21566901", "PMID:9269833", "PMID:9834267", "PMID:24970145", "PMID:22367369", "PMID:10778170", "PMID:30018351", "PMID:28628803", "PMID:16149605", "PMID:32134186", "PMID:28632300", "PMID:11308020", "PMID:10365852", "PMID:17195456", "PMID:23567325", "PMID:11014575", "PMID:2342728", "PMID:8575847", "PMID:1851822", "PMID:11735169", "PMID:20960853", "PMID:7846011"], "term_xref": ["GlycoEpitope:EP0022", "CID:51351800", "CHEBI:61818"], "function": [{"src": "GlycoEpitope:EP0022", "content": "apoptosis of monocyte-derived dendritic cells"}, {"src": "GlycoEpitope:EP0022", "content": "decrease of adhesion and increase of migration"}, {"src": "GlycoEpitope:EP0022", "content": "increase of tumor growth"}, {"src": "GlycoEpitope:EP0022", "content": "associated with morphological changes, decreased growth and increased migration of MDA-MB-231 cells."}], "disease_associations": [{"src": "GlycoEpitope:EP0022", "content": "anaplastic meningioma"}, {"src": "GlycoEpitope:EP0022", "content": "Barrett's esophagus"}, {"src": "GlycoEpitope:EP0022", "content": "bladder cancer"}, {"src": "GlycoEpitope:EP0022", "content": "breast cancer"}, {"src": "GlycoEpitope:EP0022", "content": "colon cancer"}, {"src": "GlycoEpitope:EP0022", "content": "colorectal cancer"}, {"src": "GlycoEpitope:EP0022", "content": "erythroblastic leukemia"}, {"src": "GlycoEpitope:EP0022", "content": "esophageal cancer"}, {"src": "GlycoEpitope:EP0022", "content": "gastric cancer"}, {"src": "GlycoEpitope:EP0022", "content": "helicobacter pylori chronic gastritis(HpCG)"}, {"src": "GlycoEpitope:EP0022", "content": "liver cancer"}, {"src": "GlycoEpitope:EP0022", "content": "iterome cancer"}, {"src": "GlycoEpitope:EP0022", "content": "ovary tumor"}, {"src": "GlycoEpitope:EP0022", "content": "pancreas cancer"}]}
{"raw_term": "SSEA-1", "normalized_term": "SSEA-1", "retain": "keep", "synonyms": [], "gsd_id": "GSD000159", "glytoucan_id": ["G85497PI"], "term_in_sentence": "Our findings suggest that expression of SSEA-1 immunoreactivity in thyroid neoplasms was associated with more aggressive thyroid carcinomas.[PMID:27550342]", "definition": "", "publication": ["PMID:27550342", "PMID:25564944", "PMID:30987116", "PMID:10778174", "PMID:19427293", "PMID:24923741", "PMID:28092949", "PMID:16499901", "PMID:10470652", "PMID:18787210", "PMID:2885312", "PMID:16149609", "PMID:17003364", "PMID:27363517", "PMID:15505339", "PMID:27990704", "PMID:2568298", "PMID:20491542", "PMID:23572256", "PMID:1977666", "PMID:9553168", "PMID:20458727", "PMID:2566639", "PMID:14577357", "PMID:20960856", "PMID:15547746", "PMID:9096265", "PMID:30639212", "PMID:1357195", "PMID:1359630", "PMID:20181261", "PMID:20508065", "PMID:2907526", "PMID:22624699", "PMID:22988836", "PMID:17183690", "PMID:27188587", "PMID:7908065", "PMID:10400391", "PMID:6137429", "PMID:1979260", "PMID:2898921", "PMID:14736812", "PMID:30919971"], "term_xref": ["GlycoEpitope:EP0042", "CID:91851144", "CHEBI:154343"], "function": [{"src": "GlycoEpitope:EP0042", "content": "This determinant is specifically recognized by the antibody raised against stage-specific embryonic antigen-1 (SSEA-1)[GlycoEpitope:EP0042]. The SSEA-1 antibody requires Lex hapten carried by i-antigenic structure (e.g.,nor-nLc6Cer)."}], "disease_associations": []}
{"raw_term": "SSEA-3", "normalized_term": "SSEA-3", "retain": "keep", "synonyms": [], "gsd_id": "GSD000160", "glytoucan_id": ["G25129BT"], "term_in_sentence": "Glycosphingolipids (GSLs), such as the globo-series GSLs stage-specific embryonic antigen 3 (SSEA-3), SSEA-4, and Globo-H, are specifically expressed on pluripotent stem cells and cancer cells, and are known to be associated with various biological processes such as cell recognition, cell adhesion, and signal transduction.[PMID:31817926]", "definition": "An amino trisaccharide consisting of β-D-galactopyranose, 2-acetamido-2-deoxy-β-D-galactopyranose and α-D-galactopyranose residues joined in sequence by (1→3) glycosidic linkages.[CHEBI:149071]", "publication": ["PMID:31817926", "PMID:30271856", "PMID:32684574", "PMID:26677875", "PMID:23175153", "PMID:32525407", "PMID:29227830", "PMID:18773292", "PMID:25561682", "PMID:10837462", "PMID:2412924", "PMID:21149348", "PMID:17008424", "PMID:2874662", "PMID:25171543", "PMID:31304790", "PMID:31642560", "PMID:30484221", "PMID:30525067", "PMID:21161592", "PMID:27325407", "PMID:28170296", "PMID:29637816", "PMID:27318475", "PMID:31346146", "PMID:7648586", "PMID:24236059", "PMID:21964054", "PMID:27456773", "PMID:30558911", "PMID:21559451", "PMID:29312455", "PMID:27549315", "PMID:30599359", "PMID:6141938", "PMID:28883415", "PMID:30733757", "PMID:26041528", "PMID:16643871"], "term_xref": ["GlycoEpitope:EP0039", "CID:91855781", "CHEBI:149071", "GlycoMotif:GGM.000079"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0039", "content": "embryonal carcinoma"}, {"src": "GlycoEpitope:EP0039", "content": "teratocarcinoma"}, {"src": "GlycoEpitope:EP0039", "content": "yolk sac carcinoma"}]}
{"raw_term": "SSEA-4", "normalized_term": "SSEA-4", "retain": "keep", "synonyms": [], "gsd_id": "GSD000161", "glytoucan_id": ["G84263XI"], "term_in_sentence": "Glycosphingolipids (GSLs), such as the globo-series GSLs stage-specific embryonic antigen 3 (SSEA-3), SSEA-4, and Globo-H, are specifically expressed on pluripotent stem cells and cancer cells, and are known to be associated with various biological processes such as cell recognition, cell adhesion, and signal transduction.[PMID:31817926]", "definition": "", "publication": ["PMID:27845370", "PMID:31817926", "PMID:26295543", "PMID:25171543", "PMID:25978997", "PMID:30296654", "PMID:25853231", "PMID:24862940", "PMID:31243630", "PMID:28736232", "PMID:22895512", "PMID:24578244", "PMID:29478902", "PMID:23574147", "PMID:23768762", "PMID:27797400", "PMID:29227830", "PMID:18773292", "PMID:25123923", "PMID:22924692", "PMID:22665977", "PMID:23330736", "PMID:31831622", "PMID:31916611", "PMID:2412924", "PMID:16033656", "PMID:24866102", "PMID:20458727", "PMID:21149348", "PMID:26940129", "PMID:17008424", "PMID:2874662", "PMID:23301556", "PMID:27836003", "PMID:19118716", "PMID:24550271", "PMID:32988880", "PMID:22743677", "PMID:20683402", "PMID:17062733", "PMID:23570331", "PMID:30310530", "PMID:31545316", "PMID:23509763", "PMID:24364909", "PMID:18273440", "PMID:28985528", "PMID:22266579"], "term_xref": ["GlycoEpitope:EP0044", "CID:91845478", "CHEBI:154843"], "function": [], "disease_associations": [{"src": "GlycoEpitope:EP0044", "content": "teratocarcinoma"}]}
{"raw_term": "Sulfated LacdiNAc", "normalized_term": "sulfated LacdiNAc", "retain": "keep", "synonyms": ["4'-O-sulfated LacdiNAc", "4'-sulfated LDN", "sulfated LDN"], "gsd_id": "GSD000191", "glytoucan_id": ["G18464VS"], "term_in_sentence": "The mRNA expression of the enzymes related to the formation of sulfated LacdiNAc:β(1,4)-N-acetylgalactosaminyltransferases 3 (B4GALNT3) and 4 (B4GALNT4), carbohydrate sulfotransferases 8 (CHST8) and 9 (CHST9); and β(1,4)-galactosyltransferase 1 (B4GALT1) in these cells was confirmed by RT-PCR (Fig. S4).[PMID:31558607]", "definition": "", "publication": ["PMID:31558607", "PMID:27318476", "PMID:19756298", "PMID:11279168", "PMID:26688390"], "term_xref": ["GlycoMotif:GGM.000049"], "function": [], "disease_associations": []}
{"raw_term": "Sulfatide", "normalized_term": "sulfatide", "retain": "keep", "synonyms": [], "gsd_id": "GSD000162", "glytoucan_id": ["G72548RZ"], "term_in_sentence": "In a previous study we found that sulfatide was efficient in lowering HIV-1 viral loads in SCID mice engrafted with human fetal liver/thymus tissues (SCID-hu).[PMID:23550344]", "definition": "", "publication": ["PMID:23550344", "PMID:18465098", "PMID:26542149", "PMID:15158666", "PMID:10434709", "PMID:22619219", "PMID:29676479", "PMID:30196830", "PMID:16143863", "PMID:1052451", "PMID:30400820", "PMID:29887538", "PMID:26981544", "PMID:17986152", "PMID:31739035", "PMID:19941861", "PMID:24578319", "PMID:30531843", "PMID:25645724", "PMID:31197846", "PMID:22821828", "PMID:27861899", "PMID:31037952", "PMID:23593400", "PMID:23604989", "PMID:17855742", "PMID:25966258", "PMID:25989600", "PMID:9657940", "PMID:29497057", "PMID:12838515", "PMID:25170267", "PMID:9878314", "PMID:20554435", "PMID:1410493", "PMID:26585924", "PMID:17257892", "PMID:17044925", "PMID:21089387", "PMID:11445552", "PMID:22977233", "PMID:21437360", "PMID:17179664", "PMID:6273571", "PMID:8370675"], "term_xref": ["GlycoMotif:GGM.000063"], "function": [], "disease_associations": []}
{"raw_term": "T antigen", "normalized_term": "T antigen", "retain": "keep", "synonyms": ["TF antigen"], "gsd_id": "GSD000163", "glytoucan_id": ["G00031MO"], "term_in_sentence": "Tn, sTn, and T antigen neo- or over-expression occurs in many types of cancer including gastric, colon, breast, lung, esophageal, prostate, and endometrial cancer.[PMID:27679419]", "definition": "An amino disaccharide composed of D-galactose and N-acetyl-α-D-galactosaminyl residues in β-(1→3) linkage.[CHEBI:61820]", "publication": ["PMID:723127", "PMID:19505650", "PMID:31527246", "PMID:28113048", "PMID:25868857", "PMID:26731525", "PMID:22994493", "PMID:3849428", "PMID:25589241", "PMID:12709866", "PMID:26615524", "PMID:26136575", "PMID:19671663", "PMID:18551603", "PMID:11160729", "PMID:22261839", "PMID:30758913", "PMID:25681708", "PMID:29113555", "PMID:24998850", "PMID:1654819", "PMID:28039910", "PMID:29206210", "PMID:32404521", "PMID:10555041", "PMID:26517398", "PMID:2446015", "PMID:2998768", "PMID:3026642", "PMID:18812503", "PMID:6092664", "PMID:2153691", "PMID:8709258", "PMID:3009889", "PMID:15109748", "PMID:12709866", "PMID:31787742", "PMID:27433780", "PMID:26017382", "PMID:24048785", "PMID:26735515", "PMID:9224657", "PMID:26061652", "PMID:29343574", "PMID:25681708", "PMID:23805194", "PMID:26751495", "PMID:22023388", "PMID:15381338", "PMID:8249277", "PMID:3023660", "PMID:25866902"], "term_xref": ["GlycoEpitope:EP0020", "CID:5288347", "CHEBI:61820", "GlycoMotif:GGM.000009"], "function": [{"src": "GlycoEpitope:EP0020", "content": "accumulation Lipoprotein(a) or LDL within arterial walls in atherogenesis"}, {"src": "GlycoEpitope:EP0020", "content": "cancer progression (increase interaction/communication of the cells)"}, {"src": "GlycoEpitope:EP0020", "content": "T antigen expression in RMA lymphoma cells leads to a reduced growth of the tumor"}, {"src": "GlycoEpitope:EP0020", "content": "correlation with elevated Golgi pH in cancer cell (breast, colorectal cancer cells)"}, {"src": "GlycoEpitope:EP0020", "content": "T antigen on apical surfaces of corneal epithelial cells provide protection against rose bengal penetrance."}, {"src": "GlycoEpitope:EP0020", "content": "reduction of a flexibility of the glycosidic bond and thereby favour certain glycan conformation"}, {"src": "GlycoEpitope:EP0020", "content": "T antigen is a target for NK cell-mediated lysis"}, {"src": "GlycoEpitope:EP0020", "content": "inverse relationship between T antigen expression and VWF plasma levels"}], "disease_associations": [{"src": "GlycoEpitope:EP0020", "content": "anaplastic meningioma"}, {"src": "GlycoEpitope:EP0020", "content": "breast cancer"}, {"src": "GlycoEpitope:EP0020", "content": "colorectal cancer"}, {"src": "GlycoEpitope:EP0020", "content": "colon cancer"}, {"src": "unknown", "content": "esophageal cancer"}, {"src": "GlycoEpitope:EP0020", "content": "gastric cancer"}, {"src": "GlycoEpitope:EP0020", "content": "liver cancer"}, {"src": "GlycoEpitope:EP0020", "content": "ovarian cancer"}, {"src": "GlycoEpitope:EP0020", "content": "prostate cancer"}, {"src": "GlycoEpitope:EP0020", "content": "bladder tumor"}, {"src": "GlycoEpitope:EP0020", "content": "invasive pneumococcal infection (hemolytic uremic syndrome, hemolytic anemia)"}]}
{"raw_term": "Tetraantennary", "normalized_term": "tetraantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000164", "glytoucan_id": [], "term_in_sentence": "In contrast, myeloma IgE showed a higher abundance of triantennary and tetraantennary glycan structures and a low abundance of species with a bisecting N-acetylglucosamine.[PMID:24308486]", "definition": "Type of N-linked glycan in which four antennae are present on the trimannosyl core, each initiated by GlcNAc additions catalyzed by position-specific N-acetylglucosaminyltransferases (GlcNAcTs). The four antennae are initiated by addition of 2 GlcNAcs to the _3 Man (at the 2 and 4 positions) and 2 GlcNAcs to the _6 Man (at the 2 and 6 positions) of the trimannosyl core. Each antenna can be extended or capped with HexNAc, deoxyHex, Hex, or sialic acid residues.  [Essentials of Glycobiology:Glossary]", "publication": ["PMID:24308486", "PMID:17951374", "PMID:28880909", "PMID:9177699", "PMID:9760189", "PMID:12322961", "PMID:20129637", "PMID:2492275", "PMID:3402460", "PMID:2361735", "PMID:6525453", "PMID:27730440", "PMID:2551687", "PMID:25365149", "PMID:9751793", "PMID:29875690", "PMID:29479898", "PMID:9134426", "PMID:30943309", "PMID:3546284", "PMID:29888905", "PMID:30624066", "PMID:30537828", "PMID:31110965", "PMID:29311294", "PMID:12852965", "PMID:3015940", "PMID:1907570", "PMID:29137999", "PMID:29359131", "PMID:29858715", "PMID:30295034", "PMID:31829566", "PMID:8381405", "PMID:26929217", "PMID:20662591", "PMID:30612270", "PMID:3089784", "PMID:28186213", "PMID:3427034", "PMID:26763099", "PMID:27354006", "PMID:24991291", "PMID:7496138", "PMID:1940447", "PMID:11114588", "PMID:29031301", "PMID:9448855", "PMID:3979385", "PMID:27722599", "PMID:31126011", "PMID:28002670", "PMID:28991403", "PMID:24032650", "PMID:15316281", "PMID:25154914", "PMID:22490318", "PMID:22430811", "PMID:1463783", "PMID:18803208", "PMID:7881173", "PMID:7697655", "PMID:7240157", "PMID:1768292"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Tetraantennary complex-type", "normalized_term": "tetraantennary complex-type N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000165", "glytoucan_id": [], "term_in_sentence": "A variety of high-mannose structures , as well as bi-, tri-, and tetraantennary complex-type carbohydrate , has been found, in relative amounts of 1-25% of the total oligosaccharides.[PMID:1899031]", "definition": "Type of N-linked glycan in which four antennae are present on the trimannosyl core, each initiated by GlcNAc additions catalyzed by position-specific N-acetylglucosaminyltransferases (GlcNAcTs). The four antennae are initiated by addition of 2 GlcNAcs to the _3 Man (at the 2 and 4 positions) and 2 GlcNAcs to the _6 Man (at the 2 and 6 positions) of the trimannosyl core. Each antenna can be extended or capped with HexNAc, deoxyHex, Hex, or sialic acid residues.  [Essentials of Glycobiology:Glossary]", "publication": ["PMID:1899031", "PMID:8251489", "PMID:8274017", "PMID:1899031", "PMID:6317691", "PMID:23668542", "PMID:6088518", "PMID:21495009", "PMID:1457971", "PMID:1783599", "PMID:10988252", "PMID:11425798", "PMID:7522229", "PMID:2574992", "PMID:3730425", "PMID:10200178", "PMID:2939068", "PMID:21584695", "PMID:7524670", "PMID:7682847", "PMID:2930192", "PMID:1726466", "PMID:9881746", "PMID:11068879", "PMID:6704968", "PMID:2302846", "PMID:24032650", "PMID:15316281", "PMID:11051207", "PMID:10220588", "PMID:2813359", "PMID:2174368", "PMID:21755550", "PMID:3571208", "PMID:1929437", "PMID:3681300", "PMID:6581225", "PMID:3364983", "PMID:2902877", "PMID:2297756", "PMID:1315684", "PMID:6830758", "PMID:1998670"], "term_xref": ["https://www.sigmaaldrich.com/technical-documents/articles/biology/glycobiology/n-glycans.html"], "function": [], "disease_associations": []}
{"raw_term": "Tn antigen", "normalized_term": "Tn antigen", "retain": "keep", "synonyms": [], "gsd_id": "GSD000167", "glytoucan_id": ["G57321FI"], "term_in_sentence": "Furthermore, we confirmed that LS174T cells (Tn-positive) transfected with wild-type Cosmc, thus expressing no Tn antigen, had down-regulation of H-Ras expression and subsequent inhibition of EMT process.[PMID:30637914]", "definition": "Tn anitigen or alpha-galnac or N-Acetylgalactosamine is an N-acetyl-D-galactosamine having alpha-configuration at the anomeric centre. It has a role as an epitope. It derives from an alpha-D-galactosamine.[CHEBI:40356,HMDB0000212]", "publication": ["PMID:27679419", "PMID:31938254", "PMID:30637914", "PMID:24643043", "PMID:31225574", "PMID:21259410", "PMID:31742337", "PMID:28514044", "PMID:33014816", "PMID:28708980", "PMID:27432485", "PMID:33050853", "PMID:26045765", "PMID:27542280", "PMID:24411673", "PMID:27760846", "PMID:30115016", "PMID:1410473", "PMID:29802864", "PMID:29669308", "PMID:29251002", "PMID:32541028", "PMID:31019509", "PMID:1582597", "PMID:2981150", "PMID:10842187", "PMID:29638123", "PMID:22367369", "PMID:10778170", "PMID:1510031", "PMID:19372570", "PMID:20641477", "PMID:16149605", "PMID:15770530", "PMID:27856425", "PMID:23814067", "PMID:28068458", "PMID:32134186", "PMID:8174100", "PMID:10571017", "PMID:27453399", "PMID:1727666", "PMID:23740330"], "term_xref": ["GlycoEpitope:EP0021", "CID:84265", "CHEBI:40356", "GlycoMotif:GGM.000008"], "function": [{"src": "GlycoEpitope:EP0021", "content": "lymphatic metastasis"}, {"src": "GlycoEpitope:EP0021", "content": "tube formation in Drosophila development"}, {"src": "GlycoEpitope:EP0021", "content": "modulation of malignant phenotype (gastric carcinoma cell)"}, {"src": "GlycoEpitope:EP0021", "content": "correlation with tumor stage, lymphatic invasion and lymph node matastasis"}], "disease_associations": [{"src": "GlycoEpitope:EP0021", "content": "breast cancer"}, {"src": "GlycoEpitope:EP0021", "content": "cervical cancer"}, {"src": "GlycoEpitope:EP0021", "content": "colon cancer"}, {"src": "GlycoEpitope:EP0021", "content": "colorectal cancer"}, {"src": "GlycoEpitope:EP0021", "content": "fibrosarcoma"}, {"src": "GlycoEpitope:EP0021", "content": "gastric cancer"}, {"src": "GlycoEpitope:EP0021", "content": "liver cancer"}, {"src": "GlycoEpitope:EP0021", "content": "ovarian cancer"}, {"src": "GlycoEpitope:EP0021", "content": "pancreas cancer"}, {"src": "GlycoEpitope:EP0021", "content": "prostate cancer"}, {"src": "GlycoEpitope:EP0021", "content": "Tn syndorome"}, {"src": "GlycoEpitope:EP0021", "content": "Barrett'sesophagus"}, {"src": "unknown", "content": "Schindler/Kanzaki desease (alpha-N acetylgalactosaminidase deficiency)[GlycoEpitope:EP0021]."}]}
{"raw_term": "Triantennary complex", "normalized_term": "triantennary complex-type N-glycan", "retain": "keep", "synonyms": ["Triantennary complex-type"], "gsd_id": "GSD000169", "glytoucan_id": [], "term_in_sentence": "Fucosylated biantennary complex-type and small amounts (less than 5%) of triantennary complex-type structures were identified on the glycosylated asparagine residues using sequential exoglycosidase and endoglycosidase digestions combined with matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS).[PMID:9118998]", "definition": "A complex N-glycan that has three branches attached to the non-reducing terminal Man residues of the trimannosyl core.[CHEBI:156252]  Each branch is initiated with a GlcNAc and can be exteneded or capped with HexNAc, deoxyHex, Hex, or sialic acid residues.", "publication": ["PMID:9118998", "PMID:9061362", "PMID:18395704", "PMID:3814128", "PMID:7451505", "PMID:10460831", "PMID:26926155", "PMID:26966183", "PMID:16581187", "PMID:16973123", "PMID:8204583", "PMID:29809215", "PMID:11114588", "PMID:31322324", "PMID:15044389", "PMID:16372382", "PMID:8251489", "PMID:8299583", "PMID:1555586", "PMID:7509658", "PMID:1569060", "PMID:16261636"], "term_xref": ["CHEBI:156252"], "function": [], "disease_associations": []}
{"raw_term": "Triantennary N-glycans", "normalized_term": "triantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000170", "glytoucan_id": [], "term_in_sentence": "Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma.[PMID:29399163]", "definition": "Type of N-linked glycan in which three antennae are present on the trimannosyl core, each initiated by GlcNAc additions catalyzed by position-specific N-acetylglucosaminyltransferases (GlcNAcTs). The three antennae can be be initiated by addition of 2 GlcNAcs to the _3 Man (at the 2 and 4 positions) and 1 GlcNAc to the _6 Man (at the 2 position) of the trimannosyl core or 1 on the _3 and 2 on the _6 Man (at the 2 and 6 positions). Each antenna can be extended or capped with HexNAc, deoxyHex, Hex, or sialic acid residues.  [Essentials of Glycobiology:Glossary]", "publication": ["PMID:29399163", "PMID:22325877", "PMID:18439991", "PMID:24873509", "PMID:11454001"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Triantennary trisialylated fucosylated", "normalized_term": "fucosylated trisialylated triantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000172", "glytoucan_id": [], "term_in_sentence": "Diantennary monosialylated glycans and triantennary trisialylated fucosylated and non-fucosylated structures have also been identified.[PMID:17591618]", "definition": "A triantennary glycan with three GlcNAc branches linked to the core and the addition of three sialic acid residues and fucose added.", "publication": ["PMID:17591618"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Trifucosyl Lewis b antigen", "normalized_term": "trifucosyl Lewis b", "retain": "keep", "synonyms": ["trifucosyl-Leb antigen"], "gsd_id": "GSD000173", "glytoucan_id": ["G74578MX"], "term_in_sentence": "Extended type-1 chain glycosphingolipid antigens. Isolation and characterization of trifucosyl-Leb antigen (III4V4VI2Fuc3Lc6)[PMID:1735443]", "definition": "N-[(2R,3R,4R,5S,6R)-4-[(2R,3R,4S,5S,6R)-4-[(2S,3R,4R,5S,6R)-3-Acetamido-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide is an amino sugar.[CHEBI:153783]", "publication": ["PMID:1735443"], "term_xref": ["GlycoEpitope:EP0092", "CID:91845957", "CHEBI:153783"], "function": [{"src": "GlycoEpitope: EP0092", "content": "cancer-associated antigen"}], "disease_associations": [{"src": "GlycoEpitope: EP0092", "content": "colonic cancer"}, {"src": "GlycoEpitope: EP0092", "content": "endometrial cancer"}, {"src": "GlycoEpitope: EP0092", "content": "liver cancer"}, {"src": "GlycoEpitope: EP0092", "content": "pancreatic cancer"}, {"src": "GlycoEpitope: EP0092", "content": "rectal cancer"}]}
{"raw_term": "Trifucosyl lewis y", "normalized_term": "trifucosyl lewis y", "retain": "keep", "synonyms": ["trifucosyl Ley"], "gsd_id": "GSD000174", "glytoucan_id": ["G74917JX"], "term_in_sentence": "The third, major component, common in all eight cases, has been identified as trifucosyl Ley (lactotrifucononaosylceramide, III3FucV3FucVI2FucnLc6, Structure 2 below) based on 1H NMR spectroscopy, methylation analysis, and direct-probe electron-impact mass spectrometry.[PMID:3733752]", "definition": "A branched heptasaccharide derivative consisting of two repeating units of β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc (joined by a (1→3)-linkage) with an α-L-fucosyl residue attached at the 2-position of the galactose residue at the non-reducing end.[CHEBI:61332]", "publication": ["PMID:3733752", "PMID:2426269"], "term_xref": ["GlycoEpitope: EP0094", "CID:50909806", "CHEBI:61332"], "function": [], "disease_associations": [{"src": "GlycoEpitope: EP0094", "content": "colonic adenocarcinomia"}]}
{"raw_term": "Trimannosyl core", "normalized_term": "trimannosyl core", "retain": "keep", "synonyms": [], "gsd_id": "GSD000175", "glytoucan_id": [], "term_in_sentence": "This glycoengineered H. polymorpha strain produced glycoproteins mainly containing trimannosyl core N-glycan (Man(3)GlcNAc(2)), which is the common core backbone of various human-type N-glycans.[PMID:18320567]", "definition": "A glycan that constitutes the core structure common to all high-mannose, complex, or hybrid N-glycans. The trimannosyl core composition is Man3 GlcNAc2 and includes a chitobiose at the reducing terminal which is extended by a single b-linked Man residue. The b-linked Man is branched by two additional a-linked Man residues, one at the 3 position and one at the 6 position.", "publication": ["PMID:18320567", "PMID:27629418", "PMID:26514868", "PMID:26821880", "PMID:2477227", "PMID:6213618", "PMID:31747570", "PMID:29273674", "PMID:31064325", "PMID:1291063", "PMID:28353332", "PMID:1421754", "PMID:29666272", "PMID:11421342", "PMID:15648688", "PMID:28179475", "PMID:28903882", "PMID:27189951", "PMID:9455915", "PMID:22768188", "PMID:9254048", "PMID:8721739", "PMID:2249985", "PMID:22933239", "PMID:25629585", "PMID:24489949", "PMID:2981047", "PMID:11067815", "PMID:1729985", "PMID:1710649", "PMID:16672288", "PMID:2719668", "PMID:19003000", "PMID:23025485", "PMID:22500028", "PMID:10409642", "PMID:1325461", "PMID:23136055", "PMID:23085445", "PMID:21656680", "PMID:22448293", "PMID:22132163", "PMID:1425696", "PMID:20696712", "PMID:18056652", "PMID:15084511", "PMID:18633282", "PMID:15814299"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Trisialylated diantennary", "normalized_term": "trisialylated biantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000178", "glytoucan_id": [], "term_in_sentence": "Determination of glycan primary structures and characterization of a new type of trisialylated diantennary glycan.[PMID:1997323]", "definition": "A diantennary/biantennary glycans with three sialic acid components.", "publication": ["PMID:1997323"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "Trisialylated triantennary", "normalized_term": "trisialylated triantennary N-glycan", "retain": "keep", "synonyms": [], "gsd_id": "GSD000179", "glytoucan_id": [], "term_in_sentence": "The N-glycans are of the complex type with the core-fucosylated disialylated biantennary and trisialylated triantennary structures predominating.[PMID:8942648]", "definition": "A triantennry glycan with three sialic acid components.", "publication": ["PMID:30194503", "PMID:27501865", "PMID:10998266", "PMID:20578731", "PMID:17591618", "PMID:14751029", "PMID:18818422", "PMID:8942648", "PMID:8900952"], "term_xref": [], "function": [], "disease_associations": []}
{"raw_term": "VIM-2", "normalized_term": "VIM-2", "retain": "keep", "synonyms": [], "gsd_id": "GSD000180", "glytoucan_id": ["G22418PV"], "term_in_sentence": "Anti-SSEA-1 which binds to glycoconjugates with a Gal beta 1-4(fuc alpha 1-3)GlcNAc epitope and VIM-2 which binds to gangliosides with a NeuAc alpha 2-3GlcNAc beta-4(FUC alpha 1-3) GlcNAc beta 1-3Gal-epitope were used to determine the expression of their corresponding carbohydrate antigens in human leukocytes and leukemia cells.[PMID:1690317]", "definition": "α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-[α-L-Fucp-(1→3)]-D-GlcpNAc in which the anomeric configuration of the N-acetyl-D-glucosamine residue at the reducing end is β.[CHEBI:85946]", "publication": ["PMID:27834790", "PMID:31523406", "PMID:29978304", "PMID:29575185", "PMID:27326514", "PMID:29029114", "PMID:32450200", "PMID:29432937", "PMID:31906402", "PMID:28739428", "PMID:29298123", "PMID:30976429", "PMID:29091730", "PMID:27770796", "PMID:31330771", "PMID:31138570", "PMID:27154587", "PMID:31542553", "PMID:30519059", "PMID:30590504", "PMID:25880997", "PMID:27490501", "PMID:29981456", "PMID:28559273", "PMID:28193652", "PMID:26638216", "PMID:25897818", "PMID:26238337", "PMID:19553129", "PMID:29644540", "PMID:26242685", "PMID:28487556", "PMID:32622213", "PMID:30248413", "PMID:24762211", "PMID:11451678", "PMID:33169865", "PMID:11897589", "PMID:31479607"], "term_xref": ["GlycoEpitope:EP0019", "CID:91825708", "CHEBI:85946", "GlycoMotif:GGM.000033"], "function": [{"src": "GlycoEpitope:EP0019", "content": "CDw65 have been shown to interact with the ELAM-1 molecule on activated endothelium."}], "disease_associations": [{"src": "GlycoEpitope:EP0019", "content": "chronic myelogenous leukemia."}]}
